Sentence,class,file
https://www.clinicaltrials.gov/ct2/show/NCT02228590.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://www.clinicaltrials.gov/ct2/show/ NCT00809302.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"https://www.clinicaltrials.gov/ct2/show/ NCT01693081  [80] Jafarieh, O.; Md, S.; Ali, M.; Baboota, S.; Sahni, J.K.; Kumari, B.; Bhatnagar, A.; Ali, J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Behav., 2014, 124, 204-210. http://dx.doi.org/10.1016/ j.pbb.2014.06.011 [82] Betz, A.J.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Psychopharmacology (Berl)., 2007, 194(3), 347-359. http://dx.doi.org/10.1007/s00213-007-0844-6 [83] Koller, W.C. Pharmacologic treatment of parkinsonian tremor.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Arch Neurol., 1986, 43(2), 1 2 6-127. http://dx.doi.org/10.1001/ archneur.1986.00520020020009 [84] Wawruch, M.; Macugova, A.; Kostkova, L.; Luha, J.; Dukat, A.; Murin, J.; Drobna, V.; Wilton, L .",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Drug Saf., 2012, 21(2), 170-176. http://dx.doi.org/10.1002/pds.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Assoc., 2014, 15(11), 825-829. http://dx.doi.org/10.1016/j.jamda.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"JAMA Neurol., 2014, 71(7), 884. http://dx.doi.org/10.1001/jamaneurol.2014.753 [87] Sakakibara, R. Cognitive Adverse Effects of Anticholinergic Medication for Overactive Bladder in PD/DLB.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Rinsho Shinkeigaku., 2013, 53(11), 1389-1392. http://dx.doi.org/10.5692/ clinicalneurol.53.1389 [88] Hubsher, G.; Haider, M.; Okun, M.S.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2012, 78(14), 1096-1099. http://dx.doi.org/10.1212/WNL.0b013e31824 e8f0d [89] Lee, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2013, 260(12), 3030-3038. http://dx.doi.org/10.1007/s00415-013-7108-7 [90] Pereira Da Silva-Júnior, F.; Braga-Neto, P.; Sueli Monte, F.; Meireles Sales De Bruin, V. Amantadine Reduces the Duration of Levodopa-Induced Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2005, 11(7), 449-452. http://dx.doi.org/10.1016/j.parkreldis.2005.05.008 [91] Sawada, H.; Oeda, T.; Kuno, S.; Nomoto, M.; Yamamoto, K.; Yamamoto, M.; Hisanaga, K.; Kawamura, T. Amantadine for Dyskinesias in Parkinson’s Disease: A Randomized Controlled Trial.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1371/ journal.pone.0015298 [92] Raz, A.; Lev, N.; Orbach-Zinger, S.; Djaldetti, R. Safety of Perioperative Treatment With Intravenous Amantadine in Patients With Parkinson Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuropharmacol., 2013, 36(5), 166-169. http://dx.doi.org/10.1097/WNF.0b013e31829bd066 [93] Chan, H.F.; Kukkle, P.L.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2013, 19(3), 316-319. http://dx.doi.org/10.1016/j.parkreldis.2012.11.005 [94] Cera, N.; Bifolchetti, S.; Martinotti, G.; Gambi, F.; Sepede, G.; Thomas, A.; Di Giannantonio, M.; Onofrj, M. Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Treat., 2014, 10, 1093-1101. http://dx.doi.org/ 10.2147/NDT.S54423 [95] Ory Magne, F.; Corvol, J. C.; Azulay, J.P.; Bonnet, A.M.; Brefel Courbon, C.; Damier, P.; Dellapina, E.; Destee, A.; Durif, F.; Galitzky, M.; Lebouvier, T.; Meissner, W.; Thalamas, C.; Tison, F.; Salis, A.; Sommet, A.; Viallet, F.; Vidailhet, M.; Rascol, O.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2014, 82(4), 300-307. http://dx.doi.org/10.1212/WNL.0000000000000050 [96] Thomas, A.; Iacono, D.; Luciano, A.L.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuropharmacol., 2014, 37(2), 41-44. http://dx.doi.org/10.1097/WNF.0000000000000016",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Rural Pract., 2015, 6 (1), 65. http://dx.doi.org/10.4103/0976-3147.143197 [100] Williams-Gray, C.H.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Psychiatry, 2013, 84(11), 1258-1264. http://dx.doi.org/10.1136/jnnp-2013-305277 [101] Perez, F.; Helmer, C.; Foubert-Samier, A.; Auriacombe, S.; Dartigues, J.F.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"J., 2015, 91 ( 1 0 7 4 ) ,  2 1 2-220. http://dx.doi.org/ 10.1136/postgradmedj-2015-133247 [103] Sadowsky, C.H.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Care Companion CNS Disord., 2014, 16(5), http://dx.doi.org/10.4088/pcc.14r01654 [104] Mori, E.; Ikeda, M.; Nagai, R .",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2013, 36(3-4), 229-241. http://dx.doi.org/10.1159/000351672 [106] Wang, H.F.; Yu, J.T.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Psychiatry., 2015, 86(2), 135-143. http://dx.doi.org/10.1136/jnnp-2014-307659 [107] Schrempf, W.; Brandt, M. D.; Storch, A.; Reichmann, H. Sleep Disorders in Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2012, 71(1), 49-56. http://dx.doi.org/10.1002/ana.22655 [109] Litvinenko, I.V.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2011, 26(1), 90-99. http://dx.doi.org/10.1002/mds.23441 [111] Eggert, K.; Öhlwein, C.; Kassubek, J.; Wolz, M.; Kupsch, A.; Ceballos-Baumann, A.; Ehret, R.; Polzer, U.; Klostermann, F.; Schwarz, J.; Fuchs, G.; Jost, W.; Albert, A.; Haag, A.; Hermsen, A.; Lohmüller, K.; Kuhn, K.; Wangemann, M.; Oertel, W. H. Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepines http://dx.doi.org/10.1097/WNF.0000000000000041s (PiViCog-PD).",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2013, 19(7), 670-675. http://dx.doi.org/10.1016/j.parkreldis.2013.03.003 [115] Di Giacopo, R.; Fasano, A.; Quaranta, D.; Marca, G. Della; Bove, F.; Bentivoglio, A.R.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2012, 27(4), 559-561. http://dx.doi.org/10.1002/mds.24909 [116] Ricciardi, L.; De Nigris, F.; Specchia, A.; Fasano, A. Homotaurine in Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Sci., 2015, 36(9), 1581-1587. http://dx.doi.org/10.1007/s10072-015-2201-6 [117] Troeung, L.; Egan, S.J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1371/journal.pone.0079510 [118] Liu, J.; Dong, J.; Wang, L.; Su, Y.; Yan, P.; Sun, S. Comparative Efficacy and Acceptability of Antidepressants in Parkinson’s Disease: A Network Meta-Analysis.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1371/journal.pone.0076651 [119] Smith, K. M.; Eyal, E.; Weintraub, D. Combined Rasagiline  and Antidepressant Use in Parkinson Disease in the ADAGIO Study.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"JAMA Neurol., 2015, 72 (1), 88. http://dx.doi.org/10.1001/ jamaneurol.2014.2472 [120] Fernie, B.A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Res., 2015, 78(5), 411-419. http://dx.doi.org/10.1016/j.jpsychores.2015.02.012 [121] Schapira, A.H.V; Olanow, C.W.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"[122] Filograna, R.; Beltramini, M.; http://dx.doi.org/10.1016/S0140-6736(14)61010-2 Bubacco, L.; Bisaglia, M. Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurodegener., 2015, 10(1), 4. http://dx.doi.org/10.1186/ 1750-1326-10-4 [124] Holmay, M.J.; Terpstra, M.; Coles, L.D.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuropharmacol., 2013, 36(4), 103-106. http://dx.doi.org/10.1097/ WNF.0b013e31829ae713 [125] N-Acetylcysteine for Neuroprotection in Parkinson's Disease (NAC for PD).",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://www.clinicaltrials.gov/ct2/show/NCT01470027.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://www.clinicaltrials.gov/ct2/ show/NCT00461942.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://clinicaltrials.gov/ct2/show/ NCT00873392.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://clinicaltrials.gov/ct2/show/NCT01560754.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2009, 24(7), 979-983. http://dx.doi.org/10.1002/mds.22401 [130] Intranasal Glutathione In Parkinson's Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Redox Signal., 2014, 21(2), 195-210. http://dx.doi.org/10.1089/ars.2013.5593 [133] Parkinson Study Group.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2013, 28(13), 1823-1831. http://dx.doi.org/10.1002/mds.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Arch Neurol., 2007, 64(7), 938-944. http://dx.doi.org/10.1001/ archneur.64.7.nct60005 [136] Jang, W.; Park, J.; Shin, K.J.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Sci., 2014, 337(1-2), 47-54. http://dx.doi.org/10.1016/j.jns.2013.11.015 [137] Pedroso, I.; Bringas, M.L.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology., 2006, 66(5), 664-671. http://dx.doi.org/10.1212/01.wnl.0000201252.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuropharmacol., 2008, 31(3), 141-150. http://dx.doi.org/10.1097/WNF.0b013e3181342f32 [140] Foltynie, T.; Aviles-Olmos, I. Exenatide as a Potential Treatment for Patients with Parkinson’s Disease: First Steps into the Clinic.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://clinicaltrials.gov/ct2/show/NCT01971242.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2009, 361(13), 1268-1278. http://dx.doi.org/10.1056/NEJMoa0809335 [144] Rascol, O.; Fitzer-Attas, C.J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2011, 10(5), 415-423. http://dx.doi.org/ 10.1016/S1474-4422(11)70073-4 [145] Whone, A.L.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2003, 54(1), 93-101. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"JAMA, 2002, 287(13), 1653-61. http://dx.doi.org/ 10.1001/jama.287.13.1653 [147] Schapira, A.H.; McDermott, M.P.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2013, 12(8), 747-755. http://dx.doi.org/10.1016/ S1474-4422(13)70117-0 [148] Kansara, S.; Trivedi, A.; Chen, S.; Jankovic, J.; Le, W. Early Diagnosis and Therapy of Parkinson’s Disease: Can Disease Progression Be Curbed?",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"J. Neural Transm., 2013, 120(1), 197-210. http://dx.doi.org/10.1007/s00702-012-0840-9 [149] Beal, M.F.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"J. Neural Transm., 2013, 120(1), 83-89. http://dx.doi.org/10.1007/s00702-012-0876-x [152] Zhu, W.; Xie, W.; Pan, T.; Jankovic, J.; Li, J.; Youdim, M.B.H.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurochem., 2008, 105(5), 1970-1978. http://dx.doi.org/10.1111/j.1471-4159.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Res., 2010, 35 (10), 1546-1556. http://dx.doi.org/10.1007/s11064-010-0214-3 [154] Parvez, S.; Winkler-Stuck, K.; Hertel, S.; Schönfeld, P.; Siemen, D. The Dopamine-D2-Receptor Agonist Ropinirole Dose-Dependently Blocks the Ca2+-Triggered Permeability Transition of Mitochondria.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2015, 21 (5), 500-503. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Genes Nutr., 2009, 4 ( 4 ) ,  2 8 3-296. http://dx.doi.org/10.1007/s12263-009-0143-4 [157] Barreto, G.E.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Commun., 2009, 30(7), 513-518. http://dx.doi.org/10.1097/MNM.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Brain., 2012, 135(6), 1914-1925. http://dx.doi.org/10.1093/brain/ aws054 [160] Heinzelman, P.; Priebe, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Prog., 2015, 31(3), 668-677. http://dx.doi.org/10.1002/btpr.2071 [161] Le, W. Role of Iron in UPS Impairment Model of Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1016/S1353-8020(13)70038-5 [162] Bar-Am, O.; Amit, T.; Kupershmidt, L.; Aluf, Y.; Mechlovich, D.; Kabha, H.; Danovitch, L.; Zurawski, V.R.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Aging., 2015, 36(3), 1529-1542. http://dx.doi.org/10.1016/j.neurobiolaging.2014.10.026",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuroscientist., 2015. http://dx.doi.org/10.1177/1073858415581986 [165] Rizzone, M.G.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2014, 20(4), 376-381. http://dx.doi.org/10.1016/j.parkreldis.2014.01.012 [166] Weaver, F.M.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2012, 79(1), 55-65. http://dx.doi.org/10.1212/WNL.0b013e31825dcdc1 [167] Odekerken, V.J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2013, 12(1), 37-44. http://dx.doi.org/10.1016/S1474-4422(12)70264-8 [168] Xie, T.; Vigil, J.; MacCracken, E.; Gasparaitis, A.; Young, J.; Kang, W.; Bernard, J.; Warnke, P.; Kang, U.J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology., 2015, 84(4), 415-420. http://dx.doi.org/10.1212/WNL.0000000000001184 [169] Khoo, H.M.; Kishima, H.; Hosomi, K.; Maruo, T.; Tani, N.; Oshino, S.; Shimokawa, T.; Yokoe, M.; Mochizuki, H.; Saitoh, Y.; Yoshimine, T. Low-Frequency Subthalamic Nucleus Stimulation in Parkinson’s Disease: A Randomized Clinical Trial.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2014, 1-5. http://dx.doi.org/10.1002/mds.25810 [170] Contarino, M.F.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2014, 83(13), 1163-1169. http://dx.doi.org/10.1212/ WNL.0000000000000823 [171] Merola, A.; Zibetti, M.; Angrisano, S.; Rizzi, L.; Ricchi, V.; Artusi, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Brain, 2011, 134(7), 2074-2084. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2012, 68(6), 361-366. http://dx.doi.org/10.1159/000341380 [174] Wallace, B.A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Brain, 2007, 130(8), 2129-2145. http://dx.doi.org/10.1093/brain/awm137 [175] Spieles-Engemann, A.L.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2011, 10(4), 309-319. http://dx.doi.org/10.1016/S1474-4422(11) 70039-4 [178] Bartus, R.T.; Baumann, T.L.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2013, 80(18), 1698-1701. http://dx.doi.org/10.1212/WNL.0b013e3182904faa [179] Mittermeyer, G.; Christine, C.W.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Gene Ther., 2012, 23(4), 377-381. http://dx.doi.org/10.1089/hum.2011.220 [180] Marks, W.J.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Lancet Neurol., 2010, 9(12), 1164-1172. http://dx.doi.org/10.1016/S1474-4422(10)70254-4 [181] Lewis, T.; Glasgow, J.; Harms, A.; Standaert, D.; Curiel, D. Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Res., 2013, 30(10), 2549-2559. http://dx.doi.org/10.1007/s11095-013-1005-8 [183] Venkataramana, N.K.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Res., 2010, 155 (2), 62-70. http://dx.doi.org/10.1016/j.trsl.2009.07.006 [184] Gonzalez, C.; Bonilla, S.; Flores, A.I.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Curr Stem Cell Res Ther., 2015, [Epub ahead of print] http://dx.doi.org/ 10.3727/096368914X678274 [185] Acquarone, M.; de Melo, T.M.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Cell Transplant., 2014, 23(4), 435-439. http://dx.doi.org/10.3727/096368914X678274 [187] Gonzalez, R.; Garitaonandia, I.; Crain, A.; Poustovoitov, M.; Abramihina, T.; Noskov, A.; Jiang, C.; Morey, R.; Laurent, L.C.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Cell Transplant., 2015, 24(4), 681-690. http://dx.doi.org/10.3727/096368915X687769 [188] Han, F.; Wang, W.; Chen, B.; Chen, C.; Li, S.; Lu, X.; Duan, J.; Zhang, Y.; Zhang, Y.A.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Cytotherapy., 2015, 17(5), 665-679. http://dx.doi.org/ 10.1016/j.jcyt.2015.02.001",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Cell Rep., 2014, 7(6), 1755-1761. http://dx.doi.org/10.1016/j.celrep.2014.05.027 [190] Zigmond, M.J.; Smeyne, R.J.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology., 2014, 83(5), 413-425. http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurology, 2015, 84(3), 304-312. http://dx.doi.org/10.1212/ WNL.0000000000001155 [194] Cruickshank, T.M.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
http://dx.doi.org/10.1097/MD.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Sci., 2015, 353(1-2), 9-19. http://dx.doi.org/10.1016/j.jns.2015.04.004 [196] Li, F.; Harmer, P.; Fitzgerald, K.; Eckstrom, E.; Stock, R.; Galver, J.; Maddalozzo, G.; Batya, S.S. Tai Chi and Postural Stability in Patients with Parkinson’s Disease.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2012, 366(6), 511-519. http://dx.doi.org/10.1056/NEJMoa1107911 [197] Tsang, W.W.N.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1016/S1836-9553(13)70148-6 [198] Yang, Y.; Li, X.Y.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1371/journal.pone.0102942 [199] Schmitz-Hübsch, T.; Pyfer, D.; Kielwein, K.; Fimmers, R.; Klockgether, T.; Wüllner, U. Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2006, 21(4), 543-548. http://dx.doi.org/10.1002/mds.20705 [200] Burini, D.; Farabollini, B.; Iacucci, S.; Rimatori, C.; Riccardi, G.; Capecci, M.; Provinciali, L.; Ceravolo, M.G.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Rev., 2014, 47, 445-456. http://dx.doi.org/ 10.1016/j.neubiorev.2014.09.009 [204] Hackney, M.E.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Ther., 2007, 31(4), 173-179. http://dx.doi.org/10.1097/NPT.0b013e31815ce78b [205] Donoyama, N.; Ohkoshi, N. Effects of Traditional Japanese Massage Therapy on Various Symptoms in Patients with Parkinson’s Disease: A Case-Series Study.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pract., 2014, 20(4), 251-261. http://dx.doi.org/10.1016/j.ctcp.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2012, 18(8), 948-952. http://dx.doi.org/10.1016/j.parkreldis.2012.04.030 [208] Chae, Y.; Lee, H.; Kim, H.; Kim, C.H.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2009, 24(12), 1794-1802. http://dx.doi.org/10.1002/mds.22673 [209] Doi, H.; Sakakibara, R.; Sato, M.; Hirai, S.; Masaka, T.; Kishi, M.; Tsuyusaki, Y.; Tateno, A.; Tateno, F.; Takahashi, O.; Ogata, T. Dietary Herb Extract Rikkunshi-To Ameliorates Gastroparesis in Parkinson’s Disease: A Pilot Study.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2014, 71(3-4), 193-195. http://dx.doi.org/10.1159/000355608 [210] Hatano, T.; Hattori, N.; Kawanabe, T.; Terayama, Y.; Suzuki, N.; Iwasaki, Y.; Fujioka, T. An Exploratory Study of the Efficacy and Safety of Yokukansan for Neuropsychiatric Symptoms in Patients with Parkinson’s Disease.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"J. Neural Transm., 2014, 121(3), 275-281. http://dx.doi.org/10.1007/s00702-013-1105-y [211] Li, M.; Liu, Y.; Feng, Y.; Wang, H.M.; Ren, F. Effect of Bushen Huoxue Herbs on Depression of Patients with Parkinson’s Disease.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Zhong Xi Yi Jie He Xue Bao., 2010, 8(3), 231-237. http://dx.doi.org/10.3736/jcim20100306 [213] Zhang, J.; Ma, Y.; Shen, X.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2013, 11(4), 285-290. http://dx.doi.org/10.3736/jintegrmed2013035 [214] Melrose, H.L.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"2015, 97, 16-26. http://dx.doi.org/10.1016/j.phrs.2015.03.010 [216] Guan, Q.; Liu, X.; He, Y.; Jin, L.; Zhao, L. Effect of Cdk5 Antagonist on L-Dopa-Induced Dyskinesias in a Rat Model of Parkinson’s Disease.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurosci., 2010, 120(6), 421-427. http://dx.doi.org/10.3109/00207451003797694 [217] Cho, E.G.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"http://dx.doi.org/10.1371/journal.pone.0024027 [218] Johnson, D.A.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Med., 2015, 88, 253-267. http://dx.doi.org/10.1016/j.freeradbiomed.2015.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2013, 9(11), 629-636. http://dx.doi.org/10.1038/ nrneurol.2013.209 [220] Lawand, N. B.; Saadé, N. E.; El-Agnaf, O. M.; Safieh-Garabedian, B.; Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Pat., 2014, 24(7), 745-757. http://dx.doi.org/10.1517/ 13543776.2014.907275 [222] LRRK2 and Other Novel Exosome Proteins in Parkinson’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
https://www.clinicaltrials.gov/ct2/show/NCT01860118.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurosci., 2013, 4 ( 2 ) ,  3 5 0-360. http://dx.doi.org/10.1021/ cn300182g [225] Wang, W.; Yang, Y.; Ying, C.; Li, W.; Ruan, H.; Zhu, X.; You, Y.; Han, Y.; Chen, R.; Wang, Y.; Li, M. Inhibition of Glycogen Synthase K i nase-3β Protects Dopaminergic Neurons from MPTP Toxicity.",OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neuropharmacology,2007, 52, 1678-1684. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Disord., 2014, 29(4), 470-478. http://dx.doi.org/10.1002/ mds.25824 [227] Reinhart, F.; Massri, N. El; Darlot, F.; Torres, N.; Johnstone, D. M.; Chabrol, C.; Costecalde, T.; Stone, J.; Mitrofanis, J.; Benabid, A.L.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Res., 2015, 92, 86-90. http://dx.doi.org/10.1016/j.neures.2014.11.005 [228] Johnstone, D. M.; el Massri, N.; Moro, C.; Spana, S.; Wang, X. S.; Torres, N.; Chabrol, C.; De Jaeger, X.; Reinhart, F.; Purushothuman, S.; Benabid, A.-L.; Stone, J.; Mitrofanis, J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a8/CN-14-339.PMC4876590.pdf
"Neurol., 2013, 20(1), 5-15. http://dx.doi.org/10.1111/j.1468-1331.2012.03866.x [2] Kostic, V.; Przedborski, S.; Flaster, E.; Sternic, N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 1991, 41(2 (Pt 1)), 202-205. http://dx.doi.org/10.1212/WNL.41.2_Part_1.202 [3] Olanow, C.W.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2004, 19(9), 997-1005. http://dx.doi.org/10.1002/mds.20243 [4] Olanow, C.W.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"http://dx.doi.org/10.1212/WNL.0b013e318199068b [5] Kurlan, R. “Levodopa phobia”: a new iatrogenic cause of disability in Parkinson disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2008, 71(7), 470-471. http://dx.doi.org/10.1212/01.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Lancet, 2014, 384(9949), 1164-1166. http://dx.doi.org/10.1016/S0140-6736(14)60962-4 [10] Parkinson Study, G. A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2002, 59(12), 1937-1943. http://dx.doi.org/10.1001/archneur.59.12.1937 [11] Parkinson Study, G. A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2004, 61(4), 561-566. http://dx.doi.org/10.1001/archneur.61.4.561 [12] Olanow, C.W.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Med., 2009, 361(13), 1268-1278. http://dx.doi.org/10.1056/NEJMoa0809335 [13] Mena, M.A.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neuroreport, 1993, 4(4), 438-440. http://dx.doi.org/ 10.1097/00001756-199304000-00025 [14] Michel, P.P.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Res., 1990, 26(4), 428-435. http://dx.doi.org/10.1002/jnr.490260405 [15] Mytilineou, C.; Han, S.K.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurochem.,  1993, 61(4), 1470-1478. http://dx.doi.org/10.1111/j.1471-4159.1993.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Brain Res., 1995, 682(1-2), 133-143. http://dx.doi.org/10.1016/0006-8993(95)00341-M [17] Steece-Collier, K.; Collier, T.J.; Sladek, C.D.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 1990, 110(2), 201-208. http://dx.doi.org/10.1016/0014-4886(90)90031-M [18] Olanow, C.W.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 1991, 29(5), 556-559. http://dx.doi.org/10.1002/ana.410290516 [19] Desagher, S.; Glowinski, J.; Premont, J. Astrocytes protect neurons from hydrogen peroxide toxicity.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Lett., 1995, 192(1), 13-16. http://dx.doi.org/10.1016/ 0304-3940(95)11596-O [21] Mena, M.A.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"J. Neural Transm., 1997, 104(4-5), 317-328. http://dx.doi.org/10.1007/ BF01277654 [22] Murer, M.G.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 1998, 43(5), 561-575. http://dx.doi.org/10.1002/ana.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurochem., 1984, 43(4), 990-993. http://dx.doi.org/ 10.1111/j.1471-4159.1984.tb12834.x [24] Reches, A.; Fahn, S.; Bhawan, J.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 1982, 32(6), 684-685. http://dx.doi.org/10.1212/ WNL.32.6.684 [25] Lyras, L.; Zeng, B.Y.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"J. Neural Transm., 2002, 109(1), 53-67. http://dx.doi.org/10.1007/s702-002-8236-2 [26] Pearce, R.K.; Heikkila, M.; Linden, I.B.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Psychopharmacology (Berl), 2001, 156(4), 402-409. http://dx.doi.org/10.1007/s002130100733 [27] Quinn, N.; Parkes, D.; Janota, I.; Marsden, C.D.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 1986, 1(1), 65-68. http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 1997, 12(5), 634-638. http://dx.doi.org/10.1002/mds.870120503 [29] Fahn, S.; Oakes, D.; Shoulson, I.; Kieburtz, K.; Rudolph, A.; Lang, A.; Olanow, C.W.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Med., 2004, 351(24), 2498-2508. http://dx.doi.org/10.1056/ NEJMoa033447 [30] Olanow, C.W.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"http://dx.doi.org/10.1002/ana.410440725 [31] Schapira, A.H. Dopamine agonists and neuroprotection in Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2002, 9 Suppl 3, 7-14. http://dx.doi.org/10.1046/j.1468-1331.9.s3.9.x [32] Iravani, M.M.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurochem., 2006, 96(5), 1315-1321. http://dx.doi.org/ 10.1111/j.1471-4159.2005.03625.x [33] Gu, M.; Iravani, M.M.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurochem., 2004, 91(5), 1075-1081. http://dx.doi.org/10.1111/j.1471-4159.2004.02804.x [34] Schapira, A.H. Neuroprotection in PD--a role for dopamine agonists?",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"JAMA, 2000, 284(15), 1931-1938. http://dx.doi.org/ 10.1001/jama.284.15.1931 [36] Whone, A.L.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2003, 54(1), 93-101. http://dx.doi.org/10.1002/ana.10609 [37] Parkinson Study, G. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"JAMA, 2002, 287(13), 1653-1661. http://dx.doi.org/ 10.1001/jama.287.13.1653 [38] Jennings, D., Tabamo, R., Seibyl, J.P., Marek, K. INSPECT: investigating the effect of short-term treatment with pramipexole or levodopa on 123IB-CIT-SPECT imaging.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Med., 2000, 342(20), 1484-1491. http://dx.doi.org/10.1056/NEJM200005183422004 [40] Oertel, W.H.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2006, 21(3), 343-353. http://dx.doi.org/10.1002/mds.20724 [41] AlDakheel, A.; Kalia, L.V.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurotherapeutics, 2014, 11(1), 6-23. http://dx.doi.org/10.1007/s13311-013-0218-1 [42] Datla, K.P.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Nutr., 2007, 26(4), 341-349. http://dx.doi.org/10.1080/07315724.2007.10719621 [43] Mandel, S.; Maor, G.; Youdim, M.B.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurosci., 2004, 24(3), 401-416. http://dx.doi.org/10.1385/JMN:24:3:401 [44] Nie, G.; Cao, Y.; Zhao, B.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Redox Rep., 2002, 7(3), 171-177. http://dx.doi.org/ 10.1179/135100002125000424 [45] Yang, S.F.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Sin., 2005, 26(1), 56-62. http://dx.doi.org/10.1111/j.1745-7254.2005.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Pharmacol., 2003, 473(1), 1-7. http://dx.doi.org/10.1016/S0014-2999(03)01945-9 [49] Van Kampen, J.; Robertson, H.; Hagg, T.; Drobitch, R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2003, 184(1), 521-529. http://dx.doi.org/10.1016/j.expneurol.2003.08.002 [50] Tan, L.; Methawasin., K. Complementary and Alternative Medicine in Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"JAMA, 2014, 311(16), 1670-1683. http://dx.doi.org/10.1001/jama.2014.3654 [52] Reardon, K.A.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 1999, 14(4), 605-611. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2009, 72(24), 2137; author reply 2137-2138. http://dx.doi.org/ 10.1212/01.wnl.0000349695.96741.88 [54] Hely, M.A.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Psychiatry, 1989, 52(3), 324-328. http://dx.doi.org/ 10.1136/jnnp.52.3.324 [55] Bracco, F.; Battaglia, A.; Chouza, C.; Dupont, E.; Gershanik, O.; Marti Masso, J.F.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"CNS Drugs, 2004, 18(11), 733-746. http://dx.doi.org/10.2165/ 00023210-200418110-00003 [56] Rinne, U.K.; Bracco, F.; Chouza, C.; Dupont, E.; Gershanik, O.; Marti Masso, J.F.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Drugs, 1998, 55 Suppl 1, 23-30. http://dx.doi.org/10.2165/00003495-199855001-00004 [57] Miyasaki, J.M.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"http://dx.doi.org/10.1007/s00415-010-5718-x [58] Parkinson Study Group, C.C.I.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2009, 66(5), 563-570. http://dx.doi.org/10.1001/archneurol.2009.32 [59] Miyasaki, J.M.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2002, 58(1), 11-17. http://dx.doi.org/10.1212/WNL.58.1.11 [60] Katzenschlager, R.; Head, J.; Schrag, A.; Ben-Shlomo, Y.; Evans, A.; Lees, A.J.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2008, 71(7), 474-480. http://dx.doi.org/10.1212/01.wnl.0000310812.43352.66 [61] Comparisons o f  t h e r a p e u t i c  e f f e c t s  o f  l e v o d o p a ,  l e v o d o p a  a n d  selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2005, 20(2), 190-199. http://dx.doi.org/10.1002/mds.20324 [63] Group, P.D.M.C.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Lancet, 2014, 384(9949), 1196-1205. http://dx.doi.org/10.1016/S0140-6736(14)60683-8 [64] Stocchi, F.; Rascol, O.; Kieburtz, K.; Poewe, W.; Jankovic, J.; Tolosa, E.; Barone, P.; Lang, A.E.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2010, 68(1), 18-27. http://dx.doi.org/10.1002/ana.22060 [65] Warren, O., C.; Kieburtz, K.; Rascol, O.; Poewe, W.; Schapira, A.H.; Emre, M.; Nissinen, H.; Leinonen, M.; Stocchi, F. Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease, I.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2013, 28(8), 1064-1071. http://dx.doi.org/10.1002/mds.25364 [66] Rajput, A.H. Factors predictive of the development of levodopa-induced dyskinesia and Wearing-Off in Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2014, 29(3), 429. http://dx.doi.org/10.1002/mds.25800 [67] Stowe, R.L.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
http://dx.doi.org/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Drugs Aging, 2010, 27(4), 295-310. http://dx.doi.org/10.2165/11318330-000000000-00000 [70] Pontone, G.; Williams, J.R.; Bassett, S.S.; Marsh, L. Clinical features associated with impulse control disorders in Parkinson disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2006, 67(7), 1258-1261. http://dx.doi.org/ 10.1212/01.wnl.0000238401.76928.45 [71] Weintraub, D.; Koester, J.; Potenza, M.N.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2010, 67(5), 589-595. http://dx.doi.org/10.1001/archneurol.2010.65 [72] Driver-Dunckley, E.; Samanta, J.; Stacy, M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2003, 61(3), 422-423. http://dx.doi.org/10.1212/ 01.WNL.0000076478.45005.EC [73] Weintraub, D.; Siderowf, A.D.; Potenza, M.N.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2006, 66(11), 1750-1752. http://dx.doi.org/ 10.1212/01.wnl.0000218206.20920.4d [75] Avanzi, M.; Baratti, M.; Cabrini, S.; Uber, E.; Brighetti, G.; Bonfa, F. Prevalence of pathological gambling in patients with Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2006, 21(12), 2068-2072. http://dx.doi.org/ 10.1002/mds.21072 [76] Voon, V.; Hassan, K.; Zurowski, M.; de Souza, M.; Thomsen, T.; Fox, S.; Lang, A.E.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2006, 67(7), 1254-1257. http://dx.doi.org/10.1212/01.wnl.0000238503.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"N e u r o s c i ., 2010, 17(4), 539-540. http://dx.doi.org/10.1016/j.jocn.2009.09.001 [78] Evans, A.H.; Strafella, A.P.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2009, 24(11), 1561-1570. http://dx.doi.org/10.1002/mds.22505 [79] Evans, A. Dopamine agonist-induced substance addiction: the next piece of the puzzle.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurosci., 2011, 18(2), 191-192. http://dx.doi.org/10.1016/j.jocn.2010.04.024 [80] Fahn, S. The spectrum of levodopa-induced dyskinesias.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 1991, 41(2 (Pt 1)), 168-173. http://dx.doi.org/10.1212/ WNL.41.2_Part_1.168 [82] Martinez-Martin, P.; Reddy, P.; Katzenschlager, R.; Antonini, A.; Todorova, A.; Odin, P.; Henriksen, T.; Martin, A.; Calandrella, D.; Rizos, A.; Bryndum, N.; Glad, A.; Dafsari, H.S.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2015, 30(4), 510-516. http://dx.doi.org/10.1002/mds.26067 [83] Gershanik, O.; Jenner, P. Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2012, 19(12), 1502-1508. http://dx.doi.org/10.1111/j.1468-1331.2011.03593.x [84] Antonini, A.; Ursino, G.; Calandrella, D.; Bernardi, L.; Plebani, M. Continuous dopaminergic delivery in Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"http://dx.doi.org/10.1007/ s00415-010-5714-1 [85] Nutt, J.G.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"http://dx.doi.org/10.1016/S1471-1931(00)00029-X [86] Stocchi, F.; Vacca, L.; Ruggieri, S.; Olanow, C.W.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2005, 62(6), 905-910. http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Lancet Neurol., 2009, 8(5), 464-474. http://dx.doi.org/10.1016/ S1474-4422(09)70068-7 [88] Storch, A.; Schneider, C.B.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurology, 2013, 80(9), 800-809. http://dx.doi.org/ 10.1212/WNL.0b013e318285c0ed [89] Olanow, C.W.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 2010, 25(12), 1774-1779. http://dx.doi.org/10.1002/mds.23288 [90] Conditions, N.C.C.f.C.",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Disord., 1987, 2(2), 73-91. http://dx.doi.org/10.1002/ mds.870020201 [92] Shannon, K.M.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2008, 4(11), 590-591. http://dx.doi.org/10.1038/ ncpneuro0934 [93] Vlaar, A.; Hovestadt, A.; van Laar, T.; Bloem, B.R.",OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Neurol., 2011, 11(3), 145-152. http://dx.doi.org/10.1136/practneurol-2011-000011   Received: July 27, 2015 Revised: August 16, 2015 Accepted: October 09, 2015",Non-OADS,/arxiv_data1/oa_pdf/21/51/CN-14-356.PMC4876591.pdf
"Cell, 2012, 148 (6), 120 4-22. http://dx.doi.org/10.1016/ j.cell.2012.02.040 [2] Amanatkar, H. R.; Grossberg, G. T. Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurother., 2014, 14 ( 1 0 ) ,  1 1 1 9-1125. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Brain Res., 2011, 221 ( 2 ) ,  3 3 4-40. http://dx.doi.org/10.1016/ j.bbr.2009.12.044 [5] Qiu, Y.; Wu, X. J.; Chen, H. Z.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"4    373 Lett., 2003, 352 ( 1 ) , 4 1-4. http://dx.doi.org/10.1016/j.neulet.2003.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Commun., 2009, 384 (1), 110-3. http://dx.doi.org/ 10.1016/j.bbrc.2009.04.080 [7] Zhou, W.; Zhu, X.; Zhu, L.; Cui, Y. Y.; Wang, H.; Qi, H.; Ren, Q. S.; Chen, H. Z. Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurobiol., 2008, 28 ( 2 ) ,  2 6 3-75. http://dx.doi.org/ 10.1007/s10571-007-9251-0 [8] Tan, P. P.; Yuan, H. H.; Zhu, X.; Cui, Y. Y.; Li, H.; Feng, X. M.; Qiu, Y.; Chen, H. Z.; Zhou, W. Activation of muscarinic receptors protects against retinal neurons damage and optic nerve degeneration in vitro and in vivo models.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Therap., 2014, 20 (3), 227-36. http://dx.doi.org/10.1111/cns.12187 [9] Wang, H.; L u ,  Y .",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Lett., 2003, 344 (3), 173-6. http://dx.doi.org/10.1016/S0304-3940(03)00444-0 [10] Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Drug Discov., 2012, 11 (1), 52-68. http://dx.doi.org/10.1038/nrd3620 [12] Paoletti, P.; Bellone, C.; Zhou, Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurosci., 2013, 14 ( 6 ) ,  3 8 3-400. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2012, 55 (22), 1028 2-6. http://dx.doi.org/ 10.1021/jm300871x [14] Greenfield, S. Discovering and targeting the basic mechanism of neurodegeneration: the role of peptides from the C-terminus of acetylcholinesterase: non-hydrolytic effects of ache: the actions of peptides derived from the C-terminal and their relevance to neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Interact., 2013, 203 ( 3 ) ,  5 4 3-6. http://dx.doi.org/10.1016/j.cbi.2013.03.015 [15] Zimmermann, M. Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Pharmacol., 2013, 170 ( 5 ) ,  9 5 3-967. http://dx.doi.org/10.1111/ bph.12359 [16] Inestrosa, N. C.; Alvarez, A.; Perez, C. A.; Moreno, R. D.; Vicente, M.; Linker, C.; Casanueva, O. I.; Soto, C.; Garrido, J. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neuron, 1996, 16 ( 4 ) ,  8 8 1-91. http://dx.doi.org/ 10.1016/S0896-6273(00)80108-7 [17] Koch, M. W.; Korngut, L.; Patry, D. G.; Agha-Khani, Y.; White, C.; Sarna, J. R.; Yeung, M.; Yong, V. W.; Heng, D. Y.; Cutter, G.; Metz, L. The promise of futility trials in neurological diseases.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurol., 2015, 11 ( 5 ) ,  3 0 0-305. http://dx.doi.org/10.1038/ nrneurol.2015.34 [18] Xie, Q.; Wang, H.; Xia, Z.; Lu, M.; Zhang, W.; Wang, X.; Fu, W.; Tang, Y.; Sheng, W.; Li, W.; Zhou, W.; Zhu, X.; Qiu, Z.; Chen, H. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Ther., 2014, 20 ( 1 ) ,  5 9-66. http://dx.doi.org/10.1111/cns.12161 [20] Cottingham, M. G.; Hollinshead, M. S.; Vaux, D. J. T. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurosci., 2015, 18 ( 6 ) ,  7 9 4-9. http://dx.doi.org/10.1038/ nn.4017 [22] Benilova, I.; Karran, E.; De Strooper, B.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurosci., 2012, 15 (3), 349-57. http://dx.doi.org/10.1038/nn.3028 [23] Heppner, F. L.; Ransohoff, R. M.; Becher, B.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurosci., 2015, 16 (6), 358-72. http://dx.doi.org/10.1038/nrn3880 [24] Ryan, S. D.; Whitehead, S. N.; Swayne, L. A.; Moffat, T. C.; Hou, W.; Ethier, M.; Bourgeois, A. J.; Rashidian, J.; Blanchard, A. P.; Fraser, P. E.; Park, D. S.; Figeys, D.; Bennett, S. A. Amyloid-beta42 s i g n a l s  t a u  h y p e r p h o s p h o r y l a t i o n  a n d  c o m p r o m i s e s  neuronal viability by disrupting alkylacylglycerophosphocholine metabolism.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neuroreport, 2004, 15 (3), 509-13. http://dx.doi.org/10.1097/00001756-200403010-00025 [26] Bate, C.; Kempster, S.; Williams, A. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neuropharmacology, 2006, 51 ( 2 ) ,  1 7 3-81. http://dx.doi.org/10.1016/j.neuropharm.2006.02.015 [27] Trillo, L.; Das, D.; Hsieh, W.; Medina, B.; Moghadam, S.; Lin, B.; Dang, V.; Sanchez, M. M.; De Miguel, Z.; Ashford, J. W.; Salehi, A. Ascending monoaminergic systems alterations in Alzheimer's disease.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Rev., 2013, 37 ( 8 ) ,  1 3 6 3-79. http://dx.doi.org/10.1016/ j.neubiorev.2013.05.008 [28] Parameshwaran, K.; Dhanasekaran, M.; Suppiramaniam, V. Amyloid beta peptides and glutamatergic synaptic dysregulation.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurol., 2008, 210 ( 1 ) ,  7-13. http://dx.doi.org/10.1016/ j.expneurol.2007.10.008 [29] Leon, R.; Garcia, A. G.; Marco-Contelles, J.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Rev., 2013, 33 ( 1 ) ,  1 3 9-89. http://dx.doi.org/10.1002/med.20248 [30] Dias, K. S.; Viegas, C., Jr. Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neuropharmacol., 2014, 12 ( 3 ) ,  2 3 9-55. http://dx.doi.org/10.2174/1570159X1203140511153200 [31] Agis-Torres, A.; Solhuber, M.; Fernandez, M.; Sanchez-Montero, J. M. Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neuropharmacol., 2014, 12 ( 1 ) ,  2-36. http://dx.doi.org/ 10.2174/1570159X113116660047 [32] Rochais, C.; Lecoutey, C.; Gaven, F.; Giannoni, P.; Hamidouche, K.; Hedou, D.; Dubost, E.; Genest, D.; Yahiaoui, S.; Freret, T.; Bouet, V.; Dauphin, F.; Sopkova de Oliveira Santos, J.; Ballandonne, C.; Corvaisier, S.; Malzert-Freon, A.; Legay, R.; Boulouard, M.; Claeysen, S.; Dallemagne, P. Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Practice, 2006, 60 ( 1 ) ,  1 1 0-8. http://dx.doi.org/10.1111/j.1368-5031.2005.00769.x [35] Klatte, E. T.; Scharre, D. W.; Nagaraja, H. N.; Davis, R. A.; Beversdorf, D. Q.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Opin., 2007, 23 ( 5 ) ,  1187-97. http://dx.doi.org/10.1185/030079907X188071 [37] Morphy, R.; Rankovic, Z.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2006, 49 (16), 4961-70. http://dx.doi.org/10.1021/jm0603015 [38] Gemma, S.; Gabellieri, E.; Huleatt, P.; Fattorusso, C.; Borriello, M.; Catalanotti, B.; Butini, S.; De Angelis, M.; Novellino, E.; Nacci, V.; Belinskaya, T.; Saxena, A.; Campiani, G. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2006, 49 (11), 3421-5. http://dx.doi.org/10.1021/jm060257t [39] Munoz-Ruiz, P.; Rubio, L.; Garcia-Palomero, E.; Dorronsoro, I.; del Monte-Millan, M.; Valenzuela, R.; Usan, P.; de Austria, C.; Bartolini, M.; Andrisano, V.; Bidon-Chanal, A.; Orozco, M.; Luque, F. J.; Medina, M.; Martinez, A.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2005, 48 (23), 7223-33. http://dx.doi.org/10.1021/ jm0503289 [40] Kwon, Y. E.; Park, J. Y.; No, K. T.; Shin, J. H.; Lee, S. K.; Eun, J. S.; Yang, J. H.; Shin, T. Y.; Kim, D. K.; Chae, B. S.; Leem, J. Y.; Kim, K. H. Synthesis, in vitro a s s a y ,  a n d  m o l e c u l a r  m o d e l i n g  of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2007, 15 ( 2 0 ) ,  6 5 9 6-607. http://dx.doi.org/10.1016/j.bmc.2007.07.003 [41] Piazzi, L.; Rampa, A.; Bisi, A.; Gobbi, S.; Belluti, F.; Cavalli, A.; Bartolini, M.; Andrisano, V.; Valenti, P.; Recanatini, M. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2003, 46 (12), 2279-82. http://dx.doi.org/10.1021/jm0340602 [42] Guo, T.; Hobbs, D. W. Development of BACE1 inhibitors for Alzheimer's disease.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2006, 13 ( 1 5 ) ,  1 8 1 1-29. http://dx.doi.org/10.2174/092986706777452489 [43] Tarozzi, A.; Bartolini, M.; Piazzi, L.; Valgimigli, L.; Amorati, R.; Bolondi, C.; Djemil, A.; Mancini, F.; Andrisano, V.; Rampa, A.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Ther., 2014, 20 (2), 165-71. http://dx.doi.org/10.1111/cns.12183 [45] Lecoutey, C.; Hedoua, D.; Freret, T.; Giannoni, P.; Gaven, F.; Since, M.; Bouet, V.; Ballandonne, C.; Corvaisier, S.; Freon, A. M.; Mignani, S.; Cresteil, T.; Boulouard, M.; Claeysen, S.; Rochais, C.; Dallemagne, P. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"http://dx.doi.org/ 10.1073/pnas.1410315111 [46] Le Texier, L.; Favre, E.; Redeuilh, C.; Blavet, N.; Bellahsene, T.; Dive, G.; Pirotzky, E.; Godfroid, J. J. Structure-activity relationships in platelet-activating factor (PAF).",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Cell Signal., 1996, 13 ( 3 ) ,  1 8 9-205. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Cell Signal., 1996, 13 ( 3 ) ,  2 0 7-22. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"In Vitro, 2006, 20 (6), 824-31. http://dx.doi.org/10.1016/j.tiv.2006.01.002 [50] Ezoulin, M. J.; Li, J.; Wu, G.; Dong, C. Z.; Ombetta, J. E.; Chen, H. Z.; Massicot, F.; Heymans, F. Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Lett., 2005, 389 ( 2 ) ,  6 1-5. http://dx.doi.org/10.1016/ j.neulet.2005.07.026 [51] Ezoulin, M. J.; Liu, Z.; Dutertre-Catella, H.; Wu, G.; Dong, C. Z.; Heymans, F.; Ombetta, J. E.; Rat, P.; Massicot, F. A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Immunopharmacol., 2007, 7 ( 1 3 ) ,  1 6 8 5-94. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurobiol., 2009, 29 ( 4 ) ,  5 8 9-95. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurobiol., 2008, 28 (1), 125-36. http://dx.doi.org/ 10.1007/s10571-007-9190-9 [54] Yang, H. Q.; Sun, Z. K.; Zhao, Y. X.; Pan, J.; Ba, M. W.; Lu, G. Q.; Ding, J. Q.; Chen, H. Z.; Chen, S. D. PMS777, a new cholinesterase inhibitor with anti-platelet activated factor activity, regulates amyloid precursor protein processing in vitro.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Res., 2009, 34 ( 3 ) ,  5 2 8-35. http://dx.doi.org/10.1007/s11064-008-9816-4 [55] Miezan, E.J.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"J. Collegium Internationale Neuropsychopharmacologicum (CINP), 2009, 12 (10), 1409-19. http://dx.doi.org/10.1021/jm050746d [56] Rodriguez-Franco, M. I.; Fernandez-Bachiller, M. I.; Perez, C.; Hernandez-Ledesma, B.; Bartolome, B.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Commun., 1998, 250 ( 3 ) ,  6 0 2-5. http://dx.doi.org/10.1006/bbrc.1998.9370 [59] Lahiri, D. K.; Chen, D. M.; Lahiri, P.; Bondy, S.; Greig, N. H. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Sci., 2005, 1056, 430-49. http://dx.doi.org/10.1196/annals.1352.008 [60] Cheng, S.; Zheng, W.; Gong, P.; Zhou, Q.; Xie, Q.; Yu, L.; Zhang, P.; Chen, L.; Li, J.; Chen, J.; Chen, H.; Chen, H. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-beta aggregation with high antioxidant potency for Alzheimer's therapy.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2015, 23 (13), 3110-8. http://dx.doi.org/10.1016/j.bmc.2015.04.084 [61] Rosini, M.; Andrisano, V.; Bartolini, M.; Bolognesi, M. L.; Hrelia, P.; Minarini, A.; Tarozzi, A.; Melchiorre, C. Rational approach to discover multipotent anti-Alzheimer drugs.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2005, 48 (2), 360-3. http://dx.doi.org/10.1021/jm049112h [62] Ono, K.; Hirohata, M.; Yamada, M. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Commun., 2006, 341 (4), 1046-52. http://dx.doi.org/ 10.1016/j.bbrc.2006.01.063",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Biochem., 2005, 270 ( 1-2), 29-37. http://dx.doi.org/10.1007/ s11010-005-3301-z [64] Jesudason, E. P.; Masilamoni, J. G.; Ashok, B. S.; Baben, B.; Arul, V.; Jesudoss, K. S.; Jebaraj, W. C.; Dhandayuthapani, S.; Vignesh, S.; Jayakumar, R. Inhibitory effects of short-term administration of DL-alpha-lipoic acid on oxidative vulnerability induced by Abeta amyloid fibrils (25-35) in mice.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2012, 58, 519-32. http://dx.doi.org/10.1016/ j.ejmech.2012.10.045 [67] Luo, Z.; Sheng, J.; Sun, Y.; Lu, C.; Yan, J.; Liu, A.; Luo, H. B.; Huang, L.; Li, X. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2013, 56 ( 2 2 ) ,  9 0 8 9-99. http://dx.doi.org/10.1021/jm401047q [68] Huang, L.; Miao, H.; Sun, Y.; Meng, F.; Li, X.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2014, 87, 429-39. http://dx.doi.org/10.1016/j.ejmech.2014.09.081 [69] Bruhlmann, C.; Ooms, F.; Carrupt, P. A.; Testa, B.; Catto, M.; Leonetti, F.; Altomare, C.; Carotti, A. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2001, 44 ( 1 9 ) ,  3 1 9 5-8. http://dx.doi.org/10.1021/ jm010894d [70] Bautista-Aguilera, O. M.; Samadi, A.; Chioua, M.; Nikolic, K.; Filipic, S.; Agbaba, D.; Soriano, E.; de Andres, L.; Rodriguez-Franco, M. I.; Alcaro, S.; Ramsay, R. R.; Ortuso, F.; Yanez, M.; Marco-Contelles, J. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl) piperidin-4-yl)propoxy)-1H-indol-2- y l ) m e t h y l ) p r o p-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2014, 57 ( 2 4 ) ,  1 0 4 5 5-63. http://dx.doi.org/10.1021/ jm501501a [71] Nasica-Labouze, J.; Nguyen, P. H.; Sterpone, F.; Berthoumieu, O.; Buchete, N. V.; Cote, S.; De Simone, A.; Doig, A. J.; Faller, P.; Garcia, A.; Laio, A.; Li, M. S.; Melchionna, S.; Mousseau, N.; Mu, Y.; Paravastu, A.; Pasquali, S.; Rosenman, D. J.; Strodel, B.; Tarus, B.; Viles, J. H.; Zhang, T.; Wang, C.; Derreumaux, P. Amyloid beta Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Rev., 2015, 115 (9), 3518-63. http://dx.doi.org/10.1021/cr500638n [72] Zheng, W.; Li, J.; Qiu, Z.; Xia, Z.; Li, W.; Yu, L.; Chen, H.; Chen, J.; Chen, Y.; Hu, Z.; Zhou, W.; Shao, B.; Cui, Y.; Xie, Q.; Chen, H. Novel bis-(-)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing property.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Pharmacol., 2012, 264 (1), 6 5-72. http://dx.doi.org/10.1016/j.taap.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Sci., 2013, 4 (11), 4137-4145. http://dx.doi.org/10.1039/c3sc51902c [74] Danysz, W.; Parsons, C. G. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2010, 53 (9), 3611-7. http://dx.doi.org/10.1021/jm1000024 [76] Rosini, M.; Simoni, E.; Minarini, A.; Melchiorre, C. Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Res., 2014, 39 ( 1 0 ) ,  1 9 1 4-23. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2012, 55 (22), 9708-21. http://dx.doi.org/10.1021/jm3009458 [78] Toda, N.; Kaneko, T.; Kogen, H. Development of an efficient therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Bull., 2010, 58 ( 3 ) ,  2 7 3-87. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2010, 53 (3), 1338-46. http://dx.doi.org/10.1021/jm901614b [80] Marco-Contelles, J.; Leon, R.; de los Rios, C.; Samadi, A.; Bartolini, M.; Andrisano, V.; Huertas, O.; Barril, X.; Luque, F. J.; Rodriguez-Franco, M. I.; Lopez, B.; Lopez, M. G.; Garcia, A. G.; Carreiras Mdo, C.; Villarroya, M. Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2009, 52 ( 9 ) ,  2724-32. http://dx.doi.org/10.1021/jm801292b [81] Fang, J.; Li, Y.; Liu, R.; Pang, X.; Li, C.; Yang, R.; He, Y.; Lian, W.; Liu, A. L.; Du, G. H. Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Information Modeling, 2015, 55 (1), 149-64. http://dx.doi.org/10.1021/ci500574n [82] Harvey, A. L.; Edrada-Ebel, R.; Quinn, R. J.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Drug Discov., 2015, 14 (2), 111-29. http://dx.doi.org/10.1038/nrd4510 [83] Sun, Z. K.; Yang, H. Q.; Chen, S. D. Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Chem., 2015, 22 ( 1 9 ) ,  2 3 9 2-403. http://dx.doi.org/10.2174/0929867322666150520095509 [85] Murray, A. P.; Faraoni, M. B.; Castro, M. J.; Alza, N. P.; Cavallaro, V. Natural AChE Inhibitors from Plants and their Contribution to Alzheimer's Disease Therapy.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neuro- pharmacol., 2013, 11 ( 4 ) ,  3 8 8-413. http://dx.doi.org/10.2174/ 1570159X11311040004 [86] Jia, J. Y.; Zhao, Q. H.; Liu, Y.; Gui, Y.",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Life Sci., 2006, 830 (1), 120-5. http://dx.doi.org/10.1016/j.jchromb.2005.10.027 [88] Bansode, S. B.; Jana, A. K.; Batkulwar, K. B.; Warkad, S. D.; Joshi, R. S.; Sengupta, N.; Kulkarni, M. J. Molecular Investigations of Protriptyline as a Multi-Target Directed Ligand in Alzheimer's Disease.",OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Aging, 2015, 36 ( 5 ) ,  1 7 9 2-807. http://dx.doi.org/10.1016/j.neurobiolaging.2015.02.002  Received: October 02, 2015 Revised: November 12, 2015 Accepted: November 12, 2015",Non-OADS,/arxiv_data1/oa_pdf/cf/b7/CN-14-364.PMC4876592.pdf
"Neurol., 1991, 50, 743-755. http://dx.doi.org/10.1097/00005072-199111000-00006 [2] Hely, M.A.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2002, 1, 95-109.http://dx.doi.org/ 10.1385/NMM:1:2:95 [4] Tanner, C.M.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Brain Res., 2005, 134, 103-108.http://dx.doi.org/10.1016/j.molbrainres.2005.01.012 [7] Dick, F.D.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2007, 64, 666-672.http://dx.doi.org/10.1136/oem.2006.027003 [8] Kurosinski, P.; Guggisberg, M.; Götz, J. Alzheimer’s and Parkinson’s disease-overlapping or synergistic pathologies?",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Legs Synd., 2011, 1, 5-7.http://dx.doi.org/10.7157/ jprls.2011v1n1pp5-7 [10] Yamaguchi, H.; Kajitani, K.; Dan, Y.; Furuichi, M.; Ohno, M.; Sakumi, K.; Kang, D.; Nakabeppu, Y. MTH1, an oxidized purine  nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Differ., 2006, 13, 551-563.http://dx.doi.org/10.1038/sj.cdd.4401788 [11] Adams, J.D.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 1991, 10, 161-169.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurol., 2003, 16,  3-7.http://dx.doi.org/10.1097/00019052-200312001-00002 [13] Yuan, H.; Sarre, S.; Ebinger, G.; Michotte, Y. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Brain Res., 2004, 1026, 95-107.http://dx.doi.org/10.1016/j.brainres.2004.08.015 [14] Brunton, L.L.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"[15] http://www.nytimes.com/health/guides/disease/parkinsons-disease/ print.html  [16] Singh, N.; Pillay, V.; Choonara, Y.E.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2010, 1184, 154-172.http://dx.doi.org/10.1111/j.1749-6632.2009.05108.x [18] Pollock, M.; Hornabrook, R.W.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Brain, 1966, 89, 429-448. http://dx.doi.org/10.1093/brain/89.3.429 [19] Lemke, M.R.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurol., 2008, 15, 21-25.http://dx.doi.org/10.1111/j.1468-1331.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"J. Parkinsonism Restless Legs Syndrome, 2012, 2, 34-35.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"J. Parkinsonism & Restless Legs Syndrome, 2012, 2, 11-14.http://dx.doi.org/10.7157/jprls.2012.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"J. Parkinsonism & Restless Legs Syndrome, 2012, 2, 32-33.http://dx.doi.org/10.7157/jprls.2012.v2n1pp32-33 [25] Gabathuler, R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Dis., 2010, 37, 48-57.http://dx.doi.org/10.1016/j.nbd.2009.07.028 [26] Re, F.; Gregori, M.; Masserini, M. Nanotechnology for neuro- degenerative disorders.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Maturitas, 2012, 73, 45-51.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Progress Neurobiol., 2009, 88, 272-285.http://dx.doi.org/10.1016/j.pneurobio.2009.05.002 [29] Abbott, N.J.; Chugani, D.C.; Zaharchuk, G.; Rosen, B.R.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rev., 1999, 37, 253-277.http://dx.doi.org/10.1016/S0169-409X(98)00097-0 [30] Guilloteau, D.; Vergote, J.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Commun., 2001, 22, 1207-1214.http://dx.doi.org/ 10.1097/00006231-200111000-00007 [35] Farde, L.; Suhara, T.; Nyberg, S.; Karlsson, P.; Nakashima, Y.; Hietala, J.; Halldin, C. A PET-study of [11C]FLB 457 to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug treated patients.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Psychopharmacology, 1997, 133, 396-404. http://dx.doi.org/10.1007/s002130050420 [36] Delforge, J.; Bottlaender, M.; Loch, C.; Dolle, F.; Syrota, A. Parametric images of the extrastriatal D2 receptor density obtained using a high-affinity ligand (FLB 457) and a double-saturation method.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"J. Cerebral Blood F l o w  &  M e t a b o l i s m, 2001, 21, 1493-1503.http://dx.doi.org/10.1097/00004647-200112000-00014 [37] Nikolaus, S.; Larisch, R.; Beu, M.; Vosberg, H.; Forutan, F.; Wirrwar, A.; Müller, H.W.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Synapse, 1997, 27, 1-13.http://dx.doi.org/10.1002/ (SICI)1098-2396(199709)27:1%3C1::AID-SYN1%3E3.0.CO;2-9 [40] Schreckenberger, M.; Hagele, S.; Siessmeier, T.; Buchholz, H.G.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Imaging, 2004, 31, 1128-1135.http://dx.doi.org/10.1007/s00259-004-1465-5 [41] Farde, K.; Hall, H.; Ehrin, E.; Sedvall, G. Quantitative analysis of D2 dopamine receptor binding in the livin g hu man brain b y PET.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Science, 1986, 231, 258-261.http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharmacol., 1991, 194, 133-134.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Life Sci., 1999, 65, 2715-2726.http://dx.doi.org/10.1016/S0024-3205(99)00540-8 [46] Guilloteau, D.; Emond, P.; Baulieu, J.L.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biol., 1998, 25, 331-337.http://dx.doi.org/10.1016/S0969-8051(97)00224-2 [47] Schou, M., Steiger, C., Varrone, A., Guilloteau, D., Halldin, C. Synthesis, radiolabeling and preliminary in vivo e v a l u a t i o n  o f  [18F]FE-PE2I, a new probe for the dopamine transporter.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Lett., 2009, 19, 4843-485.http://dx.doi.org/10.1016/ j.bmcl.2009.06.032 [48] Satish, K.C.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biol., 2008, 35, 75-82.http://dx.doi.org/10.1016/ j.nucmedbio.2007.09.001 [49] Chalon, S.; Hall, H.; Saba, W.; Garreau, L.; Dolle, F.; Halldin, C.; Emond, P.; Bottlaender, M.; Deloye, J.B.; Helfenbein, J.; Madelmont, J.C.; Bodard, S.; Mincheva, Z.; Besnard, J.C.; Guilloteau, D. Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2β-carbomethoxy-3β-(4’-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"JPET, 2006, 317, 147-152.http://dx.doi.org/10.1124/ jpet.105.096792 [50] Saba, W.; Valette, H.; Schöllhorn-Peyronneau, M.A.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Synapse, 2007, 61, 17-23.http://dx.doi.org/10.1002/syn.20337 [51] Dolle, F.; Emond, P.; Mavel, S.; Demphel, S.; Hinnen, F.; Mincheva, Z.; Saba, W.; Valette, H.; Chalon, S.; Halldin, C.; Helfenbein, J.; Legaillard, J.; Madelmont, J.C.; Deloye, J.B.; Bottlaendera, M.; Guilloteau, D. Synthesis, radiosynthesis and in vivo p r e l i m i n a r y  e v a l u a t i o n  o f  [ 1 1 C ] L B T-999, a selective radioligand for the visualisation of t he d opamine  transp orter with PET.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2006, 14, 1115-1125.http://dx.doi.org/ 10.1016/j.bmc.2005.09.035 [52] An, Y.; Tang, L.; Jiang, X.; Chen, H.; Yang, M.; Jin, L.; Zhang, S.; Wang, C.; Zhang, W. A photoelectrochemical immunosensor based on Au-doped TiO2 nanotube arrays for the detection of  α-synuclein.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"201001654.http://dx.doi.org/10.1002/chem.201001654 [53] Yu, J.; Lyubchenko, Y.L.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharmacol., 2009, 4, 10-16.http://dx.doi.org/ 10.1007/s11481-008-9115-5 [54] Baron, R.; Zayats, M.; Willner, I. Dopamine-, L-DOPA-, adrenaline-, and noradrenaline-induced growth of Au nanoparticles: assays for  the detection of neurotransmitters and of tyrosinase activity.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2005, 77, 1566-1571.http://dx.doi.org/10.1021/ac048691v [55] Horstink, M.; Tolosa, E.; Bonuccelli, U.; D e u s c h l ,  G .",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurol., 2006, 13, 1170-1185.http://dx.doi.org/10.1111/j.1468-1331.2006.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2001, 344, 710-719.http://dx.doi.org/10.1056/NEJM200103083441002 [58] Pouratian, N.; Thakkar, S.; Kim, W.; Bronstein, J.M.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2011, 8, 359-374.http://dx.doi.org/10.1517/ 17425247.2011.556616 [60] Silindir, M.; Ozer, A.Y.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2014, 35, 1505-1511. http://dx.doi.org/10.1007/s10072-014-1891-5 [61] Silindir, M.; Erdoğan, S.; Özer, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Target, 2012, 20, 401-415.http://dx.doi.org/10.3109/1061186X.2012.685477 [62] Mitra, A.; Nan, A.; Line, B.R.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Des., 2006, 12, 4729-4749.http://dx.doi.org/10.2174/138161206779026317 [63] Torchilin, V.P.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Today, 1996, 2, 242-249.http://dx.doi.org/10.1016/ 1357-4310(96)88805-8 [65] Torchilin, V.P.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2005, 2, 319-327.http://dx.doi.org/10.2174/ 156720105774370221 [66] Manjunath, K.; Reddy, J.S.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharmacol., 2005, 27, 127-144.http://dx.doi.org/10.1358/mf.2005.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Polymer Sci., 2014, 39, 268-307.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2010, 7, 753-763.http://dx.doi.org/10.1517/17425241003777010 [69] Huanga, X.; El-Sayed, M.A.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Res., 2010, 1, 13-28.http://dx.doi.org/10.1016/j.jare.2010.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Technol., 2009, 1,  3-17.http://dx.doi.org/10.1179/175889709X446507 [71] Klibanov, A.L.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rev., 1999, 37, 139-157.http://dx.doi.org/10.1016/S0169-409X(98)00104-5 [72] Vatta, L.L.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2006, 78, 1793-1801.http://dx.doi.org/10.1351/pac200678091793 [73] Issa, B.; Obaidat, I.M.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2013, 14, 21266-21305.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2008, 5, 263-267.http://dx.doi.org/10.1517/17425247.5.3.263 [75] Aggeliki, K. Quantum Dots Advantages and Disadvantages.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Ed: Stonecypher L, 2013 (http://www.brighthubengineering.com/ manufacturing-technology/89345-quantum-dots advantages-and-disadvantages/)).",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Science, 1990, 249, 1527-1533.http://dx.doi.org/10.1126/science.2218494 [77] Kshirsagar, N.A.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2012, 19, 68-80.http://dx.doi.org/10.3109/10717544.2011.635721 [80] Robinon, D.H.; Mauger, J.W.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharmacol., 2010, 197, 3-53.http://dx.doi.org/10.1007/978-3-642-00477-3_1 [83] Park, K. Nanotechnology: What it can do for drug delivery.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rel., 2007, 120, 1-3.http://dx.doi.org/10.1016/j.jconrel.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Technol., 2007, 181, 52-58.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"D e s., 2006, 12, 4729-4749. http://dx.doi.org/10.2174/138161206779026317 [86] Ostro, M.J.; Cullis, P.R.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Deliv., 2010, 7, 145-158.http://dx.doi.org/10.1517/ 17425240903436479 [89] Torchilin, V.P.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Res., 2007, 24, 1-16.http://dx.doi.org/10.1007/s11095-006-9132-0 [90] Lembo, D.; Cavalli, R. Nanoparticulate delivery systems for antiviral drugs.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chemother., 2010, 2 1, 53-70. http://dx.doi.org/10.3851/IMP1684 [91] Mayer, C. Nanocapsules as drug delivery systems.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Nanotechnol., 2010, 10, 8469-8481.http://dx.doi.org/ 10.1166/jnn.2010.2689 [95] Uekama, K.; Otagiri, M. Cyclodextrins in drug carrier systems.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Target, 2012, 20, 401-415.http://dx.doi.org/10.3109/1061186X.2012.685477 [97] Mamalis, A.G.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Technol., 2007, 181, 52-58.http://dx.doi.org/10.1016/ j.jmatprotec.2006.03.052 [98] Garnett, M.C.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2006, 56, 307-311.http://dx.doi.org/10.1093/occmed/kql052 [99] Chan, V.S.W.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharmacol., 2006, 46, 218-224.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2014, 2, 1-27.http://dx.doi.org/10.3389/fchem.2014.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Cancers (Basel), 2013, 5, 296-319.http://dx.doi.org/10.3390/ cancers5010296 [102] Bhaskar, S.; Tian, F.; Stoeger, T.; Kreyling, W.; de la Fuente, J.M.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Toxicol., 2010, 7, 3.http://dx.doi.org/10.1186/1743-8977-7-3 [103] Zavaleta, C.L.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharm., 2007, 337, 316-328.http://dx.doi.org/ 10.1016/j.ijpharm.2007.01.010 [104] Guenoun, J.; Koning, G.A.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Transplant., 2012, 21, 191-205.http://dx.doi.org/10.3727/096368911X593118 [105] Seltzer, S.E.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Radiol., 1989, 171, 19-21.http://dx.doi.org/10.1148/radiology.171.1.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Helv., 1995, 70, 95-111.http://dx.doi.org/10.1016/0031-6865(95) 00010-7 [107] Bangham, A.D.; Standish, M.M.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biol., 1965, 13, 238-252.http://dx.doi.org/10.1016/S0022-2836(65) 80093-6 [108] Betageri, G.V.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"In: Frontiers in Nanobiomedical Research: Handbook of Nanobiomedical Research, Fundamentals, Applications and Recent Developments, 3-Applications in Diagnostics, Ed: Torchilin V.P., World Scientific, USA, 2014, pp: 47-76.http://dx.doi.org/10.1142/9789814520652_0037 [113] Pichandy, M.; Mishra, M.; Kanaiyan, S.; Srinivasa, R.T.; Anbu, J. Formulation and psychopharmacological evaluation of surfactant modified liposome for parkinsonism disease.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 1997, 123, 126-129.http://dx.doi.org/10.1007/ BF02766431 [116] During, M.J.; Freese, A.; Deutch, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurol., 1992, 115, 193-199.http://dx.doi.org/10.1016/0014-4886(92)90053-S [117] Alemdar, A.Y.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Cell Transplant., 2004, 13, 263-271.http://dx.doi.org/10.3727/000000004783983936 [118] Jain, N.K.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"P h a r m., 1998, 24, 671-675. http://dx.doi.org/10.3109/03639049809082370 [119] Schnyder, A.; Huwyler, J.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"NeuroRx, 2005, 2, 99-107.http://dx.doi.org/10.1602/ neurorx.2.1.99 [120] Amicarelli, F.; Gasbarri, A.; Masciocco, L.; Pompili, A.; Pacitti, C.; Carlucci, G.; Palumbo, G.; Miranda, M. The effect of intrastriatal injection of liposome-entrapped tyrosinase on the dopamine levels in the rat brain.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Res., 2010, 35, 1575-1587.http://dx.doi.org/10.1007/s11064-010-0217-0 [122] Xiang, Y.; Wu, Q.; Liang, L.; Wang, X.; Wang, J.; Zhang, X.; Pu, X.; Zhang, Q. Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against the Parkinson’s disease in the MPTP-induced mice model.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Target., 2012, 20, 67-75.http://dx.doi.org/10.3109/1061186X.2011.595490 [123] Wang, Y.; Xu, H.; Fu, Q.; Ma, R.; Xiang, J.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2011, 304, 29-34.http://dx.doi.org/10.1016/j.jns.2011.02.025 [124] Migliore, M.M.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neuroscience, 2 0 1 4, 274, 11-23.http://dx.doi.org/10.1016/ j.neuroscience.2014.05.019 [125] Kizelsztein, P.; Ovadia, H.; Garbuzenko, O.; Sigal, A.; Barenholz, Y. Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neuroimmun., 2009, 213, 20-25.http://dx.doi.org/10.1016/ j.jneuroim.2009.05.019 [126] Micklus, M.J.; Greig, N.H.; Rapoport, S.I.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2007, 9, 605-612.http://dx.doi.org/ 10.1002/jgm.1046 [129] Xia, C.F.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"J. Gene Med., 2008, 10, 306-315.http://dx.doi.org/10.1002/jgm.1152 [130] Pardridge, W.M.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rev., 2005, 34, 970-994.http://dx.doi.org/ 10.1039/b307062j [133] Foged, C.; Nielsen, H.M. Cell-penetrating peptides for drug delivery across membrane barriers.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2008, 5, 1435-1342.http://dx.doi.org/10.1517/17425247.5.1.105 [134] Gielen, M. ER.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"; John Wiley & Sons Ltd: England, 2005, p.693.http://dx.doi.org/10.1002/ 0470864052 [135] Iqbal, A.; Ahmad, I.; Khalid, M.H.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2009, 284, 6972-6981.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharm., 2011, 419, 296-307.http://dx.doi.org/ 10.1016/j.ijpharm.2011.07.036 [138] Huang, R.; Ke, W.; Liu, Y.; Wu, D.; Feng, L.; Jiang, C.; Pei, Y. Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2010, 290, 123-130.http://dx.doi.org/10.1016/j.jns.2009.09.032 [139] Hu, K.; Shi, Y.; Jiang, W.; Han, J.; Huang, S.; Jiang, X. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharm., 2011, 415, 273-283.http://dx.doi.org/10.1016/ j.ijpharm.2011.05.062 [140] Huang, R.; Han, L.; Li, J.; Ren, F.; Ke, W.; Jiang, C.; Pei, Y. Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin modified nanoparticles.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2009, 11, 754-763. http://dx.doi.org/10.1002/jgm.1361 [141] Huan, R.; Ma, H.; Guo, Y.; Liu, S. ;  K u a n g ,  Y .",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Res., 2013, 30, 2549-2559.http://dx.doi.org/10.1007/s11095-013-1005-8 [142] Esposito, E.; Fantin, M.; Marti, M.; Drechsler, M.; Paccamiccio, L.; Mariani, P.; Sivieri, E.; Lain, F.; Menegatti, E.; Morari, M.; Cortesi, R. Solid lipid nanoparticles as delivery systems for bromocriptine, Pharm.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Res., 2008, 25, 1521-1530.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Deliv., 2014, 11, 827-842.http://dx.doi.org/10.1517/ 17425247.2014.894504 [144] Wen, Z.; Yan, Z.; Hu, K.; Pang, Z.; Cheng, X.; Guo, L.R.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rel., 2011, 151, 131-138.http://dx.doi.org/10.1016/ j.jconrel.2011.02.022 [145] Tsai, M.J.; Huang, Y.B.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2011, 100, 547-557.http://dx.doi.org/10.1002/jps.22285 [146] Jafarieh, O.; Md, S.; Ali, M.; Baboota, S.; Sahni, J.K.; Kumari, B.; Bhatnagar, A.; Ali, J.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurobiol., 2014, 23, 246-252.http://dx.doi.org/10.5607/en.2014.23.3.246 [148] Fitzgerald, P.; Mandel, A.; Bolton, A.E.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurosci., 2008, 27, 294-300.http://dx.doi.org/10.1111/j.1460-9568.2007.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Med., 2013, 65, 704-718.http://dx.doi.org/10.1016/j.freeradbiomed.2013.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"07.042 [151] Liu, Y.; Guo, Y.; An, S.; Kuang, Y.; He, X.; Ma, H.; Li, J.; Lv, J.; Zhang, N.; Jiang, C. Targeting Caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson’s Disease, PLoS One, 2013, 8, e62905.http://dx.doi.org/10.1371/journal.pone.0062905 [152] De Giglio, E.; Trapani, A.; Cafagna, D.; Sabbatini, L.; Cometa, S. Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2011, 400, 1997-2002.http://dx.doi.org/10.1007/s00216-011-4962-y [153] Sibov, T.T.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Nanoscale, 2011, 3, 5110.http://dx.doi.org/ 10.1039/c1nr10797f [155] 155.http://www.cytodiagnostics.com/store/pc/Gold-Nanoparticle-Properties-d2.htm (Accessed January 3, 2015).",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Langmuir, 2005, 2 1, 10644-10654.http://dx.doi.org/ 10.1021/la0513712 [157] Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials at the nanolevel.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Science, 2006, 311, 622-627. http://dx.doi.org/ 10.1126/science.1114397 [158] Jain, S.; Hirst, D.G.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Radiol., 2012, 85, 101-113. http://dx.doi.org/10.1259/bjr/59448833 [159] Yang, J.A.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"B, 2014, 118, 3559-3571.http://dx.doi.org/ 10.1021/jp501114h [160] An, Y.; Tang, L.; Jiang, X.; Chen, H.; Yang, M.; Jin, L.; Zhang, S.; Wang, C.; Zhang, W. A photoelectrochemical immunosensor based on Au-doped TiO2 nanotube arrays for the detection of  α-synuclein.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"J., 2010, 16, 14439-14446.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"org/10.1002/chem.201001654 [161] Microspheres-Nanospheres, http://microspheres-nanospheres.com/ (Accessed February 5, 2015).",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Bullet., 2014, 103, 60-65.http://dx.doi.org/10.1016/j.brainresbull.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rel., 2009, 135, 119-126.http://dx.doi.org/ 10.1016/j.jconrel.2008.12.010 [164] Herrán, E.; Ruiz-Ortega, J.A.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Synapse, 2002, 44, 124-131.http://dx.doi.org/10.1002/syn.10063 [166] Ye, L.; Guan, X.; Tian, J.; Zhang, J.; Du, G.; Yu, X.; Yu, P.; Cen, X.; Liu, W.; Li, Y.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Toxicol., 2013, 56, 81-92.http://dx.doi.org/10.1016/j.fct.2013.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biomaterials, 2006, 27, 937-946.http://dx.doi.org/10.1016/j.biomaterials.2005.07.005 [168] Mohanraj, K.; Sethuraman, S.; Krishnan, U.M.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biomater., 2013, 1 0 1 B, 840-847.http://dx.doi.org/10.1002/ jbm.b.32888 [169] Fernández, M.; Barcia, E.; Fernández-Carballido, A.; Garcia, L.; Slowing, K.; Negro, S. Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharm., 2011, 8, 2408-2415.http://dx.doi.org/10.1021/mp200337h [171] Unger, E.C.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rev., 2004, 56, 1291-1314.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Eng., 2007, 9, 415-447. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Discov., 2004, 3, 527-532. http://dx.doi.org/10.1038/nrd1417 [174] Lindner, J.R., Song, J., Jayaweera, A.R., Sklenar, J., Kaul, S. Microvascular rheology of definity microbubbles after intra-arterial and intravenous administration.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Echocardiogr., 2002, 15, 396-403.http://dx.doi.org/10.1067/mje.2002.117290 [175] Blomley, M.J.K.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Technol., 2009, 1, 3-17. http://dx.doi.org/10.1179/175889709X446507 [177] Epstein, P.S.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"doi.org/10.1063/1.1747520 [178] 178.Soutter, W. What are Nanobubbles?, http://www.azonano.com/ article.aspx?ArticleID=3151 , (Accessed Jun 25, 2014).",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Sci., 2009, 98, 3735-3747. http://dx.doi.org/10.1002/jps.21687 [180] Astruc, D.; Boisselier, E.; Ornelas, C.; Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, and nanomedicine.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Rev., 2010, 110, 1857-1959.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"http://www.starpharma.com/technology/what_are_ dendrimers_, (Accessed March 3, 2015).",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Drug Carrier  Syst., 2006, 23, 437-495.http://dx.doi.org/10.1615/CritRevTherDrug CarrierSyst.v23.i6.10 [184] Luo, D.; Li, Y. Dendrimer-like modular delivery vector.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Chem., 2011, 22, 1115-1127.http://dx.doi.org/10.1021/bc1005812 [186] Rekas, A.; Lo, V.; Gadd, G.E.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biosci., 2009, 9, 230-238.http://dx.doi.org/10.1002/mabi.200800242 [187] Milowska, K.; Grochowina, J.; Katir, N.; El Kadib, A.; Majoral, J.P.; Bryszewska, M.; Gabryelak, T. Viologen-phosphorus dendrimers inhibit αsynuclein fibrillation.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Pharm., 2013, 10, 1131-1137.http://dx.doi.org/10.1021/mp300636h [188] Linazasoro, G. Neuroprotection and neurorescue in Parkinson’s disease: love story or mission impossible?",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Neurother., 2002, 2, 403-416.http://dx.doi.org/10.1586/14737175.2.3.403 [189] Lee, C.; MacKay, J.; Frechet, J.; Szoka, F. Designing dendrimers for biological applications.",OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Biotechnol., 2005, 23, 1517-1526.http://dx.doi.org/10.1038/nbt1171   Received: June 10, 2015 Revised: December 03, 2015 Accepted: December 29, 2015",Non-OADS,/arxiv_data1/oa_pdf/70/f6/CN-14-376.PMC4876593.pdf
"Circ., 2003, 34, 2964-2969. http://dx.doi.org/ 10.1161/01.STR.0000103140.52838.45 [8] Marlet, J.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"F o r e n s i c  S c i ., 1982, 27, 880-888. http://dx.doi.org/10.1520/JFS12205J [9] Koeppen, A.H.; Dickson, A.C.; McEvoy, J.A.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Sci., 1995, 134 Suppl, 102-112.http://dx.doi.org/10.1016/0022-510X(95) 00215-N [10] Figueiredo, R.T.; Fernandez, P.L.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Chem., 2007, 282, 20221-20229. http://dx.doi.org/10.1074/jbc.M610737200 [11] Ryter, S.W.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Med., 2000, 28, 289-309.http://dx.doi.org/10.1016/S0891-5849(99)00223-3 [12] Larsen, R.; Gouveia, Z.; Soares, M.P.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurosurg., 1998, 89, 991-996.http://dx.doi.org/10.3171/jns.1998.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2001, 32, 2932-2938.http://dx.doi.org/10.1161/hs1201.099820 [15] Wu, J.; Hua, Y.; Keep, R.F.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Brain Res., 2002, 953, 45-52.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Invest., 1988, 82, 1510-1515. http://dx.doi.org/ 10.1172/JCI113759 [17] Sadrzadeh, S.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Invest., 1987, 79, 662-664.http://dx.doi.org/ 10.1172/JCI112865 [18] Antonini, E.; Brunori, M.; Wyman, J.; Noble, R.W.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"), 1996, 35, 6976-6983.http://dx.doi.org/10.1021/bi960442g [20] Doyle, M.P.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Biochem., 1981, 14, 351-358.http://dx.doi.org/10.1016/S0162-0134(00)80291-3 [21] Hess, J.R.; MacDonald, V.W.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood, 2002, 100, 879-887.http://dx.doi.org/ 10.1182/blood.V100.3.879 [25] Nagy, E.; Eaton, J.W.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Commun., 2006, 350, 233-237.http://dx.doi.org/ 10.1016/j.bbrc.2006.09.036 [27] Koeppen, A.H.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"1995, 134 Suppl, 1-9.http://dx.doi.org/10.1016/0022-510X(95) 00202-D [28] Zecca, L.; Youdim, M.B.H.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurosci., 2004, 5, 863-873.http://dx.doi.org/10.1038/nrn1537 [29] Sadrzadeh, S.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurosci., 2002, 24, 154-160.http://dx.doi.org/10.1159/000065703 [31] Wang, J.; Tsirka, S.E.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"2005, 36, 613-618. http://dx.doi.org/10.1161/01.STR.0000155729.12931.8f [32] Chan, P.H.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood Flow Metab., 2001, 21, 2-14.http://dx.doi.org/10.1097/ 00004647-200101000-00002 [33] Pun, P.B.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2009, 43, 348-364.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood Flow Metab., 1983, 3, 207-214.http://dx.doi.org/10.1038/jcbfm.1983.28 [35] Li, H.; Swiercz, R.; Englander, E.W.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurochem., 2009, 110, 1774-1783.http://dx.doi.org/10.1111/j.1471-4159.2009.06271.x [36] Mantle, D.; Siddique, S.; Eddeb, F.; Mendelow, A.D.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"C h e m ., 2001, 312, 185-190.http://dx.doi.org/10.1016/ S0009-8981(01)00623-4 [37] Mairuae, N.; Connor, J.R.; Cheepsunthorn, P. Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Glia, 2006, 54, 795-804. http://dx.doi.org/10.1002/glia.20416 [39] Yu, J.; Guo, Y.; Sun, M.; Li, B.; Zhang, Y.; Li, C. Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Brain Res., 2009, 1257, 102-107.http://dx.doi.org/ 10.1016/j.brainres.2008.12.030 [40] Germanò, A.; Caffo, M.; Angileri, F.F.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"J. Neurotrauma, 2007, 24, 732-744.http://dx.doi.org/10.1089/neu.2006.0181 [41] Liu, X.; Hunter, C.; Weiss, H.R.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Brain Res., 2012, 1455, 114-123.http://dx.doi.org/ 10.1016/j.brainres.2012.03.025 [43] Schalinske, K.L.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Chem., 1998, 273, 3740-3746.http://dx.doi.org/10.1074/jbc.273.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Autophagy, 2012, 8, 1510-1520.http://dx.doi.org/10.4161/auto.21289 [45] Wang, L.; Xi, G.; Keep, R.F.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Stroke Res., 2012, 3, 107-113.http://dx.doi.org/10.1007/s12975-011-0099-8 [46] Caliaperumal, J.; Ma, Y.; Colbourne, F. Intra-parenchymal ferrous iron infusion causes neuronal atrophy, cell death and progressive tissue loss: implications for intracerebral hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurol., 2012, 237, 363-369.http://dx.doi.org/10.1016/j.expneurol.2012.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2008, 39, 1165-1170.http://dx.doi.org/ 10.1161/STROKEAHA.107.501213 [48] Lou, M.; Lieb, K.; Selim, M. The relationship between hematoma iron content and perihematoma edema: an MRI study.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Basel Switz., 2009, 27, 266-271.http://dx.doi.org/10.1159/ 000199464 [49] Aft, R.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2011, 42, 3587-3593.http://dx.doi.org/10.1161/STROKEAHA.111.623926 [51] Swanson, R.A.; Ying, W.; Kauppinen, T.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Med., 2004, 4, 193-205. http://dx.doi.org/10.2174/1566524043479185 [52] Fernandez, P.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"C h e m ., 2010, 285, 32844-32851.http://dx.doi.org/ 10.1074/jbc.M110.146076 [53] Davies, M.J.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Acta, 1988, 964, 28-35. http://dx.doi.org/10.1016/0304-4165(88)90063-3 [54] Graça-Souza, A.V.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"N. Y. N, 1997, 216, 456-463.http://dx.doi.org/10.3181/00379727-216-44197 [56] Wagener, F.A.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood, 2001, 98, 1802-1811.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood Flow Metab., 2009, 29, 1109-1120.http://dx.doi.org/10.1038/ jcbfm.2009.34 [58] Fang, H.; Wang, P.F.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"J. Neuroinflammation, 2013, 10, 27. http://dx.doi.org/10.1186/1742-2094-10-27 [59] Zhao, X.; Song, S.; Sun, G.; Strong, R.; Zhang, J.; Grotta, J.C.; Aronowski, J. Neuroprotective role of haptoglobin after intra- cerebral hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurosci., 2009, 29, 15819-15827.http://dx.doi.org/10.1523/JNEUROSCI.3776-09.2009 [60] Galea, J.; Cruickshank, G.; Teeling, J.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurochem., 2012, 121, 785-792.http://dx.doi.org/10.1111/j.1471-4159.2012.07716.x [61] Hvidberg, V.; Maniecki, M.B.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"2011, 114, 1159-1167.http://dx.doi.org/10.3171/2010.10.JNS10861 [63] Wang, J.; Doré, S. Neuroscience, 2008, 155, 1133-1141.http://dx.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Dis., 2006, 22, 473-476.http://dx.doi.org/10.1016/j.nbd.2005.12.009",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"(Wien), 2011, 153, 319-325.http://dx.doi.org/10.1007/s00701-010-0750-2 [67] Duan, S.; Wang, X.; Wang, C.; Wang, D.; Qi, J.; Wang, H. [Expressions of heme oxygenase-1 and apoptosis-modulating proteins in peri-hematoma cortex after intracerebral hemorrhage in human being].",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Alzheimer Res., 2009, 6, 424-430.http://dx.doi.org/10.2174/ 156720509789207985 [69] Song, L.; Song, W.; Schipper, H.M. Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2007, 85, 2186-2195.http://dx.doi.org/10.1002/ jnr.21367 [70] Chen-Roetling, J.; Benvenisti-Zarom, L.; Regan, R.F.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2005, 82, 802-810.http://dx.doi.org/10.1002/jnr.20681 [71] Chen, J.; Regan, R.F.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Commun., 2004, 318, 88-94.http://dx.doi.org/10.1016/j.bbrc.2004.03.187 [72] Vesely, M.J.; Exon, D.J.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Care Med., 2012, 40, 544-552.http://dx.doi.org/10.1097/CCM.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2011, 89, 515-523.http://dx.doi.org/10.1002/jnr.22577 [75] Shah, Z.A.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neuroscience, 2007, 147, 53-59.http://dx.doi.org/10.1016/ j.neuroscience.2007.02.066 [76] Zhao, X.; Sun, G.; Zhang, J.; Strong, R.; Dash, P.K.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2007, 38, 3280-3286. http://dx.doi.org/10.1161/ STROKEAHA.107.486506 [77] Wang, J.; Fields, J.; Zhao, C.; Langer, J.; Thimmulappa, R.K.; Kensler, T.W.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Med., 2007, 43, 408-414.http://dx.doi.org/10.1016/ j.freeradbiomed.2007.04.020 [78] Pan, H.; Wang, H.; Zhu, L.; Mao, L.; Qiao, L.; Su, X. Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2011, 36, 2434-2441.http://dx.doi.org/10.1007/s11064-011-0571-6 [79] Zhang, J.; Zhu, Y.; Zhou, D.; Wang, Z.; Chen, G. Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Nrf2-ARE pathway.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"J. Pineal Res., 2012, 53, 129-137.http://dx.doi.org/10.1111/j.1600-079X.2012.00978.x [81] Zhao, X.; Sun, G.; Zhang, J.; Strong, R.; Song, W.; Gonzales, N.; Grotta, J.C.; Aronowski, J. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurol., 2007, 61, 352-362.http://dx.doi.org/10.1002/ana.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood Flow Metab., 2006, 26, 811-820.http://dx.doi.org/10.1038/sj.jcbfm.9600233 [83] Hyong, A.; Jadhav, V.; Lee, S.; Tong, W.; Rowe, J.; Zhang, J.H.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Brain Res., 2008, 1215, 218-224.http://dx.doi.org/10.1016/j.brainres.2008.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Brain Res., 2010, 1322, 102-108. http://dx.doi.org/10.1016/j.brainres.2010.01.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Sci., 2011, 305, 85-91.http://dx.doi.org/10.1016/j.jns.2011.03.006 [86] Goldstein, L.; Teng, Z.P.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2003, 73, 113-121.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"J. Neurotrauma, 2003, 20, 111-120.http://dx.doi.org/ 10.1089/08977150360517236 [88] Song, S.; Hua, Y.; Keep, R.F.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Suppl., 2008, 105, 13-18.http://dx.doi.org/10.1007/978-3-211-09469-3_3 [89] Wu, H.; Wu, T.; Xu, X.; Wang, J.; Wang, J.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Blood Flow Metab., 2011, 31, 1243-1250.http://dx.doi.org/10.1038/jcbfm.2010.209 [90] Nakamura, T.; Keep, R.F.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurosurg., 2004, 100, 672-678.http://dx.doi.org/10.3171/jns.2004.100.4.0672 [91] Frantzias, J.; Sena, E.S.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurol., 2011, 69, 389-399. http://dx.doi.org/ 10.1002/ana.22243 [92] Warkentin, L.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Brain  Res., 2010, 1309, 95-103.http://dx.doi.org/10.1016/j.brainres.2009.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurol., 2012, 234, 136-143.http://dx.doi.org/ 10.1016/j.expneurol.2011.12.030 [94] Selim, M.; Yeatts, S.; Goldstein, J.N.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2011, 42, 3067-3074.http://dx.doi.org/10.1161/STROKEAHA.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Res., 2009, 31, 183-188.http://dx.doi.org/10.1179/ 174313209X385680 [96] Wasserman, J.K.; Schlichter, L.C.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurol., 2007, 207, 227-237.http://dx.doi.org/ 10.1016/j.expneurol.2007.06.025 [97] Power, C.; Henry, S.; Del Bigio, M.R.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurol., 2003, 53, 731-742.http://dx.doi.org/10.1002/ana.10553 [98] Xue, M.; Mikliaeva, E.I.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Pathol., 2010, 176, 1193-1202.http://dx.doi.org/10.2353/ajpath.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Lancet Neurol., 2007, 6, 1045-1053.http://dx.doi.org/10.1016/S1474-4422(07)70270-3 [100] Diguet, E.; Fernagut, P.O.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurosci., 2004, 19, 3266-3276.http://dx.doi.org/10.1111/ j.0953-816X.2004.03372.x [101] Zhou, Q.; Liao, J.K. Pleiotropic effects of statins.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"N e u r o s u r g ., 2004, 101, 104-107.http://dx.doi.org/10.3171/ jns.2004.101.1.0104 [103] Jung, K.H.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2004, 35, 1744-1749.http://dx.doi.org/10.1161/ 01.STR.0000131270.45822.85 [104] Cui, J.J.; Wang, D.; Gao, F.; Li, Y.R.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Biophys., 2012, 62, 87-90.http://dx.doi.org/10.1007/s12013-011-9264-7 [105] Merlo, L.; Cimino, F.; Scibilia, A .",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"J. Neurotrauma, 2011, 28, 2493-2501.http://dx.doi.org/10.1089/ neu.2010.1624 [106] Ayer, R.E.",OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Care 2008, 8, 13-18.http://dx.doi.org/10.1007/s12028-007-0081-1 [108] Naval, N.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2008, 39, 2151-2154.http://dx.doi.org/10.1161/STROKEAHA.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Neurology, 2011, 76, 1581-1588.http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"Circ., 2012, 43, 1518-1523.http://dx.doi.org/10.1161/STROKEAHA.111.645978 [112] Kirkpatrick, P.J.",Non-OADS,/arxiv_data1/oa_pdf/0d/01/CN-14-392.PMC4876594.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e7/6b/jjm-09-03-29057.PMC4876617.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/10/hepatmon-16-03-32160.PMC4876664.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/8a/copd-11-1031.PMC4876674.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1031–1033International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1031COrrIgenDumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S10862 0Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium  bromide improve lung function versus individual treatments in moderate-to- severe Japanese COPD patients: a randomized controlled trial – Evaluation  of Airway sGaw after treatment with tripLE [Corrigendum] Saito T, Takeda A, Hashimoto K, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/8a/copd-11-1031.PMC4876674.pdf
Improvements were seen for all parameters for their adjusted Journal name: International Journal of COPD Article Designation: Corrigendum Y ear: 2016 Volume: 11 Running head verso: Saito et al Running head recto: Triple therapy with salmeterol/fluticasone DOI: http://dx.doi.org/10.2147/COPD.S108620 Figure 2 CONSORT flow diagram.,OADS,/arxiv_data1/oa_pdf/48/8a/copd-11-1031.PMC4876674.pdf
"International Journal of COPD 2016:11submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/48/8a/copd-11-1031.PMC4876674.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 1033Triple therapy with salmeterol/fluticasone On page 2398, Table 3, TGV (L) row, SFC250 + TIO vs  SFC250 (n =50): 97.5% CI column,  “-0.028” should have  read “0.028”.",Non-OADS,/arxiv_data1/oa_pdf/48/8a/copd-11-1031.PMC4876674.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/98/copd-11-1035.PMC4876676.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1035–1043International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1035OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10266 8effects of budesonide on toll-like receptor  expression in alveolar macrophages from smokers  with and without COPD Jie Ji1 Ida von schéele1 Bo Billing2 Barbro Dahlén2 ann-sofie lantz2 Kjell larsson1 lena Palmberg1 1lung and airway research, Institute  of environmental Medicine, Karolinska  Institutet, stockholm, sweden;   2Department of Medicine, Karolinska  Institutet, Karolinska University  hospital, stockholm, swedenIntroduction:  Alveolar macrophages (AMs) are equipped with innate immune receptors such  as toll-like receptor 2 (TLR2) and toll-like receptor 4 (TLR4).",Non-OADS,/arxiv_data1/oa_pdf/39/98/copd-11-1035.PMC4876676.pdf
"Keywords:  smokers, lipopolysaccarid, peptidoglycan, glucocorticosteroid Introduction Bacterial colonization of the respiratory tract commonly occurs in people who are  continuously exposed to inhaled foreign particles, such as cigarette smoke or dust.1,2  One of the key players of the innate immune defense in the human respiratory tract is  the alveolar macrophage (AM).3 The AM orchestrates airway inflammation by secreting  and responding to related cytokines and chemokines.4 The number of macrophages in Correspondence: Jie Ji lung and airway research, Institute  of environmental Medicine, Karolinska  Institutet, PO Box 287, se-171 77  stockholm, sweden Tel +46 8 5248 2203 email jie.ji@ki.s e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ji et al Running head recto: Effects of budesonide on TLR expression in alveolar macrophages DOI: http://dx.doi.org/10.2147/COPD.S102668",Non-OADS,/arxiv_data1/oa_pdf/39/98/copd-11-1035.PMC4876676.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/39/98/copd-11-1035.PMC4876676.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/98/copd-11-1035.PMC4876676.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/47/copd-11-1023.PMC4876677.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1023–1029International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1023OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9915 6a comparison of synchronized intermittent  mandatory ventilation and pressure-regulated  volume control ventilation in elderly patients  with acute exacerbations of COPD and  respiratory failure suchi Chang1 Jindong shi2 Cuiping Fu1 Xu Wu1 shanqun li1 1Department of respiratory Medicine,   Zhongshan hospital, Fudan University,   shanghai, 2Department of respiratory  Medicine, The Fifth People’s hospital  of shanghai, Fudan University,   shanghai, People’s republic of ChinaBackground:  COPD is the third leading cause of death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/copd-11-1023.PMC4876677.pdf
"Keywords:  COPD, respiratory failure, invasive mechanical ventilation, pressure-regulated  volume control, synchronized intermittent mandatory ventilation Introduction The clinical manifestations of acute exacerbations of COPD (AECOPD) with hyper - capnic respiratory failure include a partial pressure of carbon dioxide (PaCO2) in Correspondence: shanqun li Department of respiratory Medicine,  Zhongshan hospital, Fudan University,  180 Fenglin road, shanghai 200032,  People’s republic of China Tel +86 136 8197 3967 Fax +86 21 6404 8687 email lsq18616880856@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chang et al Running head recto: Comparison of SIMV and PRVC DOI: http://dx.doi.org/10.2147/COPD.S99156",Non-OADS,/arxiv_data1/oa_pdf/0f/47/copd-11-1023.PMC4876677.pdf
"Available from: http://www.goldcopd.org/Guidelines/guidelines-global- strategy-for-diagnosis-management.htm l. Accessed February 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/copd-11-1023.PMC4876677.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/copd-11-1023.PMC4876677.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/copd-11-1023.PMC4876677.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinicoeconomics and Outcomes research 2016:8 187–195submit your manuscript | www.dovepress.co m Dove press  187 http: //dx.doi.org/10.2147/CEOR.S9560 3Prolonged length of stay associated with air leak  following pulmonary resection has a negative  impact on hospital margin Douglas e Wood1 lisa M lauer2 andrew layton3 Kuo B T ong3 1Division of cardiothoracic surgery,   Department of surgery, University of  Washington, seattle, 2spiration inc.,   redmond, W a, 3Quorum consulting,   inc., san Francisco, ca, Usa correspondence: Douglas e Wood   Division of cardiothoracic surgery,  Department of surgery, University of  Washington, 1959 NE Pacific, AA-115,  seattle, W a 98195, Usa   T el +1 206 685 3228   Fax +1 206 543 0325   email dewood@uw.ed uBackground:  Protracted hospitalizations due to air leaks following lung resections are a  significant source of morbidity and prolonged hospital length of stay (LOS), with potentially  significant impact on hospital margins.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
Available from: http://www.cdc.gov/nchs/data/icd/ICD-9-CMINDEX - ADDENDAfy12.pd f.  11.,OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
"Available from: https://www.cms.gov/Medicare/Medicare-Fee-for- Service-Payment/AcuteInpatientPPS/outlier.htm l. Accessed June 30,  2014.",Non-OADS,/arxiv_data1/oa_pdf/ff/80/ceor-8-187.PMC4876678.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/4e/cia-11-651.PMC4876679.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 651–657submit your manuscript | www.dovepress.co m Dove press  651 http: //dx.doi.org/10.2147/CIA.S9725 4Dove press OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article Safety and efficacy of phacoemulsification and  intraocular lens implantation through a small pupil  using minimal iris manipulation Dimitris Papaconstantinou george Kalantzis Dimitris Brouzas Anastasios Kontaxakis Chryssanthi Koutsandrea Andreas Diagourtas Ilias georgalas Department of Ophthalmology,   national and Kapodistrian University  of Athens, Athens, GreecePurpose:  The aim of this study was to compare the results of phacoemulsification through a  small pupil using minimal iris manipulation versus phacoemulsification through a well-dilated  pupil.",Non-OADS,/arxiv_data1/oa_pdf/59/4e/cia-11-651.PMC4876679.pdf
"Keywords:  phacoemulsification, small pupil, safety, iris manipulation Introduction Cataract is a common cause of visual impairment in the elderly and represents the  commonest etiology of blindness worldwide.1 Clear corneal cataract surgery has  become a common practice since eye surgeons commenced using topical anesthesia,  phacoemulsification, and small foldable intraocular lenses (IOLs) during the past Correspondence: Ilias georgalas Department of Ophthalmology, National  and Kapodistrian University of Athens,  154 Mesogeion Ave, 15400 Athens,  greece email igeorgalas@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Papaconstantinou et al Running head recto: Phacoemulsification through a small pupil DOI: http://dx.doi.org/10.2147/CIA.S97254",Non-OADS,/arxiv_data1/oa_pdf/59/4e/cia-11-651.PMC4876679.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/59/4e/cia-11-651.PMC4876679.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/59/4e/cia-11-651.PMC4876679.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 83–91Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 83 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S83146Profile of palbociclib in the treatment of  metastatic breast cancer Moataz Ehab1 Mohamad Elbaz2,3 1Department of Pharmacy Practice,   2Department of Pharmacology,   Pharmacy School, Helwan University,   Egypt; 3Department of Pathology, The  Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USAAbstract: Breast cancer is the most common cancer diagnosed in women.",Non-OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
"3 The therapeutic options vary from primary surgery to targeted Correspondence: Mohamad Elbaz Department of Pathology,   The Comprehensive Cancer Center,   The Ohio State University Wexner Medical Center, 840 Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH 43210, USATel +1 614 500 0948Email elbaz.2@osu.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Ehab and ElbazRunning head recto: Palbociclib in metastatic breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S83146",Non-OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 91 Palbociclib in metastatic breast cancer  41.,Non-OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
Available at: http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/9e/2c/bctt-8-083.PMC4876680.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d3/f3/ccid-9-127.PMC4876681.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d3/f3/ccid-9-127.PMC4876681.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 127–134Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 127 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S108187 Enhanced effect of fibroblast growth  factor‑2‑containing dalteparin/protamine  nanoparticles on hair growth Yuki Takabayashi1  Masaki Nambu1  Masayuki Ishihara2  Masahiro Kuwabara1  Koichi Fukuda2  Shingo Nakamura2  Hidemi Hattori2  T omoharu Kiyosawa1 1Department of Plastic and  Reconstructive Surgery, 2Division of  Biomedical Engineering, Research  Institute, National Defense Medical College, T okorozawa, Saitama, JapanPurpose: Although treatments for alopecia are in high demand, not all treatments are safe and  reliable.",Non-OADS,/arxiv_data1/oa_pdf/d3/f3/ccid-9-127.PMC4876681.pdf
"5,6 The hair follicles, including DP cells, are organs, which are  responsible for the production of hair fibers by inducing and maintaining the anagen Correspondence: Masayuki Ishihara   Division of Biomedical Engineering,  Research Institute, National Defense Medical College, 3‑2 Namiki, Tokorozawa 359‑8513, Saitama, Japan   Tel +81 4 2995 1601   Fax +81 4 2991 1611   Email ishihara@ndmc.ac.jpJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Takabayashi et alRunning head recto: FGF-2&D/P NPs facilitate hair growthDOI: http://dx.doi.org/10.2147/CCID.S108187",Non-OADS,/arxiv_data1/oa_pdf/d3/f3/ccid-9-127.PMC4876681.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical‑cosmetic‑and‑investigational‑dermatology‑journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d3/f3/ccid-9-127.PMC4876681.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 134 Takabayashi et al  30.,Non-OADS,/arxiv_data1/oa_pdf/d3/f3/ccid-9-127.PMC4876681.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 665–681Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  665RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10576 9 Genes associated with Alzheimer’s disease:  an overview and current status Mohan Giri Man Zhang Yang Lü Department of Geriatrics, The First  Affiliated Hospital of Chongqing  Medical University, Yuzhong District,   Chongqing, People’s Republic of ChinaAbstract:  Alzheimer’s disease (AD) is a progressive, neurodegenerative disease and the  most common form of dementia in elderly people.",Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
"Up to 60%–80% of LOAD is  inheritable, but genetic and environmental factors play a key role in onset, progres - sion, and severity of disease.3Correspondence: Yang Lü Department of Geriatrics, The First  Affiliated Hospital of Chongqing  Medical University, No 1 Youyi Road,  Yuzhong District, Chongqing 400016,  People’s Republic of China Tel +86 23 8901 1622 Fax +86 23 6881 1487 email lyu_yang@126.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Giri et al Running head recto: Genes associated with AD DOI: http://dx.doi.org/10.2147/CIA.S105769 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
Or use: http://youtu.be/_nbEYWt-BH 8video abstract,Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
"To date, .270 highly penetrant mutations have  been described in these genes that cause familial AD and  many more are discovered each year13 (http://www.molgen.",Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/88/06/cia-11-665.PMC4876682.pdf
See http://creativecommons.org /licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/07/e0/1914.PMC4876683.pdf
"Failure to de- tect changes in sensitivity was also observed with thequantitative insulin sensitivity check index (QUICKI) (21), a related surrogate ( P= 0.014 and P= 0.268 for correla- tions in animals with high and low AIR G, respectively), and detection was not improved with second-generation HOMA2-IR estimates (http://www.dtu.ox.ac.uk/homacalculator).The ability of HOMA-IR (or QUICKI) to detect devel- opment of insulin resistance is dependent upon b-cell function.",Non-OADS,/arxiv_data1/oa_pdf/07/e0/1914.PMC4876683.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/7f/cia-11-659.PMC4876690.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 659–664Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  659OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10465 6Does severity of dermatochalasis in aging affect  corneal biomechanical properties?",Non-OADS,/arxiv_data1/oa_pdf/5a/7f/cia-11-659.PMC4876690.pdf
"The biomechanical alterations seen in the dermis and the cornea of  dermatochalasis patients may therefore result from disruptions of these collagen and  elastin fibers.4,9–11 The corneal biomechanical properties are also related to several  connective tissue and eyelid diseases such as Marfan syndrome (MS) and FES.12,13 Corneal hysteresis (CH) and corneal resistance factors (CRFs) are two important  biomechanical properties that can be analyzed in vivo and are related to the viscous Correspondence: Kurşat Atalay Department of Ophthalmology, Bagcilar  Training and research hospital, Bagcilar  Merkez, 34200, Istanbul, Turkey Tel +90 212 440 4000 email drkursatalay@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Atalay et al Running head recto: Dermatochalasis alters corneal biomechanics DOI: http://dx.doi.org/10.2147/CIA.S104656",Non-OADS,/arxiv_data1/oa_pdf/5a/7f/cia-11-659.PMC4876690.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5a/7f/cia-11-659.PMC4876690.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5a/7f/cia-11-659.PMC4876690.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c3/75/tom35.PMC4876723.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00106 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 1 |MARCH 2016 35,Non-OADS,/arxiv_data1/oa_pdf/c3/75/tom35.PMC4876723.pdf
http://dx.doi.org/10.1002/9780470034590.emrstm1253 19.,Non-OADS,/arxiv_data1/oa_pdf/c3/75/tom35.PMC4876723.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Qian Shi,1Yingnan Zhao,2Vivian Fonseca,3 Marie Krousel-Wood,4,5and Lizheng Shi1Diabetes Care Volume 37, May 2014 1321EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/17/7d/1321.PMC4876755.pdf
Available from http://www.ahrq.gov/research/diabdisp.pdf.,OADS,/arxiv_data1/oa_pdf/17/7d/1321.PMC4876755.pdf
Available from http://one.aao.org/ preferred-practice-pattern/diabetic-retinopathy- ppp –september-2008-4th-print.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/1321.PMC4876755.pdf
Avail- able from http://meps.ahrq.gov/mepsweb/ survey_comp/survey.jsp #supplemental.,OADS,/arxiv_data1/oa_pdf/17/7d/1321.PMC4876755.pdf
Available from http://www.dhcs.ca.gov/dataandstats/reports/ Documents/MMCD_Qual_Rpts/HEDIS_Reports/ HEDIS2009.pdf.,OADS,/arxiv_data1/oa_pdf/17/7d/1321.PMC4876755.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Allison B.,Non-OADS,/arxiv_data1/oa_pdf/4f/2e/e112.PMC4876756.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Gary L. Pierce, Kyle Siefers, and Lauren Wegman-Pointse110 Diabetes Care Volume 37, May 2014eLETTERS –COMMENTS AND RESPONSES",Non-OADS,/arxiv_data1/oa_pdf/03/ea/e110.PMC4876757.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.M.,Non-OADS,/arxiv_data1/oa_pdf/a5/4c/e149.PMC4876772.pdf
"Avilable from: http://www.who.int/nmh/ publications/ncd-profiles-2014/en/ 2 Mousavi SM, Gouya MM, Ramazani R, et al.",OADS,/arxiv_data1/oa_pdf/d6/b1/IJCBNM-4-186.PMC4876787.pdf
"Avilable from: http://www.who.int/cancer/country-profiles/en/ 4 Milbrandt EB, Kersten A, Rahim MT, et al.Growth of intensive care unit resource use and its estimated cost in Medicare.",Non-OADS,/arxiv_data1/oa_pdf/d6/b1/IJCBNM-4-186.PMC4876787.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 123–131International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 123 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S104313Get the most from your data: a propensity score  model comparison on real-life data Dennis Ferdinand1 Mirko Otto2 Christel Weiss1 1Department of Biomathematics and  Medical Statistics, 2Department of  Surgery, University Medical Center  Mannheim (UMM), University of Heidelberg, Mannheim, GermanyPurpose: In the past, the propensity score has been in the middle of several discussions in  terms of its abilities and limitations.",Non-OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
"2 In 1983, Rosenbaum and Rubin introduced the propensity score as a new balancing  score.2 The propensity score unifies all known covariates from a patient in one score Correspondence: Dennis Ferdinand Department of Biomathematics and Medical Statistics, Universitätsmedizin Mannheim (UMM), 13–17 Ludolf-Krehl-Strasse, Mannheim 68167, GermanyEmail d.ferdinand@stud.uni-heidelberg.deJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Ferdinand et alRunning head recto: Propensity score model comparison on real-life dataDOI: http://dx.doi.org/10.2147/IJGM.S104313",Non-OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
Available from: http://papers.ssrn.com/sol3/papers.cfm?abstract_ id=270919.,Non-OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 131 Propensity score model comparison on real-life data,Non-OADS,/arxiv_data1/oa_pdf/e3/2a/ijgm-9-123.PMC4876794.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/ba/dddt-10-1691.PMC4876795.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1691–1694Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1691Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10560 7reducing the trigger dose of recombinant  hcg in high-responder patients attending an  assisted reproductive technology program: an  observational study gian Mario Tiboni enrica concetta colangelo adalisa Ponzano Department of Medicine and aging  sciences, University “ g d’annunzio”  of chieti-Pescara, chieti, italyAbstract:  Decreasing the dose of human chorionic gonadotropin (hCG) used to trigger final  oocyte maturation in assisted reproductive technology programs is regarded as a useful interven - tion in the prevention of ovarian hyperstimulation syndrome, but the minimal effective dose has  not been yet identified.",Non-OADS,/arxiv_data1/oa_pdf/eb/ba/dddt-10-1691.PMC4876795.pdf
"The risk factors for OHSS include young age, high antral follicle correspondence: gian Mario Tiboni Department of Medicine and aging  sciences, University “g d’annunzio”  of chieti-Pescara, Via dei Vestini,  66013 chieti, italy Tel +39 085 917 2390 email tiboni@unich.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tiboni et al Running head recto: Low dose of recombinant hCG in high-responder patients DOI: http://dx.doi.org/10.2147/DDDT.S105607",Non-OADS,/arxiv_data1/oa_pdf/eb/ba/dddt-10-1691.PMC4876795.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/eb/ba/dddt-10-1691.PMC4876795.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/ba/dddt-10-1691.PMC4876795.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/eb/ba/dddt-10-1691.PMC4876795.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/e4/ijn-11-2081.PMC4876796.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2081–2090International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2081OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10156 3long-term effect of ropivacaine nanoparticles for  sciatic nerve block on postoperative pain in rats Zi Wang1,* haizhen huang2,* shaozhong Yang1 shanshan huang1 Jingxuan guo1 Qi Tang1 Feng Qi1 1Department of anesthesiology, Qilu  hospital of shandong University,   2Department of anesthesiology,   stomatology hospital of shandong  University, Jinan, shandong, People’s  republic of china *These authors contributed equally  to this workPurpose:  The analgesic effect of ropivacaine (Rop) for nerve block lasts only ~3–6 hours for  single use.",Non-OADS,/arxiv_data1/oa_pdf/58/e4/ijn-11-2081.PMC4876796.pdf
"It can not only contribute to several clinically valuable  outcomes, including earlier patient mobilization and quicker recovery, which can  result in a shortened hospital stay and reduced costs, but also prevent the devel - opment of chronic pain in the long term, which can occur if early acute pain is  prolonged.2–6 Besides providing excellent analgesia at rest and in movement, the  opioid-sparing effects of local anesthetics are associated with reduced opioid-related  side effects.7correspondence: Feng Qi Department of anesthesiology, Qilu  hospital of shandong University,  107 Wenhua Xi road, Jinan 250012,  shandong, People’s republic of china Tel +86 185 6008 3756 Fax +86 531 8869 2544 email qifeng66321@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Ropivacaine nanoparticles for sciatic nerve block DOI: http://dx.doi.org/10.2147/IJN.S101563",Non-OADS,/arxiv_data1/oa_pdf/58/e4/ijn-11-2081.PMC4876796.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/58/e4/ijn-11-2081.PMC4876796.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/e4/ijn-11-2081.PMC4876796.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/bf/copd-11-1045.PMC4876797.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1045–1052International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1045OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9979 3Investigating sensitivity, specificity, and area under  the curve of the Clinical COPD Questionnaire,  COPD Assessment T est, and Modified Medical  research Council scale according to gOlD using  st george’s respiratory Questionnaire cutoff 25  (and 20) as reference Ioanna g Tsiligianni1,2 harma J alma1,2 Corina de Jong1,2 Danijel Jelusic3 Michael Wittmann3 Michael schuler4 Konrad schultz3 Boudewijn J Kollen1 Thys van der Molen1,2 Janwillem Wh Kocks1,2 1Department of general Practice,   2grIa C research Institute,   University Medical Center groningen,   University of groningen, groningen,   the netherlands; 3Klinik Bad  reichenhall, Center for rehabilitation,   Pulmonology and Orthopedics, Bad  reichenhall, 4Department of Medical  Psychology, Psychotherapy and  rehabilitation sciences, University  of Würzburg, Würzburg, germanyBackground:  In the GOLD (Global initiative for chronic Obstructive Lung Disease) strategy  document, the Clinical COPD Questionnaire (CCQ), COPD Assessment Test (CAT), or modified  Medical Research Council (mMRC) scale are recommended for the assessment of symptoms using  the cutoff points of CCQ $1, CAT $10, and mMRC scale $2 to indicate symptomatic patients.",Non-OADS,/arxiv_data1/oa_pdf/9a/bf/copd-11-1045.PMC4876797.pdf
"Keywords:  pulmonary disease, chronic obstructive, health status Introduction COPD is a prevalent disease worldwide, characterized by persistent airflow limitation.1  COPD patients suffer for years and die prematurely due to its complications.1,2 Correspondence: Ioanna g Tsiligianni Department of general Practice,  University Medical Center groningen,  University of groningen, 1 antonius  Deusinglaan, groningen 9713 aV,  the netherlands Tel +31 50 363 7478 Fax +31 50 363 2964 email i.tsiligianni@umcg.n l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tsiligianni et al Running head recto: Questionnaire cutoff points in COPD DOI: http://dx.doi.org/10.2147/COPD.S99793",Non-OADS,/arxiv_data1/oa_pdf/9a/bf/copd-11-1045.PMC4876797.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9a/bf/copd-11-1045.PMC4876797.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/bf/copd-11-1045.PMC4876797.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/16/dddt-10-1663.PMC4876798.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1663–1674Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1663Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10382 9Ursolic acid reduces the metalloprotease/anti- metalloprotease imbalance in cerebral ischemia  and reperfusion injury Yanzhe Wang Zhiyi he shumin Deng Department of n eurology, The First  affiliated hospital of china Medical  University, shenyang, People’s  republic of chinaBackground:  Activators of PPARs, particularly PPAR γ, may be effective neuroprotective  drugs against inflammatory responses in cerebral ischemia and reperfusion injury.",Non-OADS,/arxiv_data1/oa_pdf/2f/16/dddt-10-1663.PMC4876798.pdf
"Cerebral  ischemia results from a transient or permanent local reduction in cerebral blood flow  (CBF).1 Although rapid reperfusion therapy, such as thrombolysis, within the thera - peutic window is widely accepted, post-reperfusion injury usually exacerbates the  brain injury caused by the ischemic event.correspondence: Zhiyi he Department of neurology, The First  Affiliated Hospital of China Medical  University, 155 nanjing north street,  shenyang 110001, People’s republic  of china Tel +86 24 8328 2513 email hezhiyi0301@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: Effects of ursolic acid on cerebral ischemia and reperfusion injury DOI: http://dx.doi.org/10.2147/DDDT.S103829",Non-OADS,/arxiv_data1/oa_pdf/2f/16/dddt-10-1663.PMC4876798.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2f/16/dddt-10-1663.PMC4876798.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/16/dddt-10-1663.PMC4876798.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/91/copd-11-1053.PMC4876799.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1053–1059International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1053OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10270 8hyperlipidemia in COPD is associated with  decreased incidence of pneumonia and mortality:  a nationwide health insurance data-based  retrospective cohort study Ming-Chen Chan1–3 Ching-heng lin4 Yu ru Kou1 1Institute of Physiology, national  Yang-Ming University, Taipei, 2Division  of Chest Medicine, Department of  Internal Medicine, Taichung Veterans  general hospital, 3College of nursing,   Central Taiwan University of science  and T echnology, 4Department of  Medical research, Taichung Veterans  general hospital, Taichung, TaiwanPurpose:  COPD is often associated with various comorbidities that may influence its outcomes.",Non-OADS,/arxiv_data1/oa_pdf/41/91/copd-11-1053.PMC4876799.pdf
"Keywords:  COPD, hyperlipidemia, pneumonia, mortality Introduction COPD is one of the major public health problems in modern society caused mainly by  cigarette smoking, and its importance is increasing.1,2 COPD is a complex, heterogeneous,  multicomponent disease with great variations in its clinical, radiological, and functional  aspects.3 It has a variety of systemic manifestations and thus the current guideline recom - mends a multidirectional strategy in diagnosis, treatment, and prevention of COPD.4 COPD is often associated with a variety of comorbidities, including cardiovascular  disease (CVD), malignancy, anxiety, depression, chronic renal failure, and infection.5–10  Comorbidities of COPD also have important impacts on major outcomes, including  quality of life,11 rate of acute exacerbation,12 and mortality.13 Both COPD14,15 and coro - nary artery disease16 are characterized by low-grade systemic inflammation, which is Correspondence: Yu ru Kou Institute of Physiology, national  Yang-Ming University, no 155, sec 2,  linong street, Taipei, 11221, Taiwan Tel +886 2 2826 7086 Fax +886 2 2826 4049 email yrkou@ym.edu.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chan et al Running head recto: Hyperlipidemia with better prognosis in COPD DOI: http://dx.doi.org/10.2147/COPD.S102708",Non-OADS,/arxiv_data1/oa_pdf/41/91/copd-11-1053.PMC4876799.pdf
Available from: http://www.goldcopd.com /.,Non-OADS,/arxiv_data1/oa_pdf/41/91/copd-11-1053.PMC4876799.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/41/91/copd-11-1053.PMC4876799.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/91/copd-11-1053.PMC4876799.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/35/a3/dddt-10-1683.PMC4876800.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1683–1689Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1683Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9416 7Spotlight on idarucizumab and its potential for the  reversal of anticoagulant effects of dabigatran Pierre Sié Hematology Laboratory, Academic  Hospital of Toulouse, Hospital  Rangueil, T oulouse, FranceAbstract:  Idarucizumab is the first targeted antidote of dabigatran, a direct oral anticoagulant  used for prevention and treatment of venous thromboembolism and prevention of stroke in  atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/35/a3/dddt-10-1683.PMC4876800.pdf
"The rate of major bleeding, fatal bleeding, and intracranial hemorrhages in these patients Correspondence: Pierre Sié Hématologie Laboratoire, Centre  Hospitalier Universitaire de Toulouse,  Hôpital de Rangueil, Avenue du  Professeur Jean Pouhlès, TSA 50032,  Toulouse 31059, CeDeX 9, France Tel +33 5 6132 2289 Fax +33 5 6132 2233 email sie.p@chu-toulouse.f r Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Sié Running head recto: Idarucizumab for dabigatran reversal DOI: http://dx.doi.org/10.2147/DDDT.S94167",Non-OADS,/arxiv_data1/oa_pdf/35/a3/dddt-10-1683.PMC4876800.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/35/a3/dddt-10-1683.PMC4876800.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/a3/dddt-10-1683.PMC4876800.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2107–2118International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2107RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S10350 1Current status and perspectives in atomic force  microscopy-based identification of cellular  transformation Chenbo Dong Xiao Hu Cerasela Zoica Dinu Department of Chemical and  Biomedical engineering, west virginia  University, Morgantown, wv, USAAbstract:  Understanding the complex interplay between cells and their biomechanics and how  the interplay is influenced by the extracellular microenvironment, as well as how the transforming  potential of a tissue from a benign to a cancerous one is related to the dynamics of both the cell  and its surroundings, holds promise for the development of targeted translational therapies.",Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
"Tumor-suppressor genes could, for  instance, restrain cell division as well as induce cell death, while loss of gene func - tion could result in abnormal cellular behavior, perturbation of the cell cycle, and lack  of cell regulation.6 Previous studies have also indicated that LIMD1  overexpression  could retard cell-cycle progression and block S-phase entry, leading to cell accumu - lation in the G0/G1 phase and subsequent changes in cellular behavior;7 LIMD1  is a  tumor-suppressor gene located at chromosome 3p21.3, a region commonly deleted  in many malignancies.6 Another study found that deregulation of microcephalin and  ASPM  expression (involved in the regulation of neurogenesis)8 leads to abnormal  cell division and subsequently to cancer progression.7 Microcephalin is involved  in the DNA-damage response and has been linked to tumor formation and cancer Correspondence: Cerasela Zoica Dinu Department of Chemical and Biomedical  engineering, Benjamin M Statler College  of engineering and Mineral Resources,  west virginia University, 395 evansdale  Drive, PO Box 6102, Morgantown,  wv 26506, USA Tel +1 304 293 9338 Fax +1 304 293 4139 email cerasela-zoica.dinu@mail.wvu.ed u Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Dong et al Running head recto: AFM-based identification of cell transformation DOI: http://dx.doi.org/10.2147/IJN.S103501",Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
2014;9(5):e97005 ( http://creativecommons.org/licenses/by/4.0 /).7 0 NormalG rade 1 Tumor gradeAB CD E Mean nuclear microcephalin staining Grade 2G rade 31234P<0.0001 Figure 4 Glucose metabolism is increased in cancer cells and could produce an  acidic environment that may promote degradation of the extracellular matrix and  influence local cellular invasion.,Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
2012;7:0046609 ( http://creativecommons.org/licenses/by/4.0 /).58,Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
Available from: http://science.sciencemag.org/content/333/6043/75 5.,Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/7d/ijn-11-2107.PMC4876801.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hepatic Medicine: Evidence and Research Hepatic Medicine: Evidence and Research 2016:8 61–68Dove press submit your manuscript | www.dovepress.co m Dove press   Paritaprevir/ritonavir-ombitasvir and dasabuvir,  the 3D regimen for the treatment of chronic  hepatitis C virus infection: a concise review Trana Hussaini1,2 1Faculty of Pharmaceutical  Sciences, University of British  Columbia, Vancouver, BC, Canada;   2Pharmaceutical Sciences, Vancouver  General Hospital, Vancouver, BC,   Canada Correspondence: Trana Hussaini   Vancouver General Hospital,   855 West 12th Avenue, Vancouver, BC,  V5Z IM9, Canada   T el +1 604 328 4930   Fax +1 604 875 5267   Email trana.hussaini@vch.c aAbstract:  The treatment for chronic hepatitis C has been revolutionized with the development  of direct-acting antiviral agents.",Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
Available from: http://www.who.int/ mediacentre /factsheets/fs164/en /.,Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
"Available from: http://www.hcvguidelines.org/full-report/initial- treatment-hcv-infectio n. Accessed April 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
"Available  from: http://www.abbvie.ca/content/dam/abbviecorp/ca/english/docs/ HOLKIRA_PAK_PM_EN.pd f. Accessed April 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic-medicine-evidence-and-research-journa lHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pedi - atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/7a/hmer-8-061.PMC4876802.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/82/dddt-10-1675.PMC4876803.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1675–1682Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1675Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8861 2Safety, efficacy, and clinical utility of macitentan in  the treatment of pulmonary arterial hypertension Thomas J Monaco1 Carlos D Davila2 1Division of Pulmonary and Critical  Care Medicine, Baylor College of  Medicine, Houston, TX, 2Department  of Medicine, einstein Medical Center,   Philadelphia, PA, USAAbstract:  Pulmonary arterial hypertension is a progressive, debilitating disease caused by a  dysregulation of the pulmonary vascular tone that inevitably leads to right heart failure and death  without treatment.",Non-OADS,/arxiv_data1/oa_pdf/84/82/dddt-10-1675.PMC4876803.pdf
"These changes  are mediated by vascular smooth muscle, which is influenced by three vasoactive Correspondence: Carlos D Davila Department of Medicine, einstein Medical  Center, 5501 Old York Road, Suite 363,  Philadelphia, PA 19141, USA Tel +1 215 456 3864 Fax +1 215 456 7890 email davilacc@einstein.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Monaco and Davila Running head recto: Macitentan in PAH DOI: http://dx.doi.org/10.2147/DDDT.S88612",Non-OADS,/arxiv_data1/oa_pdf/84/82/dddt-10-1675.PMC4876803.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/84/82/dddt-10-1675.PMC4876803.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/82/dddt-10-1675.PMC4876803.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Substance Abuse and Rehabilitation 2016:7 55–69Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  55Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S10166 0Systematic review and meta-analysis of internet  interventions for smoking cessation among adults Amanda L Graham1,2 Kelly M Carpenter3 Sarah Cha1 Sam Cole3 Megan A Jacobs1 Margaret Raskob3 Heather Cole-Lewis4,5 1Schroeder institute for Tobacco  Research and Policy Studies,   Truth initiative, washington,   DC, 2Department of Oncology,   Georgetown University Medical  Center/Cancer Prevention and  Control Program, Lombardi  Comprehensive Cancer Center,   washington, DC, 3Alere wellbeing,   Seattle, wA, 4Johnson & Johnson  Health and wellness Solutions, inc.,   New Brunswick, NJ, 5iCF international,   Rockville, MD, USA Correspondence: Amanda L Graham   Schroeder institute for T obacco Research  and Policy Studies, Truth initiative, 900 G  Street Nw , Fourth Floor, w ashington,  DC 20001, USA   T el +1 202 454 5938   Fax +1 202 454 5785   email agraham@truthinitiative.or gBackground:  The aim of this systematic review was to determine the effectiveness of Internet  interventions in promoting smoking cessation among adult tobacco users relative to other forms  of intervention recommended in treatment guidelines.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"Available from: https://www.healthit.gov/sites/default/files/hie- interoperability/nationwide-interoperability-roadmap-final-version- 1.0.pd f. Accessed November 14, 2015.",OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Available from: http://www.who.int/tobacco/ mpower/2008/en /.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
(Archived by WebCite®  at http://www.webcitation.org/6glLkPka Y),Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"Available from: http://www.who.int/nmh/publications/ fact_sheet_tobacco_en.pd f. Accessed February 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
(Archived  by WebCite® at http://www.webcitation.org/6glLMdeI 2).,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Available from: https://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Archived by WebCite®  at http://www.webcitation.org/6gK0Vbcl F. London: National Institute  for Health and Care Excellence; 2008.,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Available from: http://c.ymcdn.com/sites/ www.naquitline.org/resource/resmgr/Research/FINALNAQCFY13.,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"Available from:  http://docplayer.net/6348332-European-network-of-quitlines-guide - lines-to-best-practice-for-smoking-cessation-websites.htm l. Accessed  March 27, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Archived by WebCite® at http://www.webcitation.,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
(Archived by  WebCite® at http://www.webcitation.org/6glMHeK5 X).,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
(Archived  by WebCite® at http://www.webcitation.org/6glMKLCO k).,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Available from: http://docslide.us/documents/healthways-tobacco- cessation-quitnet-comprehensive-kicks-habits-with-greater-support.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Archived at http://www.webcitation.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"Available at http://www.pewinternet.org/ Reports/2013/Health-online.asp x. Washington, DC: Pew Research  Center; 2013.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
org: http://www.webcitation.org/6LxbeFGG v.  24.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Avail - able from: http://handbook.cochrane.org /.,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
(Archived by WebCite® at http://www.webcitation.org/   6glMBOgS C).,OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/sar-7-055.PMC4876804.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/d4/ijn-11-2091.PMC4876805.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2091–2105International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2091OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10485 1Improving the osteogenesis of human bone marrow  mesenchymal stem cell sheets by microrNa-21- loaded chitosan/hyaluronic acid nanoparticles via  reverse transfection Zhongshan Wang,1  guangsheng Wu,2,3  Mengying Wei,4 Qian liu,1  Jian Zhou,1 Tian Qin,1  Xiaoke Feng,1 huan liu,1  Zhihong Feng,1 Yimin Zhao1 1state Key laboratory of Military  stomatology & National clinical  research center for Oral Diseases  &   shaanxi Key laboratory of  Oral Diseases, Department of  Prosthodontics, 2state Key laboratory  of Military stomatology & National  clinical research center for Oral  Diseases & shaanxi engineering  research center for Dental  Materials and advanced Manufacture,   Department of Periodontology, school  of stomatology, The Fourth Military  Medical University, Xi’an, 3Qingdao  First sanatorium, Jinan Military  region, Qingdao, shandong Province,   4Department of Biochemistry and  Molecular Biology, The Fourth Military  Medical University, Xi’an, People’s  republic of chinaAbstract:  Cell sheet engineering has emerged as a novel approach to effectively deliver  seeding cells for tissue regeneration, and developing human bone marrow mesenchymal stem  cell (hBMMSC) sheets with high osteogenic ability is a constant requirement from clinics for  faster and higher-quality bone formation.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/ijn-11-2091.PMC4876805.pdf
"Keywords:  human bone marrow MSCs, cell sheets, microRNA, chitosan, nanoparticles,  osteogenic differentiation Introduction Recently, stem-cell therapy has become a nascent but fast-growing area in the field  of tissue regeneration.1 Stem-cell therapy has proved effective clinically and could  potentially lead to robust treatment outcomes for predictable tissue regeneration.2,3  However, the traditional transplanted models, such as direct cell suspension injec - tion or combination with biomaterials, have tended to present low efficacy, as well  as poor survival of the seeding cells, which might impede the expected therapeutic  effects in humans.4 At the same time, cell sheet engineering has emerged as a novel  approach to effectively deliver seeding cells with good preservation of in vitro- secreted extracellular matrix (ECM) around stem cells.5 Cell sheets were recently  induced using a vitamin C (Vc) inducing method because of increased cell matrix  production and deposition.6 This cell processing approach could effectively preserve correspondence: Zhihong Feng;   Yimin Zhao state Key laboratory of Military  stomatology & National clinical research  center for Oral Diseases & shaanxi Key  laboratory of Oral Diseases, Department  of Periodontology, 145 West changle  road, Xi’an 710032, People’s republic  of china Tel/fax +86 29 8477 6465 email 398823267@qq.co m;  zhaoymdentist@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Improving the osteogenesis of hBMMSC sheets by miR-21-loaded CS/HA NPs DOI: http://dx.doi.org/10.2147/IJN.S104851",Non-OADS,/arxiv_data1/oa_pdf/42/d4/ijn-11-2091.PMC4876805.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/ijn-11-2091.PMC4876805.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/d4/ijn-11-2091.PMC4876805.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fa/74/dmso-9-169.PMC4876838.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/fa/74/dmso-9-169.PMC4876838.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Diabetes, Metabolic syndrome and Obesity: Targets and Therapy 2016:9 169–176submit your manuscript | www.dovepress.co m Dove press  169 http: //dx.doi.org/10.2147/DMSO.S10243 5a qualitative study of perceptions of determinants  of disease burden among young patients with type  1 diabetes and their parents in south india henk Verloo1 Mohan Meenakumari2  elizabeth Jean abraham3 gnanam Malarvizhi3 1Department nursing sciences,   University of applied nursing  sciences, la source, lausanne,   switzerland; 2Kurinji hospital, 3Psg  college of nursing, P sg hospital,   coimbatore, Tamil nadu, india correspondence: henk Verloo   Department nursing sciences, University  of applied nursing sciences, la source,  30, avenue Vinet, ch-1004 lausanne,  switzerland   T el +41 21 641 3867   Fax +41 21 641 3810   email h.verloo@ecolelasource.c hBackground:  Diabetes is a leading threat to public health in India.",Non-OADS,/arxiv_data1/oa_pdf/fa/74/dmso-9-169.PMC4876838.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/fa/74/dmso-9-169.PMC4876838.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/74/dmso-9-169.PMC4876838.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 287–292Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 287 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S95559 Physician and medical student perceptions and  expectations of the pediatric clerkship: a Qatar  experience Mohamed A hendaus1,2 shabina Khan1 samar Osman1 Yasser Alsamman2 T ushar Khanna2 Ahmed h Alhammadi1,2 1Department of Pediatrics, general  Academic Pediatrics Division, hamad  Medical corporation, Doha, 2Weill  cornell Medical college-Qatar, Al  rayyan,  QatarBackground: The average number of clerkship weeks required for the pediatric core rotation  by the US medical schools is significantly lower than those required for internal medicine or  general surgery.",Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
"1 It is known that medical students’ attitudes toward their clerkship  might have an impact on their future career choice.2 In addition, the education setting  such as quality of teaching, structure of learning activities, and opportunities for  clinical correspondence: Mohamed A hendaus Department of Pediatrics, general Pediatrics Division, hamad Medical corporation, Doha 3050, QatarTel +974 4439 2239Fax +974 4443 9571Email mhendaus@yahoo.comJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2016V olume: 7Running head verso: Hendaus et alRunning head recto: Perceptions and expectations of the pediatric clerkshipDOI: http://dx.doi.org/10.2147/AMEP .S95559",Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
Available from: https://members.aamc.org/eweb/upload/LCME%20Standards%20May%202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 292 hendaus et al  12.,Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
Available from: http://med-ed-online.net/index.php/meo/article/view/5295.,Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
Available from: https://www.comsep.org/educationalresources/currthirdyear.cfm.,Non-OADS,/arxiv_data1/oa_pdf/19/2c/amep-7-287.PMC4876839.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/50/dmso-9-163.PMC4876841.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).An indirect comparison of HbA1c treatment effect  with albiglutide and exenatide 2.0 mg QW using  the Bucher method Alan A Martin1 Daniel Parks2 1Department of Value Evidence  Analytics, GlaxoSmithKline, Uxbridge,   Middlesex, UK; 2Department of Value  Evidence Analytics, GlaxoSmithKline,   Collegeville, PA, USA Correspondence: Alan A Martin   Department of Value Evidence Analytics,  GlaxoSmithKline, Stockley Park West,  Uxbridge, Middlesex UB11 1BT, UK   T el +44 20 8990 4307   Email alan.a.martin@gsk.co mAbstract:  No head-to-head comparisons exist between once-weekly (QW) glucagon-like  peptide-1 receptor agonists; accordingly, this indirect comparison was conducted to evalu - ate the comparative efficacy of QW albiglutide vs QW exenatide.",Non-OADS,/arxiv_data1/oa_pdf/33/50/dmso-9-163.PMC4876841.pdf
[updated April 2012]; Available from: http://www.nicedsu.org.,Non-OADS,/arxiv_data1/oa_pdf/33/50/dmso-9-163.PMC4876841.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/33/50/dmso-9-163.PMC4876841.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/50/dmso-9-163.PMC4876841.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/55/ijwh-8-145.PMC4876842.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 145–149International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  145RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10595 5Intramural myomas: to treat or not to treat Mayra J Thompson Bruce R Carr Department of Obstetrics and  Gynecology, University of Texas  Southwestern Medical Center, Dallas,   TX, USAAbstract:  A debate among gynecologic and reproductive surgeons is whether or not there is a  clinical need to treat all intramural myomas.",Non-OADS,/arxiv_data1/oa_pdf/f8/55/ijwh-8-145.PMC4876842.pdf
edu Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Thompson and Carr Running head recto: Intramural myoma treatment DOI: http://dx.doi.org/10.2147/IJWH.S105955,Non-OADS,/arxiv_data1/oa_pdf/f8/55/ijwh-8-145.PMC4876842.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f8/55/ijwh-8-145.PMC4876842.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/55/ijwh-8-145.PMC4876842.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/08/jbm-7-085.PMC4876843.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Blood Medicine 2016:7 85–98Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  85Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S8484 8Strategies to encourage physical activity in  patients with hemophilia to improve quality of life Miwa Goto1 Hideyuki Takedani2 Kazuhiko Y okota1 Nobuhiko Haga3 1Rehabilitation Center, The University  of T okyo Hospital, 2Department of  Joint Surgery, Research Hospital of  the institute of Medical Science, The  University of T okyo, 3Department of  Rehabilitation Medicine, Graduate  School of Medicine, The University of  T okyo, T okyo, Japan Correspondence: Miwa Goto   Rehabilitation Center, The University  of T okyo Hospital, Post 7-3-1, Hongo,  Bunkyo-ku, T okyo 113-8655, Japan   T el +81 3 5800 8680   Fax +81 3 5800 9028   email gotoum-reh@h.u-tokyo.ac.j pAbstract:  Hemophilia is a bleeding disorder caused by a congenital abnormality of blood  coagulation.",Non-OADS,/arxiv_data1/oa_pdf/ec/08/jbm-7-085.PMC4876843.pdf
Available from: http://www1.wfh.,Non-OADS,/arxiv_data1/oa_pdf/ec/08/jbm-7-085.PMC4876843.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/ec/08/jbm-7-085.PMC4876843.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/08/jbm-7-085.PMC4876843.pdf
"Avail - able from: https://www.presidentschallenge.org/informed/digest/ docs/199305digest.pd f. Accessed August 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ec/08/jbm-7-085.PMC4876843.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/ee/cmar-8-057.PMC4876844.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/ee/cmar-8-057.PMC4876844.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2016:3 57–65Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  57 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S104447Novel approaches to target HER2-positive breast  cancer: trastuzumab emtansine Gonzalo Recondo Jr1  Maximo de la Vega1  Fernando Galanternik1  Enrique Díaz-Cantón1  Bernardo Amadeo Leone2  José Pablo Leone3 1Centro de Educación Médica e  Investigaciones Clínicas, Buenos Aires,   2Grupo Oncológico Cooperativo del  Sur, Neuquén, Argentina; 3Division of  Hematology-Oncology and Blood  &  Marrow Transplantation, Holden  Comprehensive Cancer Center,  University of Iowa Hospitals & Clinics,   Iowa City, IA, USAAbstract:  The human epidermal growth factor receptor 2 (HER2) is overexpressed in 20% of  breast carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/98/ee/cmar-8-057.PMC4876844.pdf
"8 Multiple mechanisms of action have been pro-Correspondence: José Pablo Leone   Holden Comprehensive Cancer Center,  University of Iowa Hospitals & Clinics, C32 GH, 200 Hawkins Drive, Iowa City, IA 52242, USA Tel +1 319 356 7839   Fax +1 319 353 8383   Email jose-leone@uiowa.eduJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2016V olume: 3Running head verso: Recondo et alRunning head recto: T -DM1 in HER2-positive breast cancerDOI: http://dx.doi.org/10.2147/CMAR.S104447",Non-OADS,/arxiv_data1/oa_pdf/98/ee/cmar-8-057.PMC4876844.pdf
"Cancer Management and Research 2016:3submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/98/ee/cmar-8-057.PMC4876844.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 65 T -DM1 in HER2-positive breast cancer 20.,Non-OADS,/arxiv_data1/oa_pdf/98/ee/cmar-8-057.PMC4876844.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6b/65/ceg-9-125.PMC4876845.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6b/65/ceg-9-125.PMC4876845.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 125–130Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  125 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S80237Rectal budesonide and mesalamine formulations  in active ulcerative proctosigmoiditis: efficacy,  tolerance, and treatment approach George P Christophi Arvind Rengarajan Matthew A Ciorba Division of Gastroenterology,   Washington University School of Medicine, St. Louis, MO, USAAbstract:  Ulcerative colitis (UC) is an immune-mediated disease of the colon that is character - ized by diffuse and continuous inflammation contiguous from the rectum.",Non-OADS,/arxiv_data1/oa_pdf/6b/65/ceg-9-125.PMC4876845.pdf
"5 Left-sided colitis, seen  in around 30% of UC patients, involves continues inflammation from the anus to the Correspondence: George P Christophi Department of Gastroenterology, Washington University School of Medicine, 660 S. Euclid Avenue, Box 8121, St. Louis, MO 63110, USATel +1 314 407 9222Email gchristo@dom.wustl.eduJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Christophi et alRunning head recto: Topical treatment for ColitisDOI: http://dx.doi.org/10.2147/CEG.S80237",Non-OADS,/arxiv_data1/oa_pdf/6b/65/ceg-9-125.PMC4876845.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/6b/65/ceg-9-125.PMC4876845.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 130 Christophi et al  10.,Non-OADS,/arxiv_data1/oa_pdf/6b/65/ceg-9-125.PMC4876845.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/1b/ijn-11-2179.PMC4876846.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2179–2193International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2179OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10188 6Vesicular (liposomal and nanoparticulated)  delivery of curcumin: a comparative study  on carbon tetrachloride–mediated oxidative  hepatocellular damage in rat model somsubhra Thakur  choudhury1 Nirmalendu Das2 swarupa ghosh2 Debasree ghosh2 somsuta chakraborty2  Nahid ali1 1Infectious Diseases and Immunology,   2Drug Development, Diagnostics and  Biotechnology, csIr-Indian Institute  of chemical Biology, Kolkata, West  Bengal, India Abstract:  The liver plays a vital role in biotransforming and extricating xenobiotics and is  thus prone to their toxicities.",Non-OADS,/arxiv_data1/oa_pdf/cf/1b/ijn-11-2179.PMC4876846.pdf
"The biotransforma - tion of CCl4 takes place in liver, mainly catalyzed by different isotypes of cytochrome correspondence: Nahid ali Infectious Diseases and Immunology  Division, csIr-Indian Institute of  chemical Biology, 4, raja s.c. Mullick  road, Jadavpur, Kolkata 700032, West  Bengal, India Tel +91 33 2499 5757 Fax +91 33 2473 0284/5197 email nali@iicb.res.i n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Choudhury et al Running head recto: Vesiculated (liposomal and nanoparticulated) curcumin in hepatocellular damage DOI: http://dx.doi.org/10.2147/IJN.S101886",Non-OADS,/arxiv_data1/oa_pdf/cf/1b/ijn-11-2179.PMC4876846.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cf/1b/ijn-11-2179.PMC4876846.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/1b/ijn-11-2179.PMC4876846.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6c/ac/imcrj-9-117.PMC4876847.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/6c/ac/imcrj-9-117.PMC4876847.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal 2016:9 117–120International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  117Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9856 9an unusual case of posterior reversible  encephalopathy syndrome in a patient being  weaned from intrathecal morphine Jasper Van aalst1 onno p teernstra1 Wim e Weber2 Kim Rijkers3 1Department of Neurosurgery,   2Department of Neurology,   Maastricht University Medical  Center+, Maastricht, 3Department of  Neurosurgery, Zuyderland Medical  Center, Heerlen, the Netherlands Correspondence: Kim Rijkers   Department of Neurosurgery, Zuyderland  Medical Center, po Box 4446, 6401 CX,  Heerlen, the Netherlands   tel +31 45 576 6652   email kimrijkers@gmail.co mAbstract:  Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological entity  based on clinical signs, including headache, visual abnormalities, and seizures, and radiologi - cal abnormalities mostly consisting of vasogenic brain edema predominantly in the posterior  parietal-temporal-occipital regions.",Non-OADS,/arxiv_data1/oa_pdf/6c/ac/imcrj-9-117.PMC4876847.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/6c/ac/imcrj-9-117.PMC4876847.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/ac/imcrj-9-117.PMC4876847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/98/ijn-11-2133.PMC4876848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2133–2146International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2133OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10356 9aptamer–polymer functionalized silicon  nanosubstrates for enhanced recovered  circulating tumor cell viability and in vitro  chemosensitivity testing Qinglin shen1,2,*, caixia  Peng2,3,*, Yan Zhan1, liang Fan1,  Mengyi Wang1, Qing Zhou4, Jue  liu2,4, Xiaojuan lv1, Qiu Tang1,  Jun li1,2, Xiaodong huang2,  Jiahong Xia2 1Department of Oncology, 2Key  laboratory for Molecular Diagnosis  of hubei Province, 3central  laboratory, 4Department of Pharmacy,   The central hospital of Wuhan, T ongji  Medical college, huazhong University  of science and T echnology, Wuhan,   People’s republic of china *These authors contributed equally  to this workAbstract:  Selection of the optimal chemotherapy regimen for an individual cancer patient is  challenging.",Non-OADS,/arxiv_data1/oa_pdf/eb/98/ijn-11-2133.PMC4876848.pdf
"Currently, the existing  chemosensitivity tests, including the human tumor clonogenic assay, 3-(4,5-dimethyl- 2-thiazolyl)-2,5-diphenyl-2 H-tetrazolium bromide assay, histoculture drug response  assay, and collagen gel-droplet-embedded-culture drug sensitivity test, are costly, correspondence: Qinglin shen Department of Oncology, The central  hospital of Wuhan, Tongji Medical  college, huazhong University of science  and Technology, 26 shengli road, Jiangan  District, Wuhan, 430014, People’s  republic of china Tel +86 27 8221 1212 Fax +86 27 8281 1446 email qinglinshen@whu.edu.c n  Jiahong Xia Key laboratory for Molecular Diagnosis  of hubei Province, The central hospital  of Wuhan, Tongji Medical college,  huazhong University of science and  Technology, 26 shengli road, Jiangan  District, Wuhan, 430014, People’s  republic of china Tel +86 27 8221 1212 Fax +86 27 8281 1446 email jiahong.xia@mail.hust.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Shen et al Running head recto: Recovered circulating tumor cell for in vitro chemosensitivity testing DOI: http://dx.doi.org/10.2147/IJN.S103569",Non-OADS,/arxiv_data1/oa_pdf/eb/98/ijn-11-2133.PMC4876848.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/eb/98/ijn-11-2133.PMC4876848.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/98/ijn-11-2133.PMC4876848.pdf
The sequence reads were aligned to the human refer - ence genome using Novoalign V2.07.13 from Novocraft  (http://www.novocraft.co m).,OADS,/arxiv_data1/oa_pdf/eb/98/ijn-11-2133.PMC4876848.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/81/1c/mder-9-105.PMC4876849.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/81/1c/mder-9-105.PMC4876849.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Medical Devices: Evidence and Research 2016:9 105–114Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  105ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S10009 8Evaluation of a novel tool for bone graft delivery  in minimally invasive transforaminal lumbar  interbody fusion Jeffrey B Kleiner Hannah M Kleiner E John Grimberg Jr Stefanie J Throlson The Spine Center of Innovation,    The Medical Center of Aurora,   Aurora, CO, USA Correspondence: Jeffrey B Kleiner   The Spine Center of Innovation,   The Medical Center of Aurora,   PO Box 6287, Denver, CO 80206   Email jeffreybkleiner@gmail.co mStudy design:  Disk material removed (DMR) during L4-5 and L5-S1 transforaminal lumbar  interbody fusion (T -LIF) surgery was compared to the corresponding bone graft (BG) volumes  inserted at the time of fusion.",Non-OADS,/arxiv_data1/oa_pdf/81/1c/mder-9-105.PMC4876849.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/81/1c/mder-9-105.PMC4876849.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/48/dddt-10-1695.PMC4876850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1695–1701Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1695Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10295 9electroporation-delivered transdermal neostigmine  in rats: equivalent action to intravenous   administration szilvia Berkó1,* Kálmán F Szűcs2,* Boglárka Balázs1,3 erzsébet csányi1 gábor Varju4 anita sztojkov-ivanov2 Mária Budai-Szűcs1 Judit Bóta2 róbert gáspár2 1Department of Pharmaceutical  T echnology, Faculty of Pharmacy,   University of szeged, szeged, hungary;   2Department of Pharmacodynamics  and Biopharmacy, Faculty of Pharmacy,   University of szeged, szeged, hungary;   3gedeon richter Plc., Budapest,   4Dr Derm clinic of anti-aging  Dermatology, aesthetic laser and  Plastic surgery, Budapest, hungary *These authors contributed equally  to this workPurpose:  Transdermal electroporation has become one of the most promising noninvasive  methods for drug administration, with greatly increased transport of macromolecules through  the skin.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/dddt-10-1695.PMC4876850.pdf
"6, h-6720  szeged, hungary Tel +36 62 341 971 Fax +36 62 545 567 email gaspar@pharm.u-szeged.h u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Berkó et al Running head recto: Electroporation-delivered transdermal neostigmine in rat DOI: http://dx.doi.org/10.2147/DDDT.S102959",Non-OADS,/arxiv_data1/oa_pdf/9d/48/dddt-10-1695.PMC4876850.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/dddt-10-1695.PMC4876850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/48/dddt-10-1695.PMC4876850.pdf
"http://dx.doi.org/10.1016/j.dadm.2015.02.001This research was supported by the University of Texas Southwestern Alzheimer’s Disease Center and Dallas Heart/Brain and Aging Study,NIA AG12300.",OADS,/arxiv_data1/oa_pdf/7c/cd/main.PMC4876880.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/f2/main.PMC4876881.pdf
E-mail address: tilly.eichler@dzne.de http://dx.doi.org/10.1016/j.dadm.2014.11.007 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/30/f2/main.PMC4876881.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2014.11.007 .,OADS,/arxiv_data1/oa_pdf/30/f2/main.PMC4876881.pdf
Available at: http://www.uspreventiveservices taskforce.org/uspstf/uspsdeme.htm (published March 2014).,Non-OADS,/arxiv_data1/oa_pdf/30/f2/main.PMC4876881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/70/main.PMC4876882.pdf
E-mail address: Louis_Pasquale@meei.harvard.edu http://dx.doi.org/10.1016/j.dadm.2015.01.004 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/70/main.PMC4876882.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/70/main.PMC4876882.pdf
Transl Psychiatry 2013;3:e233.http://dx.doi.org/10.1038/tp.2012.150.,Non-OADS,/arxiv_data1/oa_pdf/bb/70/main.PMC4876882.pdf
"Of all the factors that contribute to AD, environmental exposures are one of veryfew, if any, risk factors that can be addressed by societal or http://dx.doi.org/10.1016/j.dadm.2015.05.001 2352-8729/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/82/main.PMC4876884.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/82/main.PMC4876884.pdf
Cochrane Database of Systematic Reviews 2014. http://dx.doi.org/10.1002/14651858.,OADS,/arxiv_data1/oa_pdf/33/82/main.PMC4876884.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/06/5a/main.PMC4876885.pdf
E-mail address: james.cameron@ed.ac.uk http://dx.doi.org/10.1016/j.dadm.2015.03.001 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/06/5a/main.PMC4876885.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/5a/main.PMC4876885.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.03.001 .,OADS,/arxiv_data1/oa_pdf/06/5a/main.PMC4876885.pdf
Turk J Med Sci 2014;44 http://dx.doi.org/10.3906/sag-1405-114.,OADS,/arxiv_data1/oa_pdf/06/5a/main.PMC4876885.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/6e/main.PMC4876886.pdf
E-mail address: suvankar.pal@ed.ac.uk http://dx.doi.org/10.1016/j.dadm.2014.11.004 2352-8729/ /C2112015 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/main.PMC4876886.pdf
Supplementary data Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.dadm.2014.11.004 .,OADS,/arxiv_data1/oa_pdf/71/6e/main.PMC4876886.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c3/29/main.PMC4876887.pdf
: 1972-3-6409624; Fax: 1972-3-640-6356 E-mail address: dmichael@post.tau.ac.il http://dx.doi.org/10.1016/j.dadm.2014.11.014 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/29/main.PMC4876887.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/29/main.PMC4876887.pdf
Investigators should be wary of http://dx.doi.org/10.1016/j.dadm.2015.02.002 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/ca/d8/main.PMC4876890.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/ef/main.PMC4876892.pdf
E-mail address: kazuhiko.uchida@cbiri.org http://dx.doi.org/10.1016/j.dadm.2015.04.003 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ef/main.PMC4876892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/ef/main.PMC4876892.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.04.003 .,OADS,/arxiv_data1/oa_pdf/d6/ef/main.PMC4876892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4876893.pdf
E-mail address: Sid.obryant@unthsc.edu http://dx.doi.org/10.1016/j.dadm.2014.11.001 2352-8729/ /C2112015 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4876893.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/c9/main.PMC4876894.pdf
E-mail address: aurelia.ciblis@ucd.ie http://dx.doi.org/10.1016/j.dadm.2014.11.011 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/98/c9/main.PMC4876894.pdf
Available at: http://www.guideline.gov/content.aspx?id 532612 ; 2010.,Non-OADS,/arxiv_data1/oa_pdf/98/c9/main.PMC4876894.pdf
"Editorial Introducing Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, an open access journal of the Alzheimer’s Association Welcome to the inaugural issue of Alzheimer’s & Demen- tia: Diagnosis, Assessment & Disease Monitoring (DADM ) (http://ees.elsevier.com/dadm/default.asp ), an open access journal of the Alzheimer’s Association.",Non-OADS,/arxiv_data1/oa_pdf/65/6e/main.PMC4876895.pdf
The new open access journals of the Alz-heimer’s Association are tied directly to the A&D editorial http://dx.doi.org/10.1016/j.dadm.2015.01.001 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/65/6e/main.PMC4876895.pdf
"Finally, the DADM editorial board is composed of more than 30 experienced, talented, and respected scientists andclinicians, all of whom have agreed to serve as active mem- bers of our editorial board (available at: http://ees.elsevier.",Non-OADS,/arxiv_data1/oa_pdf/65/6e/main.PMC4876895.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/2a/main.PMC4876896.pdf
E-mail address: karenchen@ntu.edu.tw http://dx.doi.org/10.1016/j.dadm.2014.11.015 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/2a/main.PMC4876896.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/2a/main.PMC4876896.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2014.11.015 .,OADS,/arxiv_data1/oa_pdf/7c/2a/main.PMC4876896.pdf
Avail- able at: http://www.motc.gov.tw .,Non-OADS,/arxiv_data1/oa_pdf/7c/2a/main.PMC4876896.pdf
Available at: http://www.epa.gov.tw/ .,OADS,/arxiv_data1/oa_pdf/7c/2a/main.PMC4876896.pdf
E-mail address: alexander.koppara@ukb.uni-bonn.de http://dx.doi.org/10.1016/j.dadm.2015.02.005 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/78/main.PMC4876897.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/78/main.PMC4876897.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/78/main.PMC4876897.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.02.005 .RESEARCH IN CONTEXT 1.,OADS,/arxiv_data1/oa_pdf/d6/78/main.PMC4876897.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/53/fb/main.PMC4876898.pdf
E-mail address: stefan.teipel@med.uni-rostock.de http://dx.doi.org/10.1016/j.dadm.2015.01.007 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/53/fb/main.PMC4876898.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/fb/main.PMC4876898.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/48/main.PMC4876901.pdf
E-mail address: memolab@hsantalucia.it http://dx.doi.org/10.1016/j.dadm.2014.12.001 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/75/48/main.PMC4876901.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/48/main.PMC4876901.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/64/main.PMC4876902.pdf
E-mail address: tgoldber@nshs.edu http://dx.doi.org/10.1016/j.dadm.2014.11.003 2352-8729/ /C2112015 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/82/64/main.PMC4876902.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2014.11.003 .,OADS,/arxiv_data1/oa_pdf/82/64/main.PMC4876902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/d8/main.PMC4876903.pdf
E-mail address: simon.lovestone@psych.ox.ac.uk http://dx.doi.org/10.1016/j.dadm.2014.11.005 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/ac/d8/main.PMC4876903.pdf
"Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing The AIBL study is a longitudinal study of ageing, neuro- imaging, biomarkers, lifestyle, and clinical and neuropsy-chological analysis, with a focus on early detection andlifestyle intervention (available at: http://www.aibl.csiro.",Non-OADS,/arxiv_data1/oa_pdf/ac/d8/main.PMC4876903.pdf
"Preprocessing of LC-MS/MS data Raw data ﬁles produced in Excalibur software (Thermo Scientiﬁc) were processed using Proteome Discoverer,version 1.3 (Thermo Scientiﬁc) to determine peptide identi-ﬁcation; the subsequent Mascot (version 2.3; available at: http://www.matrixscience.com ) output ﬁle was used for additional preprocessing and analysis (see Supplemental Methods 5a , available online).",OADS,/arxiv_data1/oa_pdf/ac/d8/main.PMC4876903.pdf
"A script was written in R to complete the preprocessing, taking into account the experi-mental setup described (available at: http://github.com/ KHP-Informatics/PRQ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/d8/main.PMC4876903.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2014.11.005 .,OADS,/arxiv_data1/oa_pdf/ac/d8/main.PMC4876903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/f1/main.PMC4876904.pdf
E-mail address: m.delcampomilan@vumc.nl http://dx.doi.org/10.1016/j.dadm.2014.11.008 2352-8729/ /C2112015 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/94/f1/main.PMC4876904.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/7b/main.PMC4876906.pdf
E-mail address: scottm@lppi.ucsf.edu http://dx.doi.org/10.1016/j.dadm.2015.04.002 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/f6/7b/main.PMC4876906.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
E-mail address: tilly.eichler@dzne.de http://dx.doi.org/10.1016/j.dadm.2015.02.004 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.02.004 .,OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
[3] Prime Minister’s challenge on dementia Available at: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
Available at: http://www.uspreventive- servicestaskforce.org/uspstf/uspsdeme.html ; 2014.,OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
Available at:http://www.racgp.org.au/your-practice/guidelines/redbook/preventive- activities-in-older-age/dementia/ ; 2012.,Non-OADS,/arxiv_data1/oa_pdf/25/c8/main.PMC4876911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/2e/main.PMC4876914.pdf
E-mail address: ikeuchi@bri.niigata-u.ac.jp http://dx.doi.org/10.1016/j.dadm.2014.11.009 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/b6/2e/main.PMC4876914.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2014.11.009 .,OADS,/arxiv_data1/oa_pdf/b6/2e/main.PMC4876914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/af/main.PMC4876915.pdf
E-mail address: a.konig@maastrichtuniversity.nl http://dx.doi.org/10.1016/j.dadm.2014.11.012 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/a7/af/main.PMC4876915.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare Journal of Multidisciplinary Healthcare 2016:9 237–245Dove press submit your manuscript | www.dovepress.co m Dove press  Study Protocolopen access to scientific and medical research open Access Full text Article 237 http: //dx.doi.org/10.2147/JMDH.S9790 4describing the characteristics, treatment  pathways, outcomes, and costs of people with  persistent noncancer pain managed by community  pain clinics and generating an indicative estimate  of cost-effectiveness: feasibility study protocol Shiekha AlAujan1 Saja AlMazrou1 roger d Knaggs1,2 rachel A Elliott1 1division for Social research in  Medicines and Health, the School of  Pharmacy, university of Nottingham,   Nottingham, uK; 2Pharmacy  department and Pain Management  Service, Nottingham university  Hospitals NHS trust, Nottingham, uK correspondence: Saja AlMazrou   division for Social research in Medicines  and Health, the School of Pharmacy,  university of Nottingham, university Park,  East drive, Nottingham NG7 2rd , uK  Email paxsa6@exmail.nottingham.ac.u kBackground:  Low back pain (LBP) and fibromyalgia (FM), also known as chronic widespread  pain (CWP), are highly prevalent chronic painful conditions that have substantial impact on  patients, health care systems, and society.",Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
Available from: http://webarchive.nationalarchives.gov.uk/   20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_4138413 .,Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
Available from: https://www.emishealth.,Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
Available from: https://www.gov.uk/government/ publications/nhs-reference-costs-2012-to-2013 .,Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
Available from: http://www.pssru.ac.uk/ project-pages/ unit-costs /.,Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/25/jmdh-9-237.PMC4876937.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/b5/imcrj-9-121.PMC4876938.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal 2016:9 121–124submit your manuscript | www.dovepress.co m Dove press  121 http: //dx.doi.org/10.2147/IMCRJ.S9151 8An unusual case of spontaneous Mycobacterium  chelonae  corneal ulcer in a healthy middle-aged  adult Vipul Bhandari R Sriganesh Kirti Relekar Department of Cornea, Nethradhama  Eye Hospital, Bengaluru, India Correspondence: Vipul Bhandari   Nethradhama Eye Hospital, 7th  Block Jayanagar, Kanakapura Road,  Bangalore,  560070, India   T el +91 99 0181 5342   Email drvipulbhandari@gmail.co mBackground:  To report a rare presentation of culture-positive Mycobacterium chelonae  corneal  ulcer and its management.",Non-OADS,/arxiv_data1/oa_pdf/74/b5/imcrj-9-121.PMC4876938.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/74/b5/imcrj-9-121.PMC4876938.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/b5/imcrj-9-121.PMC4876938.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/34/dc/prbm-9-125.PMC4876939.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/34/dc/prbm-9-125.PMC4876939.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 125–132Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 125 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S63949Mindfulness-based cognitive therapy for  depression: trends and developments Meagan B MacKenzie1 Nancy L Kocovski2 1Department of Psychology, Ryerson  University, T oronto, ON, Canada;   2Department of Psychology, Wilfrid  Laurier University, Waterloo,   ON, CanadaAbstract: Mindfulness-based cognitive therapy (MBCT) was developed as a psychological  intervention for individuals at risk of depressive relapse.",Non-OADS,/arxiv_data1/oa_pdf/34/dc/prbm-9-125.PMC4876939.pdf
"7 Mindfulness is  defined as nonevaluative present-moment awareness, and is used within MBCT to help Correspondence: Nancy Kocovski Department of Psychology, Wilfrid Laurier University, 75 University Avenue West, Waterloo, ON N2L 3C5, CanadaTel +1 519 884 0710 ext 3519Fax +1 519 746 7605Email nkocovski@wlu.caJournal name: Psychology Research and Behavior Management Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: MacKenzie and KocovskiRunning head recto: MBCT for depressionDOI: http://dx.doi.org/10.2147/PRBM.S63949",Non-OADS,/arxiv_data1/oa_pdf/34/dc/prbm-9-125.PMC4876939.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/34/dc/prbm-9-125.PMC4876939.pdf
Available from https://www.mentalhealth.org.uk/sites/default/files/Mindfulness_report_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/dc/prbm-9-125.PMC4876939.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ab/f5/jir-9-069.PMC4876940.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/ab/f5/jir-9-069.PMC4876940.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Inflammation Research 2016:9 69–78Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  69ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S10106 4Impaired bone healing in multitrauma patients is  associated with altered leukocyte kinetics after  major trauma Okan W Bastian1 anne Kuijer1 leo Koenderman2 Rebecca K stellato3 Wouter W van solinge4 luke P h leenen1 Taco J Blokhuis1 1Department of Traumatology,   2Department of Respiratory Medicine,   3Department of Biostatistics and  Research support, Julius center,   4Department of clinical chemistry  and hematology, University  Medical center Utrecht, Utrecht,   the netherlands correspondence: Okan W Bastian   Department of Traumatology,   University Medical center Utrecht,   100 heidelberglaan – hP g04.228,  Utrecht 3508 ga, the netherlands   T el +31 88 755 9882   Fax +31 88 755 8022   email okanbastian@gmail.co mAbstract:  Animal studies have shown that the systemic inflammatory response to major injury  impairs bone regeneration.",Non-OADS,/arxiv_data1/oa_pdf/ab/f5/jir-9-069.PMC4876940.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/ab/f5/jir-9-069.PMC4876940.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/f5/jir-9-069.PMC4876940.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/29/ijn-11-2163.PMC4876941.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2163–2177International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2163OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9348 3Manipulating the NF- κB pathway in macrophages  using mannosylated, si rNa-delivering nanoparticles  can induce immunostimulatory and tumor cytotoxic  functions correspondence: Todd D giorgio;   Fiona e Yull Department of cancer Biology,  Vanderbilt-Ingram cancer center, 2220  Pierce ave, Nashville, TN 37232, Usa email todd.d.giorgio@vanderbilt.ed u;   fiona.yull@vanderbil t ryan a Ortega1–3 Whitney Barham3 Kavya sharman4 Oleg Tikhomirov3 T odd D giorgio1–3 Fiona e Yull3 1Department of Biomedical  engineering, Vanderbilt University,   2Vanderbilt Institute for Nanoscale  science and engineering, 3Department  of cancer Biology, Vanderbilt-Ingram  cancer center, 4Department of  Neuroscience, Vanderbilt University,   Nashville, TN, UsaAbstract:  Tumor-associated macrophages (TAMs) are critically important in the context of  solid tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/0a/29/ijn-11-2163.PMC4876941.pdf
"This type of inflamma - tion is insufficient to induce apoptosis or other mechanisms of tumor cell death but is  significant enough to cause survivable DNA damage in the genetic material of tumor  cells as well as activate survival signals in the nearby cells.8,9 TAMs also contribute to  the immunosuppressive microenvironment by producing cytokines, such as interleukin Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ortega et al Running head recto: Manipulating the NF- κB pathway in macrophages using nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S93483",Non-OADS,/arxiv_data1/oa_pdf/0a/29/ijn-11-2163.PMC4876941.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0a/29/ijn-11-2163.PMC4876941.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/29/ijn-11-2163.PMC4876941.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b3/7d/ijn-11-2223.PMC4876942.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2223–2234International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2223OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10275 2In vivo evaluation of the anti-infection potential of  gentamicin-loaded nanotubes on titania implants Ying Yang1 hai-yong ao1 sheng-bing Yang1 Yu-gang Wang1 Wen-tao lin2 Zhi-feng Yu1 Ting-ting Tang1 1shanghai Key laboratory of  Orthopedic Implants, Department  of Orthopedic surgery, shanghai  Ninth People’s hospital, shanghai  Jiao Tong University, school of  Medicine, shanghai, 2Department  of Orthopedics, Fuzhou second  hospital, affiliated hospital of Xiamen  University, Fuzhou, People’s republic  of chinaAbstract:  Titanium-based implants have been widely used in orthopedic surgery; however,  failures still occur.",Non-OADS,/arxiv_data1/oa_pdf/b3/7d/ijn-11-2223.PMC4876942.pdf
"The systemic administration of antibiotics and the removal of intramedullary nails  are two conventional approaches applied in the treatment of implant-associated infection, correspondence: Ting-ting Tang shanghai Key laboratory of Orthopedic  Implants, Department of Orthopedic  surgery, shanghai Ninth People’s  hospital, shanghai Jiao Tong University,  school of Medicine, 639 Zhizaoju road,  shanghai 200011, People’s republic  of china Tel +86 21 2327 1133 Fax +86 21 6313 7020 email ttt@sjtu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y ang et al Running head recto: Anti-infection potential of gentamicin-loaded titania nanotubes DOI: http://dx.doi.org/10.2147/IJN.S102752",Non-OADS,/arxiv_data1/oa_pdf/b3/7d/ijn-11-2223.PMC4876942.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b3/7d/ijn-11-2223.PMC4876942.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/7d/ijn-11-2223.PMC4876942.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/2e/jir-9-079.PMC4876943.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Protective effect of soybean oil- or fish oil-rich  diets on allergic airway inflammation Roberta Araujo Navarro- Xavier1 Karina Vieira de Barros1 Iracema Senna de Andrade1 Zaira Palomino2 Dulce Elena Casarini2 Vera Lucia Flor Silveira3 1Departamento de Fisiologia,   2Departamento de Medicina,   3Departamento de Ciências Biológicas,   Universidade Federal de São Paulo,   Diadema, São Paulo, Brazil Correspondence: Vera Lucia Flor Silveira   Departamento de Ciências Biológicas,  Universidade Federal de São Paulo- Campus Diadema, Rua Professor Artur  Riedel, 275, Bairro Eldorado, Diadema,  São Paulo, CEP 09972-270, Brazil   T el/Fax +55 11 5576 4765   Email veraflorsilveira@gmail.co mBackground:  The increased prevalence of asthma and allergic diseases in westernized societies  has been associated with increased intake of diets rich in n-6 fatty acids (FAs) and poor in n-3  FAs.",Non-OADS,/arxiv_data1/oa_pdf/11/2e/jir-9-079.PMC4876943.pdf
Available from: http://www.cobea.org.br/arquivo/ download?ID_ARQUIVO =20.,Non-OADS,/arxiv_data1/oa_pdf/11/2e/jir-9-079.PMC4876943.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/11/2e/jir-9-079.PMC4876943.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/2e/jir-9-079.PMC4876943.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a7/54/ijn-11-2195.PMC4876944.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2195–2207International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2195OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10450 1 In vitro and in vivo targeting imaging of pancreatic  cancer using a Fe3O4@siO2 nanoprobe modified  with anti-mesothelin antibody Fang liu1,* Wenjun le2,* Tianxiao Mei2 Tiegong Wang1 luguang chen1 Yi lei1 shaobin cui2 Bingdi chen2 Zheng cui2,3 chengwei shao1 1radiology Department of changhai  hospital, second Military Medical  University, 2shanghai east hospital,   The Institute for Biomedical  engineering & Nano science, Tongji  University school of Medicine,   shanghai, People’s republic of china;   3Department of Pathology, Wake  Forest University school of Medicine,   Winston-salem, N c, Usa *These authors contributed equally  to this workAbstract:  Pancreatic cancer is a highly malignant disease with a 5-year survival rate ,5%  mainly due to lack of early diagnosis and effective therapy.",Non-OADS,/arxiv_data1/oa_pdf/a7/54/ijn-11-2195.PMC4876944.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a7/54/ijn-11-2195.PMC4876944.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/54/ijn-11-2195.PMC4876944.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/c0/ijn-11-2209.PMC4876945.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2209–2222International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2209OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9408 9The relevancy of controlled nanocrystallization  on rifampicin characteristics and cytotoxicity salma M Mohyeldin Mohammed M Mehanna Nazik a elgindy Department of Industrial Pharmacy,   Faculty of Pharmacy, alexandria  University, alexandria, egyptPurpose:  This article investigated the influence of novel rifampicin nanosuspension (RIF NS)  for enhancing drug delivery properties.",Non-OADS,/arxiv_data1/oa_pdf/a1/c0/ijn-11-2209.PMC4876945.pdf
"Treatment of such cases is much more difficult;  the therapy is based on second-line agents that include amino glycoside antibiotics,  cycloserine, ethionamide, and fluoroquinolones.1,2 Conversely, these agents are more correspondence: Mohammed M  Mehanna Department of Industrial Pharmacy,  Faculty of Pharmacy, alexandria  University, el sultan hussein st.,  alexandria, 21521, egypt Tel +20 3 100 340 9504 email dr_mehanna@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Mohyeldin et al Running head recto: Characteristics and cytotoxicity of nanocrystallized rifampicin DOI: http://dx.doi.org/10.2147/IJN.S94089",Non-OADS,/arxiv_data1/oa_pdf/a1/c0/ijn-11-2209.PMC4876945.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a1/c0/ijn-11-2209.PMC4876945.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/c0/ijn-11-2209.PMC4876945.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/22/a6/mder-9-115.PMC4876946.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Medical Devices: evidence and Research 2016:9 115–123submit your manuscript | www.dovepress.co m Dove press  115 http: //dx.doi.org/10.2147/MDER.S60780Benign prostatic hyperplasia and new treatment  options – a critical appraisal of the UroLift system Thomas Anthony  McNicholas1–3 1Section of Urology, Royal Society  of Medicine, London, UK; 2Urology  Department, Lister Hospital, east and  North Herts NHS Trust, Stevenage,   UK; 3Faculty of Health and Human  Sciences, University of Hertfordshire,   Hatfield, Herts, UK Correspondence: Thomas Anthony  McNicholas   elm Tree House, Letchworth Lane,   Letchworth, Herts SG6 3ND, UK   T el +44 1462 683 814   Fax +44 1462 683 815   email mcnta@me.co mAbstract:  The prostatic urethral lift procedure, more commonly known as UroLift, has been  designed to improve male lower urinary tract symptoms while avoiding the complications and  disadvantages of existing drug and surgical therapies.",Non-OADS,/arxiv_data1/oa_pdf/22/a6/mder-9-115.PMC4876946.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: evidence and Research 2016:9submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 123BPH and Rx – UroLift system review  11.,Non-OADS,/arxiv_data1/oa_pdf/22/a6/mder-9-115.PMC4876946.pdf
Available from: http://www.nice.org.uk/ guidance/mtg26/resources/urolift-for-treating-lower-urinary-tract- symptoms-of-benign-prostatic-hyperplasia-6437193820486 9.,Non-OADS,/arxiv_data1/oa_pdf/22/a6/mder-9-115.PMC4876946.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-11-2147.PMC4876947.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2147–2162submit your manuscript | www.dovepress.co m Dove press  2147 http: //dx.doi.org/10.2147/IJN.S9530 1Dove press OrIg INal researchopen access to scientific and medical research Open access Full T ext article Prevention of vaginal and rectal herpes simplex  virus type 2 transmission in mice: mechanism of  antiviral action rafael ceña-Diez1,* enrique Vacas-córdoba1,* Pilar garcía-Broncano1,2 FJ de la Mata3 rafael gómez3 Marek Maly4 Mª Ángeles Muñoz-Fernández1 1Molecular Immunobiology  laboratory, general Universitary  hospital gregorio Marañon,   health research Institute gregorio  Marañon, spanish hIV hgM BioBank,   Networking research center  on Bioengineering, Biomaterials  and Nanomedicine (cIBer-BBN),   2Viral and Immune Infection Unit  center, Institute of health carlos  III, Majadahonda campus, Molecular  Immunobiology laboratory, general  Universitary hospital gregorio  Marañon, 3Organic and Inorganic  chemistry Department, alcala  University, University campus  alcala de heneras, Networking  research center on Bioengineering,   Biomaterials and Nanomedicine  (cIBer-BBN), Madrid, spain; 4Faculty  of science, J.e.",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-11-2147.PMC4876947.pdf
"esquerdo 46, 28007 Madrid, spain Tel +34 91 586 8565 email mmunoz.hgugm@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ceña-Diez et al Running head recto: Prevention of vaginal and rectal HSV -2 transmission in mice DOI: http://dx.doi.org/10.2147/IJN.S95301",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-11-2147.PMC4876947.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-11-2147.PMC4876947.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-11-2147.PMC4876947.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/98/e3/tom3.PMC4876975.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00121 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 1 |MARCH 2016 3,Non-OADS,/arxiv_data1/oa_pdf/98/e3/tom3.PMC4876975.pdf
"The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .Non- commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is  properly attributed.",Non-OADS,/arxiv_data1/oa_pdf/97/0c/nihms756587.PMC4876981.pdf
"Information on  how to request permission may be found at http://www.dovepress.com/permissions.php Correspondence: Carolyn Bingham Howard Breast Cancer Research Laboratory, Research Centers in Minority Institutions, College of  Science, Engineering and Technology, Jackson State University, 1400 J R Lynch Street, Jackson, MS 39217, USA, Tel +1 601 979  3468, Fax +1 601 979 5853, ; Email: carolyn.b.howard@jsums.edu  Disclosure : The authors report no conflicts of interest in this work.",Non-OADS,/arxiv_data1/oa_pdf/97/0c/nihms756587.PMC4876981.pdf
"Available from: http://nccam.nih.gov/health/whatiscam/  [Accessed March 11, 2015] 7.",OADS,/arxiv_data1/oa_pdf/97/0c/nihms756587.PMC4876981.pdf
Available from: http://dtp.nci.nih.gov/timeline/ flash/success_stories/S2_taxol.htm 71.,Non-OADS,/arxiv_data1/oa_pdf/97/0c/nihms756587.PMC4876981.pdf
"from: http://www.pharmacognosy.us/wordpress/wp-content/uploads/Front_Matter.pdf  [Accessed  March 11, 2015] 96.",Non-OADS,/arxiv_data1/oa_pdf/97/0c/nihms756587.PMC4876981.pdf
"6, 547–556 doi:10.1093/carcin/bgw046 Advance Access publication April 18, 2016 Original Manuscript 547 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/4e/bgw046.PMC4876992.pdf
http://www.census.gov/population/projections/data/ national/2014/summarytables.html .,OADS,/arxiv_data1/oa_pdf/64/4e/bgw046.PMC4876992.pdf
http://www.census.gov .,OADS,/arxiv_data1/oa_pdf/64/4e/bgw046.PMC4876992.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Eye Care Quality and Accessibility Improvement  in the Community (EQUALITY): impact of an eye  health education program on patient knowledge  about glaucoma and attitudes about eye care Lindsay A Rhodes1 Carrie E Huisingh1 Gerald McGwin Jr1,2 Stephen T Mennemeyer3 Mary Bregantini4 Nita Patel4 Jinan Saaddine5 John E Crews5 Christopher A Girkin1 Cynthia Owsley1 1Department of Ophthalmology,   School of Medicine, 2Department  of Epidemiology, 3Department of  Health Care Organization and Policy,   School of Public Health, University of  Alabama at Birmingham, Birmingham,   AL, 4Prevent Blindness, Chicago, IL,   USA; 5Vision Health Initiative, Division  of Diabetes Translation, Centers for  Disease Control and Prevention,   Atlanta, GA, USA Correspondence: Lindsay A Rhodes   Department of Ophthalmology, School  of Medicine, University of Alabama  at Birmingham, 1720 University Blvd,  Suite 609, Birmingham, AL 35233, USA   T el +1 205 325 8635   Fax +1 205 325 8692   Email rhodesL@uab.ed uPurpose:  To assess the impact of the education program of the Eye Care Quality and   Accessibility Improvement in the Community (EQUALITY) telemedicine program on at-risk  patients’ knowledge about glaucoma and attitudes about eye care as well as to assess patient  satisfaction with EQUALITY .",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
"Available from: http://www.brightfocus.org/ glaucom a. Accessed August 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
Available from: http://www.cdc.gov/brfss /.,OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
"Available from: https://nei.nih.gov/glaucoma/ content/english/doyoukno w. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
Available from: http://www.preventblindness.org /.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
Available from:  http://www.hrsa.gov/publichealth/healthliteracy /.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/prom-7-037.PMC4877018.pdf
Available at: http://www.ats.ucla.edu/stat/stata/faq/barcap.htm.,OADS,/arxiv_data1/oa_pdf/fa/57/i1552-5783-57-1-208.PMC4877135.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.07.004 DOI of original article: http://dx.doi.org/10.1016/j.nmni.2015.02.003,Non-OADS,/arxiv_data1/oa_pdf/ca/3a/main.PMC4877397.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.008,Non-OADS,/arxiv_data1/oa_pdf/e7/a5/main.PMC4877398.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,4 3–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e7/a5/main.PMC4877398.pdf
"Common symptoms include fatigue, malaise, myalgia, fever and New Microbe and New Infect 2015; 8:148–149 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.008",Non-OADS,/arxiv_data1/oa_pdf/e2/81/main.PMC4877399.pdf
"Parasite blood smear demonstrating presence of intra- erythrocytic ring-form trophozoite (arrow).NMNI Hot topic 149 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,8,1 4 8–149 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e2/81/main.PMC4877399.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.07.002,Non-OADS,/arxiv_data1/oa_pdf/82/66/main.PMC4877400.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 0 –153 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/82/66/main.PMC4877400.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 0 –153 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/82/66/main.PMC4877400.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 0 –153 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/82/66/main.PMC4877400.pdf
They formulated few de ﬁnitions and de ﬁned XDR bacteria as ‘isolates being non- susceptible to at least one agent in all but 2 or fewer antimi- crobial categories listed in the Clinical and Laboratory Stan- dards Institute (CLSI) guidelines ’and PDR bacteria as ‘isolates New Microbe and New Infect 2015; 8:166–170 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.01.003,Non-OADS,/arxiv_data1/oa_pdf/3b/0a/main.PMC4877402.pdf
"Burden of pandrug-resistant bacteria 167 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,8,1 6 6 –170 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/0a/main.PMC4877402.pdf
"Sample-wise distribution of resistant isolates.168 New Microbes and New Infections , Volume 8 Number C, November 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,8,1 6 6 –170 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/0a/main.PMC4877402.pdf
"Burden of pandrug-resistant bacteria 169 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,8,1 6 6 –170 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/0a/main.PMC4877402.pdf
"Antimicrob Agents Chemo- ther 2012;56:4516 –8.170 New Microbes and New Infections , Volume 8 Number C, November 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,8,1 6 6 –170 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/0a/main.PMC4877402.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.002,Non-OADS,/arxiv_data1/oa_pdf/a6/16/main.PMC4877403.pdf
http://dx.doi.org/10.1001/jamainternmed.2014.4887 .,Non-OADS,/arxiv_data1/oa_pdf/a6/16/main.PMC4877403.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 6 4 –165 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a6/16/main.PMC4877403.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.004,Non-OADS,/arxiv_data1/oa_pdf/db/55/main.PMC4877404.pdf
Acknowledgements We thank TradOnline ( http://www.tradonline.fr/en/ ) for English-language editing.,Non-OADS,/arxiv_data1/oa_pdf/db/55/main.PMC4877404.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,4 5 –46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/db/55/main.PMC4877404.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.09.004 DOI of original article: http://dx.doi.org/10.1016/j.nmni.2015.02.007,Non-OADS,/arxiv_data1/oa_pdf/d1/01/main.PMC4877405.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.009,Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 5 4–163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/63/98/main.PMC4877407.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.006,Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process.,Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
https://gold.jgi.doe.gov/index .,OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
http://prodigal.ornl.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
http://www.cbs.dtu.dk/services/TMHMM/ .,Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,8,1 3 7–147 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ac/29/main.PMC4877408.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.002,Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
Antibiotic susceptibility Antibiotic susceptibility was tested with the diffusion method according to the CASFM/EUCAST 2015 recommendations for fastidious anaerobes ( http://www.sfm-microbiologie.org/ UserFiles/ ﬁles/casfm/CASFM_EUCAST_V1_2015.pdf ) using a suspension of 1 McFarland on Wilkins Chalgren agar (Sigmausing a bacterial dilution with a turbidity equivalent to the McFarland 1.0 standard.,Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"For each selected genome, the complete genome sequence, proteome genome sequence and Orfeome genome sequence were retrieved from the National Center for Biotechnology Information ( http://www.ncbi.nlm.nih.gov/news/ 08-26-2014-new-genomes-FTP-live/ ).",OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process.,Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,3 4–42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4877409.pdf
Available at https://www.en.uni- muenchen.de/news/newsarchiv/2010/2010-spiritualcare.html .,Non-OADS,/arxiv_data1/oa_pdf/77/55/520_2016_Article_3115.PMC4877411.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.Dear Editor, Recently , we read with great interest the article by Be - ladi Mousavi et al.",Non-OADS,/arxiv_data1/oa_pdf/29/fe/jjm-09-03-26645.PMC4877441.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/66/jjm-09-03-34158.PMC4877442.pdf
"Trimmomatic, 52 Tophat2,53 Picard suite  (http://www.broadinstittute.github.io/picard), RNA-SeQC,54 and  in-house metrics were used to evaluate data quality.",OADS,/arxiv_data1/oa_pdf/81/e7/mtna201535a.PMC4877444.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/81/e7/mtna201535a.PMC4877444.pdf
EXPLORE c.2014- (cited 2015) https://clinicaltrials.gov/ ct2/show/NCT02240784?term=porphyria+natural+history&rank=1).,Non-OADS,/arxiv_data1/oa_pdf/e4/a1/mtna201536a.PMC4877445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/e4/a1/mtna201536a.PMC4877445.pdf
"35,36  Furthermore, it has been reported that methylation of DNA at CpG sites may impede the binding efficiency of Cas9 in cells,  and small molecules that enhance CRISPR genome editing Table 1 Common CRISPR/Cas9 design tools Name Web Affiliation CRISPR design http://crispr.mit.edu/ Massachusetts Institute  of Technology E-Crisp www.e-crisp.org/E-CRISP/ designcrisprDKFZ German Cancer Research Center CRISPR design  toolhttp://www.broadinstitute.org/mpg/crispr_design/The Broad Institute of Harvard and MIT Cas-OFFinder http://www.rgenome.net Harvard Medical School CROP-IT http://www.adlilab.org/CROP-IT/homepage.htmlUniversity of Virginia Figure 2 Methods for optimal CRISPR/Cas9 system for biomedical and clinical application.",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/mtna201537a.PMC4877446.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/mtna201537a.PMC4877446.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/4a/ad/mtna201523a.PMC4877448.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/cf/f1/mtna201525a.PMC4877450.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/54/jjm-09-03-31302.PMC4877466.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d5/be/jjm-09-03-32974.PMC4877467.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence ( http://creativecommons.org/licenses/by/ 4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/43/S1352465815000454a.PMC4877520.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/3a/jjm-09-03-32183.PMC4877525.pdf
"In 2006, he retired from the Catholic University and now works at a  • Received : February 18, 2016  • Revised : February 22, 2016  • Accepted : February 26, 2016 • Address for reprints : Kyu-Chang Wang, M.D., Ph.D.  Division of Pediatric Neurosurgery, Seoul National University Children’s Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080,    Korea  Tel : +82-2072-3489,  Fax : +82-2-2072-0274,  E-mail : kcwang@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 185-186, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.185 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Editorial Fig.",Non-OADS,/arxiv_data1/oa_pdf/26/fb/jkns-59-185.PMC4877537.pdf
"Key Words : Craniosynostosis · Apert syndrome · Pfeiffer syndrome · Crouzon syndrome · Antley-Bixler syndrome · Saethre-Chotzen syndrome.Pediatric Issue • Received : December 28, 2015  • Revised : March 17, 2016  • Accepted : March 21, 2016 • Address for reprints : Jung Min Ko, M.D., Ph.D.   Department of Pediatrics, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea   Tel : +82-2-2072-3570,  Fax : +82-2-743-3455,  E-mail : jmko@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 187-191, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.187 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/82/19/jkns-59-187.PMC4877538.pdf
"Key Words : Cranial sutures · Craniosynostosis · Embryonic development · Growth · Skull.Pediatric Issue • Received : February 15, 2016  • Revised : March 25, 2016  • Accepted : March 28, 2016 • Address for reprints : Ki-Bum Sim, M.D., Ph.D.   Department of Neurosurgery, Jeju National University Hospital, 102 Jejudaehak-ro, Jeju 63243, Korea  Tel : +82-64-717-1625,  Fax : +82-64-717-1630,  E-mail : kibumsim@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 192-196, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.192 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/01/1e/jkns-59-192.PMC4877539.pdf
"Key Words : Chiari Malformation · Craniosynostosis · Hydrocephalus · Intracranial hypertension · Neuropsychological.Pediatric Issue • Received : January 19, 2016  • Revised : February 27, 2016  • Accepted : March 4, 2016 • Address for reprints : Hyung-Jin Shin, M.D., Ph.D.  Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  Tel : +82-2-3410-3492,  Fax : +82-2-3410-0048,  E-mail : shinhj@skku.edu • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 197-203, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.197 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/7c/71/jkns-59-197.PMC4877540.pdf
"Department of Pediatric Neurosurgery, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka City, Osaka 534-0021, Japan  Tel : +81-6-6929-1221,  Fax : +81-6-6929-1090,  E-mail : h-sakamot@msic.med.osaka-cu.ac.jp • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 204-213, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.204 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/f1/20/jkns-59-204.PMC4877541.pdf
"Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea  Tel : +82-53-200-5654,  Fax : +82-53-423-0504,  E-mail : shwang@knu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 214-218, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.214 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/f4/18/jkns-59-214.PMC4877542.pdf
"Key Words : Skull · Cranial sutures · Craniosynostosis · Computed tomography · Plain radiograph · Magnetic resonance imaging · Ultrasonography .Pediatric Issue • Received : January 22, 2016  • Revised : April 21, 2016  • Accepted : April 22, 2016 • Address for reprints : Il Woo Lee, M.D., Ph.D.  Department of Neurosurgery, Daejeon St. Mary’s Hospital, The  Catholic University of Korea, 64 Daeheung-ro, Jung-gu, Daejeon 34943, Korea  Tel : +82-42-220-9638,  Fax : +82-42-220-9087,  E-mail : leeilwoo@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 219-226, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.219 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/28/bd/jkns-59-219.PMC4877543.pdf
"Key Words : Craniosynostosis · Suturectomy · Helmet therapy.Pediatric Issue • Received : January 25, 2016  • Revised : March 3, 2016  • Accepted : March 4, 2016 • Address for reprints : Seung-Ki Kim, M.D., Ph.D.  Division of Pediatric Neurosurgery, Seoul National University Children’s Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080,    Korea  Tel : +82-2-2072-3084,  Fax : +82-2-744-8459,  E-mail : nsthomas@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 227-232, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.227 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/95/da/jkns-59-227.PMC4877544.pdf
"Key Words : Craniosynostosis · Distraction osteogenesis · Multidirectional cranial distraction osteogenesis · Posterior cranial vault distraction osteogenesis.Pediatric Issue • Received : February 8, 2016  • Revised : March 18, 2016  • Accepted : March 21, 2016 • Address for reprints : Akira Gomi, M.D., Ph.D.  Department of Pediatric Neurosurgery, Jichi Children’s Medical Center Tochigi, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan   Tel : +81-285-58-7710,  Fax : +81-285-44-8329,  E-mail : gomi@jichi.ac.jp • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 233-241, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.233 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/a3/6a/jkns-59-233.PMC4877545.pdf
"Key Words : Craniosynostosis · Cognitive outcome · Neurodevelopment.Pediatric Issue • Received : February 15, 2016  • Revised : April 5, 2016  • Accepted : April 6, 2016 • Address for reprints : Dong-Seok Kim, M.D., Ph.D.  Department of Pediatric Neurosurgery, Severance Children’s Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea  Tel : +82-2-2228-2150,  Fax : +82-2-393-9979,  E-mail : dskim33@yuhs.ac • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 242-246, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.242 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/1d/4a/jkns-59-242.PMC4877546.pdf
"Key Words : Craniosynostosis · Neurosurgery · Pediatric.Pediatric Issue • Received : February 14, 2016  • Revised : February 22, 2016  • Accepted : March 20, 2016 • Address for reprints : Joon-Ki Kang, M.D., Ph.D.  Department of Neurosurgery, St. Peter’s Hospital, 2633 Nambusunhwan-ro, Gangnam-gu, Seoul 06268, Korea  Tel : +82-2-1544-7522,  Fax : +82-2-574-9414,  E-mail : jkkmd@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 247-249, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.247 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/97/db/jkns-59-247.PMC4877547.pdf
"Key Words : Laminectomy · Epidural fibrosis · Epidural adhesion · Anti-adhesive agent.Laboratory Investigation • Received : July 12, 2015  • Revised : September 4, 2015  • Accepted : December 21, 2015 • Address for reprints : Koang Hum Bak, M.D., Ph.D.   Department of Neurosurgery, Hanyang University Medical Center, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea  Tel : +82-2-2290-8496,  Fax : +82-2-2281-0954,  E-mail : pkh2325@hanyang.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 250-258, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.250 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/33/89/jkns-59-250.PMC4877548.pdf
"Department of Neurosurgery, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea  Tel : +82-55-360-2126,  Fax : +82-55-360-2156,  E-mail : gnsong@pusan.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 259-268, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.259 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/4e/43/jkns-59-259.PMC4877549.pdf
"Key Words : Intracranial aneurysm · Middle cerebral artery · Surgical clip · Coil embolization.Clinical Article • Received : June 13, 2015  • Revised : February 12, 2016  • Accepted : February 13, 2016 • Address for reprints : Yong Sam Shin, M.D., Ph.D.  Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea  Tel : +82-2-2258-6125,  Fax : +82-2-594-4248,  E-mail : nsshin@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 269-275, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.269 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/d8/19/jkns-59-269.PMC4877550.pdf
"Key Words : Trunk muscle · Fusion rates · Cross-sectional area · Posterior lumbar interbody fusion.Clinical Article • Received : August 5, 2015  • Revised : October 6, 2015  • Accepted : October 14, 2015 • Address for reprints : Sung Bum Kim, M.D., Ph.D.   Department of Neurosurgery, Kyung Hee University Hospital, Kyung Hee University School of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea  Tel : +82-2-958-8402,  Fax : +82-2-958-8380,  E-mail : sungbumi7@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 276-281, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.276 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/bb/94/jkns-59-276.PMC4877551.pdf
"Department of Neurosurgery, Soonchunhyang University Gumi Hospital, 179 1Gongdan-ro, Gumi 39371, Korea  Tel : +82-2-709-9268,  Fax : +82-2-792-5976,  E-mail : s90846@schmc.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 282-286, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.282 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/38/69/jkns-59-282.PMC4877552.pdf
"Key Words : Cognitive impairment · Lumbar spine surgery · Postoperative delirium · Elderly patients.Clinical Article • Received : September 7, 2015  • Revised : November 11, 2015  • Accepted : November 12, 2015 • Address for reprints : Young-Baeg Kim, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea  Tel : +82-2-6299-1607,  Fax : +82-2-6299-2069,  E-mail : ybkim1218@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 287-291, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.287 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/jkns-59-287.PMC4877553.pdf
"Key Words : Isthmic lumbar spondylolisthesis · Pelvic radius · Sagittal balance.Clinical Article • Received : June 9, 2015  • Revised : December 23, 2015  • Accepted : February 13, 2016 • Address for reprints : Cai-Liang Shen, M.D., Ph.D.  Department of Spinal Surgery, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui 230022, China   Tel : +86-0551-62923244,  Fax : +86-0551-62923244,  E-mail : shencailiang1616@163.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 292-295, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.292 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e1/06/jkns-59-292.PMC4877554.pdf
"Lecturer of Neurosurgery, Endovascular Neurosurgeon, Neurosurgery Department Faculty of Medicine, Alexandria University, Alexandria Faculty of medicine, Champollion  Street, El-Khartoum Square, Azarita Medical Campus, Alexandria 21131, Egypt  Tel : +20-1001042419,  Fax : +20-34862506,  E-mail : ahmed.sultan@alexmed.edu.eg • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 296-301, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.296 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/83/38/jkns-59-296.PMC4877555.pdf
"Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea  Tel : +82-2-2072-2862,  Fax : +82-2-744-8459,  E-mail : wook616@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 302-305, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.302 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e8/62/jkns-59-302.PMC4877556.pdf
"Department of Physical Medicine and Rehabilitation, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea  Tel : +82-2-3010-3800,  Fax : +82-2-3010-6964,  E-mail : wheel633@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 306-309, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.306 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/00/82/jkns-59-306.PMC4877557.pdf
"Department of Neurosurgery, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon 24289, Korea  Tel : +82-33-258-2410,  Fax : +82-33-251-0374,  E-mail : rabbit3540@empas.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 310-313, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.310 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/20/84/jkns-59-310.PMC4877558.pdf
"Department of Neurosurgery, Sungkyunkwan University School of Medicicne, Kangbuk Samsung Hospital, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea  Tel : +82-2-2001-2158,  Fax : +82-2-2001-2157,  E-mail : kkimsion@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 314-318, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.314 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/96/7c/jkns-59-314.PMC4877559.pdf
"Department of Neurology, Meram Faculty of Medicine, Necmettin Erbakan University, Meram, Konya 42080, Turkey   Tel : +90-332 223 7344,  Fax : +90-332 263 1245,  E-mail : hhkozak@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 319-321, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.319 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/jkns-59-319.PMC4877560.pdf
"Key Words : External ventricular drain · Device · Cerebrospinal fluid.Technical Note • Received : August 27, 2015  • Revised : November 5, 2015  • Accepted : December 16, 2015 • Address for reprints : Hack-Gun Bae, M.D., Ph.D.  Department of Neurosurgery, Cheonan Hospital, Soonchunhyang University School of Medicine, 31 Soonchunhyang 6-gil, Dongnam-gu, Cheonan 31151, Korea  Tel : +82-41-570-3648,  Fax : +82-41-572-9297,  E-mail : hgbaeb@schmc.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 322-324, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.322 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/58/cd/jkns-59-322.PMC4877561.pdf
"Department of Neurosurgery, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, Korea  Tel : +82-32-621-5289,  Fax : +82-32-261-5059,  E-mail : bumtkim@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 59  (3) : 325-326, 2016http://dx.doi.org/10.3340/jkns.2016.59.3.325 Copyright © 2016 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/e4/20/jkns-59-325.PMC4877562.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jjm-09-03-33909.PMC4877565.pdf
"To date, 17 recognized species are representatives of Planococcus (P. alkanoclasticus, P. antarcticus, P. citreus, P. colum- bae, P. donghaensis, P. halocryophilus, P. kocurii, P. maitriensis, P. New Microbe and New Infect 2016; 10:36–46 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.12.006",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"The 16S rRNA nucleotide sequence was corrected using Chromas Pro 1.34 software (Technelysium, Tewantin, Australia), and the BLASTn searches were performed by National Center for Biotech-nology Information ( http://blast.ncbi.nlm.nih.gov.gate1.inist.fr/ Blast.cgi ).",OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"nov. genome 37 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"Reference mass spectrum from Planococcus massiliensis strain ES2T.38 New Microbes and New Infections , Volume 10 Number C, March 2016 NMNI © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"nov. genome 39 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"Scale bar = 0.005% nucleotide sequence divergence.40 New Microbes and New Infections , Volume 10 Number C, March 2016 NMNI © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"nov. genome 41 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"soli Cell diameter ( μm) 0.6 –0.9 0.4 –0.8 0.4 –0.8 0.6 –0.9 0.8 –1.2 0.8 –1.2 0.4 –0.8 0.4 –0.8 0.8 –1.0 0.4 –0.8 0.8 –1.0 Oxygen requirement Aerobic Aerobic Aerobic Aerobic Aerobic Aerobic Aerobic Aerobic Aerobic Aerobic Aerobic Gram stain + + to v + to v + + + + + + + to v +Salt requirement + ++++ + + − ++ + Motility + + + + − ++ − ++ + Endospore formation − +++ −− ++ − ++ Indole − −−−− + − NA −− − Production of: Alkaline phosphatase − NA NA NA − N A + N AN A+ − Catalase − +++N A N A + N A N A + + Oxidase + w −− ++ − + −− − Nitrate reductase −− − + −− + −−− − Urease − −−− NA −− NA NA NA NA Arginine dihydrolase − NA NA NA NA −− NA NA NA NA B-Galactosidase − NA NA NA + NA −− NA −− N-acetyl- β-glucosaminidase − NA − NA + NA NA NA NA −− Acid from: L-Arabinose − −−−− − − NA −− NA D-Ribose + + −− ++ + N A N A − NA D-Mannose + −−−− +N A − NA −− D-Mannitol − −−−− +N A −−− NA D-Sucrose − −−− ++ N A − + −− D-Glucose + − w+ + + N A −− + − D-Fructose + + − + − + N A +++ − D-Maltose −− +w + + N A − NA −− D-Lactose −− + −− +N A − + −− Habitat Human gut Fermented seafood Fermented seafood Fermented seafood Sea Soil Glacier Coastal sediment Coastal sediment Coastal sediment Soil +, positive result; −, negative result; v, variable result; w, weakly positive result; NA, data not available.42 New Microbes and New Infections , Volume 10 Number C, March 2016 NMNI © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"nov. genome 43 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"Formula 2 is recommended, particularly for draft genomes.44 New Microbes and New Infections , Volume 10 Number C, March 2016 NMNI © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process and C. Andrieu for administrative assistance.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"nov. genome 45 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
"BMC Bioinformatics 2013;14:60 .46 New Microbes and New Infections , Volume 10 Number C, March 2016 NMNI © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,10,3 6–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/20/3f/main.PMC4877603.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/9c/main.PMC4877604.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.03.005 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/cd/9c/main.PMC4877604.pdf
This  is  an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/9c/main.PMC4877604.pdf
Available  from: http://www.ibge.gov.br/censo2010/primeiros  dados divulgados/index.php  [cited  2014].,Non-OADS,/arxiv_data1/oa_pdf/cd/9c/main.PMC4877604.pdf
Available from: http://www.lee.dante.br/pesquisa.html ;  2000  [cited 17.02.16].,OADS,/arxiv_data1/oa_pdf/cd/9c/main.PMC4877604.pdf
"As a result of the declining cost of sequencing, the number of sequenced bacterial genomes has rapidly grown; to date, almost 40 000 bacterial genomes have been sequenced (GOLD Database,https://gold.jgi.doe.gov/ ).",OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Currently the genus Nocardioides contains 72 species, including eight described in 2013 and species from the genera Pimelobacter and Arthrobacter that were reclassi ﬁed in the genus Nocardioides [23–36](LPSN, http://www.bacterio.",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.01.001,Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
These evidence codesare from the Gene Ontology project ( http://www.geneontology.org/GO.evidence.,OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process.,Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,4 7–57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/70/1d/main.PMC4877605.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.12.007,Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
Sequence identity to the known coatypes was analysed by Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi ).,OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"program (DNA Data Bank of Japan (DDBJ), http://clustalw.ddbj.",OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,5 8 –65 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/1e/main.PMC4877606.pdf
"The genus is composed of 331 species with validly published names ( Bacillus, http://www.doi.namesforlife.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.12.005,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"The 16S rRNA nucleotides sequence was corrected using Chromas Pro 1.34 software (Technelysium, Tewantin, Australia), and the BLASTn searches were performed in theonline PubMed National Center for Biotechnology Information (NCBI) database ( http://blast.ncbi.nlm.nih.gov.gate1.inist.fr/ Blast.cgi ).",OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
The exhaustive bacteriocin database available in our laboratories (Bacteriocins from theURMITE database) ( http://drissifatima.wix.com/bacteriocins ) was performed by collecting all currently available sequences from the databases and from NCBI.,OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
Theseevidence codes are from the Gene Ontology project ( http://www.geneontology.,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,10,2 5–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4877607.pdf
"glucose-6-phosphate dehydrogenase  (G6PD)  deﬁciency  testing http://dx.doi.org/10.1016/j.bjhh.2016.01.006 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/43/56/main.PMC4877609.pdf
This  is  an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/56/main.PMC4877609.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.04.001 1516-8484/©  2016  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/73/0b/main.PMC4877615.pdf
This  is  an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/0b/main.PMC4877615.pdf
Available  from:  http://bvsms.saude.gov.br/bvs/ publicacoes/anvisa/diagnostico.pdf [cited  10.01.15]  [Internet].,OADS,/arxiv_data1/oa_pdf/73/0b/main.PMC4877615.pdf
Available  from: https://www.nhlbi.nih.gov/ﬁles/docs/guidelines/sc mngt.pdf [cited 10.01.15]  [Internet].,Non-OADS,/arxiv_data1/oa_pdf/73/0b/main.PMC4877615.pdf
Available  from:  https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/73/0b/main.PMC4877615.pdf
"Primary laryngeal  lymphomas  are  an  extremely  rare  entity representing  less  than  1%  of  all  extranodal  lymphomas with reported  male  and  left-sided  predominance,  and  loca- tion  mainly  supraglottic.1,2A  deﬁnite  diagnosis  can  only be obtained by immunohistochemistry,  as  the  radiological ﬁndings  are similar  to  primary  squamous  cell  laryngeal cancers.3 http://dx.doi.org/10.1016/j.bjhh.2016.02.005 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c8/0b/main.PMC4877616.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/0b/main.PMC4877616.pdf
"Mammography  showed  hyperdense  nodules,  with  regular margins and  lobulated  contours,  distributed  bilaterally  (Breast Imaging-Reporting  and  Data  System  –  BI-RADS  0),  whereas ultrasonography  showed  multiple  solid  oval-shaped  nodules with lobulated  contours  and  with  vascularization  by  color http://dx.doi.org/10.1016/j.bjhh.2016.03.003 1516-8484/©  2016  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c6/9d/main.PMC4877617.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/9d/main.PMC4877617.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4877619.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.03.004 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4877619.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4877619.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/1c/main.PMC4877659.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.02.006 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/32/1c/main.PMC4877659.pdf
This  is  an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/1c/main.PMC4877659.pdf
Available  from: http://www.inca.gov.br/estimativa/2014/sintese-de-resultados-comentarios.asp .,Non-OADS,/arxiv_data1/oa_pdf/32/1c/main.PMC4877659.pdf
http://www.ibge.gov.br/home/estatistica/ populacao/trabalhoerendimento/pnad98/saude/analise.shtm .,Non-OADS,/arxiv_data1/oa_pdf/32/1c/main.PMC4877659.pdf
Available  from: http://www.cibmtr.org .,Non-OADS,/arxiv_data1/oa_pdf/32/1c/main.PMC4877659.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
"Abbreviations: ATGL, adipose tissue glycerolipase; CE, cholesterol ester; COH, free cholesterol; DAG, diacylglycerol; FA, fatty acid; GalCer, galactosylcerami de; GluCer, glucosylceramide; GSIS, glucose-stimulated insulin secretion; HSL, hormone sensitive lipase; KRHB, Krebs Ringer Hepes Buffer; MAG, monacylglyc erol; MHC, mono- hexosylceramide; MS, mass spectrometry; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; (P), plasmalogen; (O), ether lipid; PKD, protein kinase D; PLA2, phospholipase A2; TAG, triacylglycerol; SM, sphingomyelin Received February 16, 2016 /C15Revision received April 5, 2016 /C15Accepted April 7, 2016 /C15Available online 13 April 2016 http://dx.doi.org/10.1016/j.molmet.2016.04.003 Original article 404MOLECULAR METABOLISM 5 (2016) 404 e414/C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/72/main.PMC4877660.pdf
In  a  study  of  SCD  involving  35  ﬁve-year-old DOI of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2016.01.004 .,OADS,/arxiv_data1/oa_pdf/ee/e0/main.PMC4877661.pdf
"It  was  shown  that  children  and  adolescents  expect that  orthodontic  treatment  will  improve  their  dental  appear- ance and  quality  of  life.14According  to  Thiruventadam  et  al., children  who  sought  orthodontic  treatment  had  lower  qual- ity  of  life  scores  than  those  who  never  had  or  never  sought orthodontic treatment.15The  same  observation  was  found  by http://dx.doi.org/10.1016/j.bjhh.2016.03.001 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ee/e0/main.PMC4877661.pdf
(http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/ee/e0/main.PMC4877661.pdf
"Ministério  da  Saúde  do  Brasil ,  [Internet]  Available  from: http://bvsms.saude.gov.br/bvs/publicacoes/manual  educacao saude  v2.pdf  [accessed  28.2.16].",OADS,/arxiv_data1/oa_pdf/ee/e0/main.PMC4877661.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
"Received March 8, 2016 /C15Revision received March 29, 2016 /C15Accepted April 1, 2016 /C15Available online 9 April 2016 http://dx.doi.org/10.1016/j.molmet.2016.04.002 Brief communication MOLECULAR METABOLISM 5 (2016) 415 e421/C2112016 Published by Elsevier GmbH.",OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e4/main.PMC4877662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
"Received February 22, 2016 /C15Revision received March 8, 2016 /C15Accepted March 14, 2016 /C15Available online 19 March 2016 http://dx.doi.org/10.1016/j.molmet.2016.03.003 Original article MOLECULAR METABOLISM 5 (2016) 379 e391/C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d0/main.PMC4877663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
"Abbreviations: AT, Adipose tissue; APC, Antigen presenting cells; LN, Lymph nodes; NC, Normal chow; T2D, Type 2 diabetes; VL, Vastus lateralis muscle Received February 26, 2016 /C15Revision received March 17, 2016 /C15Accepted March 22, 2016 /C15Available online 28 March 2016 http://dx.doi.org/10.1016/j.molmet.2016.03.004 Original article 392MOLECULAR METABOLISM 5 (2016) 392 e403/C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/4b/main.PMC4877664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
"Received March 21, 2016 /C15Revision received March 29, 2016 /C15Accepted April 1, 2016 /C15Available online 11 April 2016 http://dx.doi.org/10.1016/j.molmet.2016.04.001 Brief communication 422MOLECULAR METABOLISM 5 (2016) 422 e432/C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
"[2] NIDDK, http://www.niddk.nih.gov/health-information/health-statistics/Pages/ overweight-obesity-statistics.aspx .",Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
"[3] Eurostat, http://ec.europa.eu/eurostat/en/web/products-press-releases/-/3- 24112011-BP .",Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/f4/main.PMC4877665.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8a/27/num-08-02-31108.PMC4877670.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/f9/jjm-09-03-31179.PMC4877671.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Ryu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/65/df/srep23494.PMC4877672.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/65/df/srep23494.PMC4877672.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/fb/main.PMC4877714.pdf
These tumors maypresent as localized and slowly growing lesions and havehttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.007 2452-2325/ &2015 Iranian Society of Opthalmology.,Non-OADS,/arxiv_data1/oa_pdf/e4/fb/main.PMC4877714.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/e4/fb/main.PMC4877714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/4b/main.PMC4877715.pdf
"Since the WTW corneal diameter is one ofthe ocular biometrics that can be simply measured with a ruler,knowledge of the relationship of this component with other ocular biometric components can be helpful in getting anhttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.001 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e1/4b/main.PMC4877715.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/e1/4b/main.PMC4877715.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/5d/main.PMC4877716.pdf
"At the time of surgery, a focal extramacular retinot-omy was made to drain the subretinal ﬂuid under air injection.http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.004 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cc/5d/main.PMC4877716.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/cc/5d/main.PMC4877716.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/a9/main.PMC4877717.pdf
"Anterior segment examination wasunremarkable, and intraocular pressure was within normalhttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.006 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/a9/main.PMC4877717.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/b0/a9/main.PMC4877717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/45/main.PMC4877718.pdf
Manyhttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.008 2452-2325/ &2015 Iranian Society of Opthalmology.,Non-OADS,/arxiv_data1/oa_pdf/e9/45/main.PMC4877718.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/e9/45/main.PMC4877718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/aa/main.PMC4877719.pdf
"7The prevalence of myopia in Tehran, Iran is estimated to be 21/8%.6http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.004 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/78/aa/main.PMC4877719.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author .,Non-OADS,/arxiv_data1/oa_pdf/78/aa/main.PMC4877719.pdf
"Theaim was to evaluate the comparative quality of life in myopicpatients who wore glasses or contact lenses and those who hadundergone refractive surgery for myopia, and to compare themhttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.005 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c8/99/main.PMC4877720.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of the Iranian Society of Ophthalmology.,Non-OADS,/arxiv_data1/oa_pdf/c8/99/main.PMC4877720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/0b/main.PMC4877721.pdf
"6,11Previous studies con ﬁrm thathttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.001 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/08/0b/main.PMC4877721.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/08/0b/main.PMC4877721.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/9a/main.PMC4877722.pdf
Neck traumas during labor arehttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.005 2452-2325/ &2015 Iranian Society of Opthalmology.,Non-OADS,/arxiv_data1/oa_pdf/34/9a/main.PMC4877722.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/34/9a/main.PMC4877722.pdf
6 References 1.http://medical-dictionary.thefreedictionary.com/facial þasymmetry .,Non-OADS,/arxiv_data1/oa_pdf/34/9a/main.PMC4877722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/d4/main.PMC4877723.pdf
Several reports on survival analyses of UM have indicated that monosomy 3 is a strong metastatic risk factor which canlead to decreasing the 5-year survival from 100% to less thanhttp://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.002 2452-2325/ &2015 Iranian Society of Opthalmology.,Non-OADS,/arxiv_data1/oa_pdf/fd/d4/main.PMC4877723.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/fd/d4/main.PMC4877723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/d7/main.PMC4877724.pdf
"4,5It is estimated that more than 11http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.002 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5b/d7/main.PMC4877724.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/5b/d7/main.PMC4877724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/18/main.PMC4877725.pdf
1 ).http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.006 2452-2325/ &2015 Iranian Society of Opthalmology.,Non-OADS,/arxiv_data1/oa_pdf/f6/18/main.PMC4877725.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f6/18/main.PMC4877725.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC4877726.pdf
18http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.09.009 2452-2325/ &2015 Iranian Society of Opthalmology.,Non-OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC4877726.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC4877726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/d6/main.PMC4877727.pdf
"The signi ﬁcance of such sophisticated methods of investiga- tion is not only to detect the ocular disease, but to obtain anadditional element for the diagnosis of BD and to con ﬁrm the disease and treat it promptly and severely to overcome theundesired consequences.http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.003 2452-2325/ &2015 Iranian Society of Opthalmology.",Non-OADS,/arxiv_data1/oa_pdf/df/d6/main.PMC4877727.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/df/d6/main.PMC4877727.pdf
This is an open access article under the CC BY li- cense ( http://creativecommons.org/licenses/by/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/upload- s/how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
E-mail address: kerstin.ritter@bccn-berlin.de http://dx.doi.org/10.1016/j.dadm.2015.01.006 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
"The ADNI was initiated in 2003 by the NIA, the National Institute of Biomedical Imaging andBioengineering (NIBIB), the Food and Drug Administra-tion, pharmaceutical companies, and nonproﬁt organizationsfor the development of diverse biomarkers for the early detection of AD [7](For more information on study proce- dures see http://adni.loni.usc.edu/methods/documents/ ).",Non-OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
We usedhere a regularized version of the EM algorithm describedin[13] (The code can be found at http://www.clidyn.ethz.,OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
We used here the library for support vectormachines (LIBSVM) LIBSVM toolbox for MATLAB [24] with a Radial Basis Function (RBF) kernel and default pa-rameters ( C51) based on standardized features (Software can be found at http://www.csie.ntu.edu.tw/ wcjlin/libsvm/ ).,OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
"Here, we used thesoftware of L. Breiman and A. Cutler with 100 trees andmset toﬃﬃ ﬃnp(http://www.stat.berkeley.edu/ wbreiman/ RandomForests/ ).",OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
"However, three of the most successfully discriminating scores were not used to make the diagnosis in ADNI, namely the FAQ, ADAS 11, and ADAS 13(http://adni.loni.usc.edu/wp-content/uploads/2010/09/ADNI_ GeneralProceduresManual.pdf ,p .2 0 - 2 1 ) .",OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.01.006 .,OADS,/arxiv_data1/oa_pdf/3f/80/main.PMC4877756.pdf
DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2016.01.005 .,OADS,/arxiv_data1/oa_pdf/2a/a1/main.PMC4877926.pdf
"High  risk  MM  is  characterized  by del(17p), t(14;16)  and  t(14;20);  intermediate  by  t(4;14),  1qgain, complex  karyotype,  hypodiploidy  or  metaphase  detected del13,  while  standard  risk  MM  is  characterized  by  all  other aberrations including  trisomies  (especially  of  chromosomes  3, http://dx.doi.org/10.1016/j.bjhh.2016.03.002 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/2a/a1/main.PMC4877926.pdf
(http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/2a/a1/main.PMC4877926.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
E-mail address: jrobilla@mail.ubc.ca http://dx.doi.org/10.1016/j.dadm.2015.03.004 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.pewinternet.org/2013/01/15/health-online- 2013/ ; 2013.,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.pewinternet.org/2012/06/06/ older-adults-and-internet-use/ ; 2012.,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Alzheimer Dis Assoc Disord 2014; http://dx.doi.org/10.1097/WAD.0000000000000055.,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
[26] Online Short-term Memory Tests & Memory Screenings n.d. Avail- able at: http://www.cognicheck.com/ .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.preventad.com/ .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.drdharma.com/Public/FreeStuff/ FreeMemoryTestQuestions/index.cfm .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.memozor.com/ memory-tests/test-for-alzheimer-online .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://cognitivelabs.com/ global_cog_map1.htm .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.mybraintest.org/online-memory-screening- tests/ .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.dailymail.co.uk/ health/article-2095705/Alzheimers-questionnaire-Test-reveal-YOU-risk.html .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.health24.,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.foodforthebrain.org/ .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at:http://www.onmemory.ca/en/signs-symptoms/memory-test .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://wexnermedical.osu.edu/patient-care/ healthcare-services/brain-spine-neuro/memory-disorders/sage .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
Available at: http://www.way-of-the-mind.com/ alzheimers-test.html .,Non-OADS,/arxiv_data1/oa_pdf/8f/1c/main.PMC4877927.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/45/main.PMC4877929.pdf
E-mail address: sallyjvogel@live.com http://dx.doi.org/10.1016/j.dadm.2015.05.002 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/45/main.PMC4877929.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/45/main.PMC4877929.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/e1/main.PMC4877930.pdf
"The  high  costs  are mostly  attributable  to  several  biochemical  characteristics  of the  recombinant  protein  such  as  the  retention  of  FVIII  within the endoplasmic  reticulum  (ER)  due  to  its  interaction  with  dif- ferent  ER  chaperones.1 Several  studies  have  provided  important  information  that helped in  the  design  and  development  of  techniques  to  bio- engineer rFVIII with  better  secretion  efﬁciency.2,3Swaroop4 developed an  rFVIII  with  a  point  mutation  in  the  A1  domain http://dx.doi.org/10.1016/j.bjhh.2016.04.002 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/33/e1/main.PMC4877930.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/e1/main.PMC4877930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4877931.pdf
E-mail address: r.paterson@ucl.ac.uk http://dx.doi.org/10.1016/j.dadm.2015.06.003 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4877931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4877931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/70/78/main.PMC4878065.pdf
The recent clinical availability of amyloid-PET now allows physicians to estimate the http://dx.doi.org/10.1016/j.dadm.2015.06.006 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/78/main.PMC4878065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/78/main.PMC4878065.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/70/78/main.PMC4878065.pdf
Available at: http://pi.lilly.com/us/ amyvid-uspi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/78/main.PMC4878065.pdf
Available at: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2014/203137s002lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/70/78/main.PMC4878065.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.011 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/b4/87/main.PMC4878125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 145 e146,Non-OADS,/arxiv_data1/oa_pdf/b4/87/main.PMC4878125.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.010 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/f3/fd/main.PMC4878126.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 142 e144,Non-OADS,/arxiv_data1/oa_pdf/f3/fd/main.PMC4878126.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.004 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/b2/4c/main.PMC4878127.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 116 e121,Non-OADS,/arxiv_data1/oa_pdf/b2/4c/main.PMC4878127.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.003 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/0a/75/main.PMC4878129.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 113 e115,Non-OADS,/arxiv_data1/oa_pdf/0a/75/main.PMC4878129.pdf
Methods This study retrospectively retrieved medical data from the NIEMS ( http://www.niems.go.th/th/DefaultTH.aspx ).,OADS,/arxiv_data1/oa_pdf/0a/75/main.PMC4878129.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.006 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 126 e130,Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
"Medimagazin, Rakamlarla 112 Acil Servis, at: http://www.medimagazin.com.",Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
"Türkdemir AH, Çavus ¸ T, Aysun A. Türkiye ’de Ambulans Kazalar ında De /C21gis¸ im, at: http://aht112acil.8m.net/about_5.html Accessed 08.10.14.",Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
"Karayollar ıTraﬁk Kaza _Istatistikleri 2013, 2014, at: http://www.tuik.gov.tr/PreHaberBultenleri.do?id ¼18510 Accessed October 09.10.14.",Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
USDOT Region V Regional University Transportation Center Final Report; 2009. at: http://www.purdue.,Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
17.€Ozdemir E. Ambulans Kullanan ATT ve Paramediklere 250 TL Fark Verilmeli ; 2014. at:http://www.attder.org.tr/ambulans-kullanan-att-ve-paramediklere-250-tl- fark-verilmeli/ .,Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
"Pennsyl- vania Department of Health, Bureau of Emergency Medical Services; 2007. at: http://www.portal.state.pa.us/portal/server.pt?",Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
"Ambulance Crash Roundup, 2011, at: http://www.emsworld.com/ article/10225399/ambulance-crashes Accessed 09.10.14.",Non-OADS,/arxiv_data1/oa_pdf/05/9b/main.PMC4878130.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.001 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/45/ae/main.PMC4878131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 109 e110,Non-OADS,/arxiv_data1/oa_pdf/45/ae/main.PMC4878131.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.008 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/d8/cf/main.PMC4878132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 136 e138,Non-OADS,/arxiv_data1/oa_pdf/d8/cf/main.PMC4878132.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.009 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/79/97/main.PMC4878133.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 139 e141,Non-OADS,/arxiv_data1/oa_pdf/79/97/main.PMC4878133.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.012 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/93/f5/main.PMC4878134.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 147 e149,Non-OADS,/arxiv_data1/oa_pdf/93/f5/main.PMC4878134.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.007 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/d3/89/main.PMC4878135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 131 e135,Non-OADS,/arxiv_data1/oa_pdf/d3/89/main.PMC4878135.pdf
Available at: http://www.justice.gov.tr/basiclaws/ Criminal_Code.pdf [accessed 11.02.15].,Non-OADS,/arxiv_data1/oa_pdf/d3/89/main.PMC4878135.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.005 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/67/9c/main.PMC4878150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 122 e125,Non-OADS,/arxiv_data1/oa_pdf/67/9c/main.PMC4878150.pdf
Available at: http://mevzuat.basbakanlik.gov.tr/Metin.Aspx?MevzuatKod ¼9.5.,Non-OADS,/arxiv_data1/oa_pdf/67/9c/main.PMC4878150.pdf
ChiCTR‑OCH‑13003729); http://www.chictr.org.cn/showproj.aspx?proj = 5831.,Non-OADS,/arxiv_data1/oa_pdf/66/12/CMJ-129-1135.PMC4878156.pdf
"[11‑13]  Like HMGA2, survivin mRNA has a long 3’‑UTR of 2100  nt with nine putative APA sites as predicted by PolyA_SVM  software  (http://exon.umdnj.edu/polya_svm_server/index.",Non-OADS,/arxiv_data1/oa_pdf/16/99/CMJ-129-1140.PMC4878157.pdf
Available from: http://www.who.int/tb/ publications/global_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/2e/3e/CMJ-129-1171.PMC4878162.pdf
Available from:  http://www.moh.gov.cn/cmsresources/mohfybjysqwss/cmsrsdocument/ doc14756.doc.,Non-OADS,/arxiv_data1/oa_pdf/34/00/CMJ-129-1193.PMC4878165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
E-mail address: shireen.sindi@ki.se http://dx.doi.org/10.1016/j.dadm.2015.06.005 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
Available at: http://www.alz.co.,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
Available at: https://www.gov.uk/government/uploads/system/up loads/attachment_data/ﬁle/265869/2901668_G8_DementiaSummitDeclaration_acc.pdf .,OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
Available at: http://www.imshealth.com/deployedﬁles/imshealth/ Global/Content/Corporate/IMS%20Health%20Institute/Reports/Patient _Apps/IIHI_Patient_Apps_Report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
Available at: http://www.itu.int/en/ITU-D/ICT-Applications/ eHEALTH/Be_healthy/Documents/mHealth_for_NCDs_June2013.,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
Available at: http://www.gov.uk/government/publications/medical-devices-software-applications-apps/medical-devic e-stand-alone-sof tware-including- apps.,Non-OADS,/arxiv_data1/oa_pdf/41/6a/main.PMC4878198.pdf
"1, 11 –20 http://dx.doi.org/10.1080/21655979.2015.1126015",Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
"Clin Infect Dis 2008; 46(2):S58-S61;PMID:18181724; http://dx.doi.org/10.1086/523341 3 .O u w e h a n dA C ,D o n g L i a nC ,W e i j i a nX ,S t e w a r tM , Ni J, Stewart T, Miller LE.",OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Vaccine 2014; 32(4):458-463; PMID:24291194; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nat Rev Gastroenterol Hepatol 2012; 9:555; PMID:23034427;http://dx.doi.org/10.1038/nrgastro.2012.165 5.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nat Biotech 2013; 31 (4):309-315; http://dx.doi.org/10.1038/nbt.2548 6.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nature 2014 509(7500):269-70; PMID:24828169; http://dx.doi.org/10.1038/509269a 8.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Curr Opin Biotechnol 2015; 32:99-103; PMID:25499742; http://dx.doi.org/10.1016/j.copbio.2014.11.021 9.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Science 2009; 326:1694-1697;PMID:19892944; http://dx.do i.org/10.1126/science.1177486 12.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Sci-ence 2005; 307:1915-1920; http://dx.doi.org/10.1126/ science.1104816 13.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nature 2010; 465:879-880; PMID:20559375; http://dx.doi.org/10.1038/465879a 14.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
EMBO Rep 2006; 7:688-693; http://dx.doi.org/10.1038/sj.embor.7400731 15.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Diabetes 2013; 62(10):3341-9. Review; PMID:24065795; http://dx.doi.org/10.2337/db13-0844 1 6 .,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nature 2010; 464(7285):59-65; PMID:20203603; http://dx.doi.org/ 10.1038/nature08821 17.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nature 2012; 488 (7410):178-184; PMID:22797518; http://dx.doi.org/ 10.1038/nature1131918 D. M. LINARES ET AL.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nature 2012; 486:207-214; PMID:22699609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nature 2012;489:242-249; PMID:22972297; http://dx.doi.org/10.1038/nature11552 22.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Mayo Clin Proc 2014; 89(1):107-114; PMID:24388028; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Lancet 2003; 361(9356): 512-519; http://dx.doi.org/10.1016/S0140-6736(03)12489-0 24.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Best Practice Res Clin Gastroenterol 2004; 18(2):337-352;PMID:15123074; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Curr Opin Microbiol 2003; 6(5):457-461; PMID:14572537;http://dx.doi.org/10.1016/j.mib.2003.09.006 26.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
"Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease.Nat Rev Gastroenterol Hepatol 2012; 9(10):565-76;PMID:22890113; http://dx.doi.or g/10.1038/nrgastro.2012.144 27.",Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Front Microbiol 2014; 5:587; PMID:25408692;http://dx.doi.org/10.3389/fmicb.2014.00587 28.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Science 2013;341:1237439; PMID:23828941; http://dx.doi.org/10.1126/science.1237439 30.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Pediatr Res 2014; 76(1):2-10; PMID:24732106;http://dx.doi.org/10.1038/pr.2014.49 31.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Infect Immun2008; 76(8):3360-3373; PMID:18474643; http://dx.doi.org/10.1128/IAI.00187-08 32.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Critical Rev Food Sci Nutri 2014; 54(7):938-956; http://dx.doi.org/10.1080/10408398.2011.619671 36.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Allergy Asthma Immunol Res 2015; 7(4):409-413; PMID:25749784; http://dx.doi.org/10.4168/aair.2015.7.4.409 37.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Benef Microbes 2015; 6(3):277-286; PMID:25391346; http://dx.doi.org/ 10.3920/BM2014.0070 38.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
PLoS One 2009; 4(9): e7056; PMID:19756155; http://dx.doi.org/10.1371/journal.pone.0007056 39.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Annu Rev Nutr 1981; 1:257-279; PMID:6764717; http://dx.doi.org/10.1146/annurev.nu.01.070181.001353 42.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nat Rev Microbiol 2013; 11:95-105;PMID:23268227; http://dx.doi.org/10.1038/nrmicro2937 43.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Science 2015; 349 (6246):1254766; PMID:26206939; http://dx.doi.org/ 10.1126/science.1254766 44.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
2015 518(7540):S12-5; PMID:25715275; http://dx.doi.org/10.1038/518S13a 48.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
2014; 73(4):477-89.Review; PMID:25196939; http://dx.doi.org/10.1017/S0029665114001426 49.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Nat Rev Gastroenterol Hepatol2014; 11(8):506-514; PMID:24912386; http://dx.doi.org/10.1038/nrgastro.2014.66 50.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Science 2012; 336:1246-1247; PMID:22674333;http://dx.doi.org/10.1126/science.336.6086.1246 51.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Science 2010; 330:1168-1169; PMID:21109643;http://dx.doi.org/10.1126/science.330.6008.1168 52.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Science 2011; 332:32-33; PMID:21454769; http://dx.doi.org/10.1126/science.332.6025.32 53. de Weerdt S. Microbiome: Microbial mystery.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
2015; 521(7551):S10-1; PMID:25970451; http://dx.doi.org/ 10.1038/521S10a 54.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Gut Microbes 2010; 1(3):164-85;PMID:21327023; http://dx.doi.org/10.4161/gmic.1.3.1212756.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Int J Food Microbiol 2011;149:185-193; PMID:218034 36; http://dx.doi.org/ 10.1016/j.ijfoodmicro.2011.07.005 57.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Curr Pharm Des 2005; 11:11-16; PMID:15638748; http://dx.doi.org/10.2174/1381612053382395 58.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
Am J Health Syst Pharm 2010; 67:449-458; PMID:20208051; http://dx.doi.org/10.2146/ajhp090168 59.,Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
J Biol Chem 2011; 286(12):10288-96; PMID:21239485;http://dx.doi.org/10.1074/jbc.M110.-168666 62.,OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
"J Med Micro- biol 2013, 62(9):1369-1378; PMID:23699066; http://dx.doi.org/10.1099/jmm.0.058933-0 63.",Non-OADS,/arxiv_data1/oa_pdf/f6/97/kbie-07-01-1126015.PMC4878258.pdf
"7We demonstrated that Epoxy induced b-cell replica- tion in pancreatic b-cell lines (INS1 832/13) and primary rat b-cell cultures through a mechanism involving activation of ERK1/2 signaling pathway and upregulation of cell cycle activa-tors such as cyclin D2 and cyclin E. In addition, Epoxy showed protection against basal and cytokine-mediated b-cell death in © Jose F L /C19opez-Acosta, Pablo Villa-P /C19erez, Cristina M Fern /C19andez-Díaz, Daniel de Luis Rom /C19an, Ana R Díaz-Marrero, Mercedes Cueto, Germ /C19an Perdomo, and Irene C/C19ozar-Castellano *Correspondence to: Irene C /C19ozar-Castellano; Email: irene.cozar@ibgm.uva.es Submitted: 05/27/2015; Revised: 07/21/2015; Accepted: 07/22/2015 http://dx.doi.org/10.1080/19382014.2015.1078053 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Diabetes Res Clin Pract 1995; 28(Suppl):S3-11; PMID:8529517; http://dx.doi.org/10.1016/0168- 8227(95)01087-T 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Diabetes Care 2004; 27(5):1047-53; PMID:15111519; http://dx.doi.org/10.2337/ diacare.27.5.1047 3.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Curr DiabRep 13(3):435-44; PMID:23494755; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Diabetes 2003 ;52(1):102-10; PMID:12502499; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Ann N Y Acad Sci 2013; 1281:92-105; PMID:23363033; http://dx.doi.org/10.1111/nyas.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
PLoS One2013; 8(1):e52862; PMID:23300997; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Science 1976; 193(4251):415-7; PMID:180605; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Environ Res 2005; 99(3):335-43; PMID:16307975; http://dx.doi.org/10.1016/j.envres.2005.03.011 10.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Diabetes 2006; 55(12):3271-8; PMID:17130470; http://dx.doi.org/10.2337/db06- 0627 12.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
J Endocrinol 1990; 127(1):161- 5; PMID:2151740; http://dx.doi.org/10.1677/joe.0.1270161 13.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Autoimmunity 1995; 20(2): 83-92; PMID:7578872; http://dx.doi.org/10.3109/ 08916939509001931 14.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
J Nat Prod 1984; 47 (6):1009-12; PMID:6152470; http://dx.doi.org/ 10.1021/np50036a018 15.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Tetrahedron 2007; 63 (37):9057-62; http://dx.doi.org/10.1016/j.tet.2007.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Chem Biodivers 2008; 5(11):2449-56; PMID:19035574; http://dx.doi.org/10.1002/cbdv.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Nat Prod Rep 2008; 25(2):298-317; PMID:18389139; http://dx.doi.org/ 10.1039/b705660p 1 8 .,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
Angew Che Int Ed 2014; (53):3859-62; PMID: 24604885; http://dx.doi.org/ 10.1002/anie.201400617 19.,OADS,/arxiv_data1/oa_pdf/4d/23/kisl-07-02-1078053.PMC4878260.pdf
"GPCRs have attracted considerable interest as putative therapeutic targets fortype 2 diabetes (T2D) and other metabolic diseases, 6with the © Sonja H €anzelmann, Jinling Wang, Emre G €uney, Yunzhao Tang, Enming Zhang, Annika S Axelsson, Hannah Nenonen, Albert S Salehi, Claes B Wollheim, Eva Zet- terberg, Erik Berntorp, Ivan G Costa, Robert Castelo, and Anders H Rosengren*Correspondence to: Anders H Rosengren; Email: anders.rosengren@med.lu.seSubmitted: 10/29/2015; Accepted: 10/30/2015 http://dx.doi.org/10.1080/19382014.2015.1118195 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
J Clin Invest 1988; 81(2):435-41; PMID:3276729; http://dx.doi.org/10.1172/JCI113338 2.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Horm Res 2005; 64 Suppl 3:8-15; PMID:16439839; http://dx.doi.org/10.1159/000089312 3.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Cell 2012; 148(6):1160-71; PMID:22424227; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Diabetes 2004; 53 Suppl 3:S16-21; PMID:15561905; http://dx.doi.org/10.2337/diabetes.53.suppl_3.S16 5.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
"Diabetes 2009; 58(4):773- 95; PMID:19336687; http://dx.doi.org/10.2337/db09-9028 6 .A m i s t e nS ,S a l e h iA ,R o r s m a nP ,J o n e sP M ,P e r - saud SJ.",Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Pharmacol Ther 2013; 139(3):359-91; PMID:23694765; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Int J Clin Pharm 2013; 35(2):159-72; PMID:23263796; http://dx.doi.org/10.1007/s11096-012-9729-9 8.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Nature 2003; 422 (6928):173-6; PMID:12629551; http://dx.doi.org/ 10.1038/nature01478 9.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Science 2002; 297(5586):1551-5; PMID:12202830; http://dx.doi.org/10.1126/science.1073374 10.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Cell Metab 2012; 16(5):625-33; PMID:23140642; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Nature 1997; 386(6624):502-6;PMID:9087410; http://dx.doi.org/10.1038/386502a0 13.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
"J Comput Biol 2009; 16(2):213-27; PMID:19178140; http://dx.doi.org/10.1089/ cmb.2008.08TT 1 4 .S h a r m a nJ L ,B e n s o nH E ,P a w s o nA J ,L u k i t oV , Mpamhanga CP, Bombail V, Davenport AP, PetersJ A ,S p e d d i n gM ,H a r m a rA J .I U P H A R - D B : updated database content and new features.",OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Nucleic Acids Res 2013; 41(Database issue):D1083-1088; PMID:23087376; http://dx.doi.org/10.1093/nar/gks960 15.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
PLoS One 2012; 7(9):e43557; PMID:23028459; http://dx.doi.org/10.1371/ journal.pone.0043557 1 6 .,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
BMC Bioinformatics 2005; 6:225; PMID:16156896; http://dx.doi.org/10.1186/1471- 2105-6-225 17.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Br J Pharmacol 2001; 134(6):1312-8; PMID:11704652; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Nat Rev Drug Discov 2009; 8(5):369-85; PMID:19365392; http://dx.doi.org/10.1038/nrd2782 21.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Proteinase-activated receptors (PARs) and calcium signaling in cancer.Adv Exp Med Biol 2012; 740:979-1000; PMID:22453980; http://dx.doi.org/10.1007/978- 94-007-2888-2_45 22.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Immunology 2004; 112(2):183-90;PMID:15147561; http://dx.doi.org/10.1111/j.1365-2567.2004.01870.x 23.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
J Biol Chem 2000; 275:31255; PMID:10893235; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Arterioscler Thromb Vasc Biol 2010; 30(12):2587-96; PMID:20930172; http://dx.doi.org/10.1161/ ATVBAHA.110.211177 25.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Cell Tissue Res 2005; 319(2):221- 30; PMID:15558323; http://dx.doi.org/10.1007/ s00441-004-1013-4 26.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Blood 2013; 122(5):807-16;PMID:23788139; http://dx.doi.org/10.1182/blood- 2013-03-488957 27.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Br J Haematol 2006; 133(3):315-22; PMID:16643434; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Circulation 2002; 106(19):2442-7;PMID:12417540; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Curr Diab Rep 2007; 7(3):223-7; PMID: 17547839; http://dx.doi.org/10.1007/s11892-007- 0035-1 31.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Diabetes2006; 55(1):202-8; PMID:16380494; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Trends Endocrinol Metab 1997; 8 (7):276-82; PMID:18406816; http://dx.doi.org/10.1016/S1043-2760(97)00094-5 3 4 .,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Diabetes2000; 49(12):2094-101; PMID:11118012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Lancet 2003; 361 (9354):301-7; PMID:12559865; http://dx.doi.org/ 10.1016/S0140-6736(03)12325-2 36.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Mol Cell Endocrinol 2012; 353(1-2):128-37;PMID:21784130; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
Cell Calcium 2010; 48(2-3):133-42; PMID:20800281; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/b1/kisl-07-04-1118195.PMC4878264.pdf
"1, 33 –38 http://dx.doi.org/10.1080/21655979.2015.1128589",Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
BMC Biotech-nol 2015; 15:78; PMID:26286037; http://dx.doi.org/10.1186/s12896-015-0185-12.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Protein Eng 1997; 10:1271-9; PMID:9514115; http://dx.doi.org/10.1093/protein/10.11.1271 6.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Int J Mol Sci 2012;13:11643-65; PMID:23109875; http://dx.doi.org/10.3390/ijms130911643 8.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
PLoS One 2015; 10:e0137384;PMID:26333173; http://dx.doi.org/10.1371/journal.pone.0137384 9.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Protein Expr Purif 2014; 97:29-36;PMID:24582823; http://dx.doi.org/10.1016/j.pep.2014.02.008 11.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Protein Expr Purif 2007; 53:264-9; PMID:17307364; http://dx.doi.org/10.1016/j.pep.2006.12.023BIOENGINEERED 37,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Nat Biotechnol 2004; 22:877-82; PMID:15195104;http://dx.doi.or g/10.1038/nbt984 17.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
J Biomol NMR 2010; 48:147-55; PMID:20844927; http://dx.doi.org/10.1007/s10858-010-9445-5 18.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Mol Microbiol 2010; 76:120-32; PMID:20199592; http://dx.doi.org/10.1111/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Carbohydr Polym 2014; 101:511-6; PMID:24299806; http://dx.doi.org/10.1016/j.carbpol.2013.09.057 20.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Microb Cell Fact 2008; 7:2; PMID:18257924; http://dx.doi.org/10.1186/1475-2859-7-2 21.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
J Biotechnol 2007;127:199-210; PMID:16959351; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
A novel genetic system for recombinant protein secretion in theAntarctic Pseudoalteromonas haloplanktis TAC125.Microb Cell Fact 2006; 5:40; PMID:17169153; http://dx.doi.org/10.1186/1475-2859-5-40 23.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Genome Res 2005; 15:1325-35; http://dx.doi.org/10.1101/gr.4126905 24.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Microb Cell Fact 2015; 14:1-11; PMID:25567661; http://dx.doi.org/ 10.1186/s12934-014-0183-3 25.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
PLoS One 2014; 9:1-6; http://dx.doi.org/10.1371/journal.pone.0090372 26.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Microb Cell Fact 2010; 9:72; PMID:20858251; http://dx.doi.org/10.1186/1475-2859-9-72 27.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Appl Environ Microbiol 2011; 77:2648-55; PMID:21335387; http://dx.doi.org/ 10.1128/AEM.02091-10 28.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.Protein Sci 1998; 7:815-36; PMID:9568890; http://dx.doi.org/10.1002/pro.5560070401 29.,Non-OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
FEBS Lett2008; 582:2620-6; PMID:18586033; http://dx.doi.org/10.1016/j.febslet.2008.06.041 30.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
Infect Dis Ther 2013; 2:15-26; PMID:25135820; http://dx.doi.org/10.1007/s40121-013-0002-x38 G. E. K. BJERGA ET AL.,OADS,/arxiv_data1/oa_pdf/5f/e9/kbie-07-01-1128589.PMC4878266.pdf
"© Min Joo Kim, Ok Kyong Choi, Kyung Sil Chae, Hakmo Lee, Sung Soo Chung, Dong-Sik Ham, Ji-Won Kim, Kun-Ho Yoon, Kyong Soo Park, and Hye Seung Jung *Correspondence to: Hye Seung Jung; Email: junghs@snu.ac.krSubmitted: 07/22/2015; Revised: 12/02/2015; Accepted: 12/02/2015 http://dx.doi.org/10.1080/19382014.2015.1129096 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Diabetes Obe- sity Metabol 2011; 13 Suppl 1:95-105; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Metab 2014; 63:9-19; http://dx.doi.org/10.1016/j.metabol.2013.09.010 3.,OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Endocrinol Metab 2013; 28:262-74; http://dx.doi.org/10.3803/ EnM.2013.28.4.262 4.,OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Diabetes 2013; 62:2595-604; PMID:23524641; http://dx.doi.org/10.2337/db12-1686 6.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Exp Opin Drug Discov 2013; 8:219-44;http://dx.doi.org/10.1517/17460441.2013.741580 7.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Diabetes 2012; 61:1243-9; PMID:22338093; http://dx.doi.org/10.2337/db11- 0936 8.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Int J Clin Prac-tice 2010; 64:984-90; http://dx.doi.org/10.1111/ j.1742-1241.2010.02382.x 9.,OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose toler- ance and b-cell function and mass in insulin recep- tor substrate-2-knockout mice fed a high-fat diet.Endocrinol 2012; 153:1093-102; http://dx.doi.org/ 10.1210/en.2011-1712 10.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Endocrinol Metab 2013; 28:6-11; http://dx.doi.org/10.3803/EnM.2013.28.1.6 12.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Cell Metab 2008; 8:325-32; PMID:18840363; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Endocrinol Metab 2015; 30:65-70; http://dx.doi.org/ 10.3803/EnM.2015.30.1.65 16.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
"Masini M, Bugliani M, Lupi R, del Guerra S, Boggi U, Filipponi F, Marselli L, Masiello P, Marchetti P. Autophagy in human type 2 diabetes pancreatic bcells.Diabetologia 2009; 52:1083-6; PMID:19367387; http://dx.doi.org/10.1007/s00125-009-1347-2 1 7 .",Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Endo- crinol 2013; 154:4512-24; http://dx.doi.org/10.1210/en.2013-1578 18.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Cell Metab 2009;9:350-61; PMID:19356716; http://dx.doi.org/ 10.1016/j.cmet.2009.02.007 20.,OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Diabetes 1997; 46:792-800; PMID:9133546; http://dx.doi.org/10.2337/diab.46.5.792 21.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Diabe tologia 2003; 46:1383- 93; PMID:13680124; http://dx.doi.org/10.1007/s00125-003-1203-8 23.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
Diabetes 2010; 59:3090- 8; PMID:20802254; http://dx.doi.org/10.2337/db10- 0624 25.,Non-OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
J Cell Biol2005; 169:425-34; PMID:15866887; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/9f/kisl-07-05-1129096.PMC4878271.pdf
"18-19 © Han-Hung Huang and Lisa Stehno-Bittel *Correspondence to: Lisa Stehno-Bittel; Email: lbittel@kumc.eduSubmitted: 10/27/2015; Revised: 12/01/2015; Accepted: 12/02/2015 http://dx.doi.org/10.1080/19382014.2015.1129097 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Islets 2011; 3(1):1-5; PMID:21266855; http://dx.doi.org/ 10.4161/isl.3.1.14131 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Islets 2011; 3(1):6-13; PMID:21325888; http://dx.doi.org/10.4161/isl.3.1.14132 4.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Diabetes 2007; 56(3):594-603; PMID:17327426; http://dx.doi.org/10.2337/db06-0779 5.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Scand J Immunol 2010; 72(6):504-10;PMID:21044124; http://dx.doi.org/10.1111/j.1365- 3083.2010.02466.x 6.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Diabetes 2001; 50(10):2244-52; PMID:11574405; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Biochem J 1994; 303(Pt 2):625-31; PMID:7980425; http://dx.doi.org/ 10.1042/bj3030625 9.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
"MacFarlane WM, Shepherd RM, Cosgrove KE, J a m e sR F ,D u n n eM J ,D o c h e r t yK .G l u c o s em o d u - lation of insulin mRNA levels is dependent on tran-scription factor PDX-1 and occurs independently of changes in intracellular Ca2 C. Diabetes 2000; 49 (3):418-23; PMID:10868963; http://dx.doi.org/ 10.2337/diabetes.49.3.418 10.",Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 2000; 275(21):15977-84; PMID:10821851; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 1998; 273 (36):23241-7; PMID:9722555; http://dx.doi.org/10.1074/jbc.273.36.23241 12.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 2003; 278(35):32969-77; PMID:12810726; http://dx.doi.org/10.1074/jbc.M301198200 13.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 2005; 280 (29):26751-9; PMID:15899886; http://dx.doi.org/ 10.1074/jbc.M503158200 14.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Genes Dev 1995; 9(8):1009- 19; PMID:7774807; http://dx.doi.org/10.1101/gad.9.8.1009 15.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 2002; 277(51):49903-10;PMID:12368292; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Mol Cell Biol 2005; 25 (12):4969-76; PMID:15923615; http://dx.doi.org/ 10.1128/MCB.25.12.4969-4976.2005 18.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Nature 1980; 283(5742):100-2; PMID:6985712; http://dx.doi.org/10.1038/283100a0 21.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Biochem J 1986; 235(2):459-67; PMID:3017307;http://dx.doi.org/10.1042/bj2350459 22.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Biochem J 1989; 257(2):431-7; PMID:2649074; http://dx.doi.org/ 10.1042/bj2570431 23.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 2003; 278(43):42080-90; PMID:12928442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
"Acta Diabetol 2013; 50(5):687- 96; PMID:22302191; http://dx.doi.org/10.1007/s00592-012-0375-4 26 Guo S, Dai C, Guo M, Taylor B, Harmon JS, Sander M, Robertson RP, Powers AC, Stein R. Inactivation ofspeciﬁc b-cell transcription factors in type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
"J Clin Invest 2013; 123(8):3305-16.; PMID:23863625; http://dx.doi.org/10.1172/JCI65390 27 Ling Z, Heimberg H, Foriers A, Schuit F, Pipeleers D. Differential expression of rat insulin I and II messengerribonucleic acid after prolonged exposure of islet b-cells to elevated glucose levels.",Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Regul Pept 2010; 163(1-3):81- 7; PMID:20451564; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Biol Chem 1999; 274(2):1011-6; PMID:9873045; http://dx.doi.org/10.1074/jbc.274.2.1011 30.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Dia-betes Metab J 2011; 35(5):469-79; PMID:22111038; http://dx.doi.org/10.4093/dmj.2011.35.5.469 31.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Biochem J 2008; 415(1):1-10; PMID:18778246; http://dx.doi.org/10.1042/ BJ20081029 32.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Islets2013; 5(2):87-94; PMID:23648896; http://dx.doi.org/ 10.4161/isl.24780 33.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
J Clin Invest 2004; 114 (6):828-36; PMID:15372107; http://dx.doi.org/ 10.1172/JCI21845 34.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Am J Physiol Endocrinol Metab 2005; 288(4):E707-714; PMID:15562255; http://dx.doi.org/10.1152/ ajpendo.00252.2004 35.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Pancreas 2010; 39(6):856-62; PMID:20467340; http://dx.doi.org/10.1097/MPA.0b013e3181d6bc69 36.,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
Mol Endocrinol 2012; 26 (7):1203-12; PMID:22570331; http://dx.doi.org/10.1210/me.2012-1004 e1129097-8 Volume 7 Issue 5 Islets,Non-OADS,/arxiv_data1/oa_pdf/b2/8d/kisl-07-05-1129097.PMC4878277.pdf
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.,OADS,/arxiv_data1/oa_pdf/a5/07/str-47-1618.PMC4878286.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.116.013392 Basic Sciences,Non-OADS,/arxiv_data1/oa_pdf/a5/07/str-47-1618.PMC4878286.pdf
Go to http://cme.ahajournals.org to take the quiz.,Non-OADS,/arxiv_data1/oa_pdf/ea/3d/str-47-1459.PMC4878287.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.115.012324,Non-OADS,/arxiv_data1/oa_pdf/ea/3d/str-47-1459.PMC4878287.pdf
"), masked to the behavioral data, manually modi- fied the boundary to avoid false-positive and false-negative areas on  RoiEditor (http://www.MRIstudio.org).18 We then transformed the  least DWI (b0) with T2-weighted contrast to the JHU-MNI-b0 atlas  using affine transformation followed by large deformation diffeomor - phic metric mapping.19,20 The resultant matrices were applied to the  stroke map for normalization and overlaid on the customized ver - sion of the JHU-MNI Brain Parcellation Map (cmrm.med.jhmi.edu) to determine percent damage to each region of interest (ROI) using DiffeoMap (http://www.MRIstudio.org).",OADS,/arxiv_data1/oa_pdf/ea/3d/str-47-1459.PMC4878287.pdf
http://dx.doi.org/10.1016/j.dadm.2015.05.005 2352-8729/ /C2112015 The Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/83/44/main.PMC4878319.pdf
Available at: http://www.who.int/mental_ health/publications/dementia_report_2012/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/83/44/main.PMC4878319.pdf
Available at: http://www.euro.who.int/en/h ealth-topics/noncommunicable- diseases/mental-health/news/news/2010/15/childrens-right-to-family-life/deﬁnition-intellectual-disability .,Non-OADS,/arxiv_data1/oa_pdf/83/44/main.PMC4878319.pdf
Available at:http://www.rcpsych.ac.uk/us efulresources/publicati ons/collegereports/cr/ cr155.aspx .,Non-OADS,/arxiv_data1/oa_pdf/83/44/main.PMC4878319.pdf
Available at:http://www.irishpsychiatry.ie/Libraries/External_Events_Documents/A_ Guidance_Document_on_Dementia_i n_Persons_with_Intellectual_ Disability_2013_doc_ﬁnal_for_web.sﬂb.ashx .,Non-OADS,/arxiv_data1/oa_pdf/83/44/main.PMC4878319.pdf
Available at: http://www.aci.health.nsw.gov.au/__data/ assets/pdf_ﬁle/0016/231514/Health_Car e_in_People_with_Intellectual_ Disability_Guidelines.pdf .,OADS,/arxiv_data1/oa_pdf/83/44/main.PMC4878319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/06/ae/main.PMC4878372.pdf
E-mail address: c-marelli@chu-montpellier.fr http://dx.doi.org/10.1016/j.dadm.2015.06.004 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/06/ae/main.PMC4878372.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/ae/main.PMC4878372.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.06.004 .,OADS,/arxiv_data1/oa_pdf/06/ae/main.PMC4878372.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.018 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 8 (2016) 18 e20,Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
"27 (1998) 257 e267, http://dx.doi.org/10.1016/S0889-8553(05)70356-3 .",Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
"Pavlidis, Coexistence of pregnancy and malignancy, Oncologist 7 (2002) 279e287, http://dx.doi.org/10.1634/theoncologist.2012-0432 .",Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
"23 (2013) 3485 e3500, http://dx.doi.org/10.1007/s00330-013-2987-7 .",Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
"274 (2006) 60 e62, http://dx.doi.org/10.1007/s00404-005-0097-8 .",Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
"Imaging 37 (2013) 501 e530, http://dx.doi.org/10.1002/jmri.24011 .",Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
http://www.ncbi.nlm.nih.gov/pubmed/24798674 .,Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
"112 (2008) 333 e340, http://dx.doi.org/10.1097/ AOG.0b013e318180a505 .R.R.",Non-OADS,/arxiv_data1/oa_pdf/d4/56/main.PMC4878457.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.019 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/7e/93/main.PMC4878458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 8 (2016) 6 e13,Non-OADS,/arxiv_data1/oa_pdf/7e/93/main.PMC4878458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/93/main.PMC4878458.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/2a/main.PMC4878459.pdf
The increased kainic acid resistance in adult Surf1/C0//C0mice and increased longevity in Surf1/C0//C0mice led us to hypothesize that cells from the Surf1/C0//C0mice would exhibit increased resistance toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.05.001 2213-2317/Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/a2/2a/main.PMC4878459.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/2a/main.PMC4878459.pdf
"The number of cells that  migrated into the scratched area were counted and the lengths  of wound were determined by Image J software, version 1.46   (http://imagej.nih.gov /ij/).",OADS,/arxiv_data1/oa_pdf/a1/08/mmr-13-06-4541.PMC4878554.pdf
"Remaining reads (length, ≥15 nt)  were aligned to the latest known human reference miRNA  precursor set [Sanger miRBase 19 (http://www.mirbase.org /)]  using Novoalign software (v2.07.11; http: //www.novocraft.",OADS,/arxiv_data1/oa_pdf/ea/d2/mmr-13-06-4969.PMC4878556.pdf
The intensities  of the bands were quantified  densi - tometrically using Image J software ( version 1.47) and were  matched compared to the control group and expressed as a  percent ( http://imagej.en.softonic.com /).,OADS,/arxiv_data1/oa_pdf/44/f0/mmr-13-06-5109.PMC4878564.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/da/main.PMC4878566.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.020 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b9/da/main.PMC4878566.pdf
The miRNA‑gene network was built to observe  closely associated miRNAs following TB infection using  Cytoscape (version 3.0.1; http://www.cytoscape.org /).,OADS,/arxiv_data1/oa_pdf/a6/bf/mmr-13-06-4620.PMC4878571.pdf
"1, e1165909 (8 pages)http://dx.doi.org/10.1080/21675511.2016.1165909",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"J Clin Oncol 2003;21:2636-44; PMID:12860938; http://dx.doi.org/10.1200/JCO.2003.11.136 [3] Remon J, Lianes P, Martinez S, Velasco M, Querol R, Zanui M. Malignant mesothelioma: new insights into a rare disease.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
Cancer Treat Rev 2013; 39:584-91; PMID:23276688; http://dx.doi.org/10.1016/j .ctrv.2012.12.005 [4] Tsao AS.,Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"J Thorac Oncol 2012; 7:S399- 400; PMID:23160333; http://dx.doi.org/10.1097/JTO.0b013e31826df254 [ 5 ]C e r e s o l iG L ,Z u c a l iP A ,G i a n o n c e l l iL ,L o r e n z iE , Santoro A. Second-line treatment for malignant pleural mesothelioma.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Cancer Treat Rev 2010; 36:24- 32; PMID:19879055; http://dx.doi.org/10.1016/j.ctrv.2009.09.003 [6] Okamoto I, Fukuoka M. S-1: a new oral ﬂuoropyrimidine in the treatment of patients with advanced non-small-celllung cancer.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Clin Lung Cancer 2009; 10:290-4;PMID:19632949; http://dx.doi.org/10.3816/CLC.2009.n.040 [7] Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, Saito H, Okabe H, Oyama K, Takeda S, et al.Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) againsthuman colon carcinoma orthotopically implanted intonude rats.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"J ClinOncol 2010; 28:5240-6; PMID:21079147; http://dx.doi.org/10.1200/JCO.2010.31.0326 [9] Yoshioka H, Okamoto I, Morita S, Ando M, Takeda K, Seto T, Yamamoto N, Saka H, Atagi S, Hirashima T, et al.",OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
Annals Oncol 2013; 24:1326-31;http://dx.doi.org/10.1093/annonc/mds629 [10] Hamamoto Y.,Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"IntCancer Conference J 2013; 2:17 –21; http://dx.doi.org/ 10.1007/s13691-012-0056-8 [11] Kaira K, Ohde Y, Nakagawa K, Okumura T, Murakami H, Takahashi T, Kondo H, Nakajima T, Endo M, Yama-moto N. Thymidylate synthase expression is closely asso-ciated with outcome in patients with pulmonaryadenocarcinoma.",OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Medical Oncol 2012; 29:1663-72; http://dx.doi.org/10.1007/s12032-011-0069-8 [12] Okuma Y, Shimokawa T, Takagi Y, Hosomi Y, Iguchi M, Okamura T, Shibuya M. S-1 is an active anticancer agentfor advanced thymic carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Lung cancer (Amster-dam, Netherlands) 2010; 70:357-63; PMID:20951466;http://dx.doi.org/10.1016/j.lungcan.2010.09.004 [13] Rusch VW.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Chest 1995; 108:1122-8; PMID:7555126; http://dx.doi.org/10.1378/chest.108.4.1122 [14] Byrne MJ, Nowak AK.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
Annals Oncol 2004; 15:257-60; http://dx.doi.org/10.1093/annonc/mdh059 [15] Inai K. Pathology of mesothelioma.,Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Environmental Health Preventive Med 2008; 13:60-4; http://dx.doi.org/ 10.1007/s12199-007-0017-6 [16] Nakano J, Huang C, Liu D, Masuya D, Nakashima T, Yokomise H, Ueno M, Wada H, Fukushima M. Eval-uations of biomarkers associated with 5-FU sensitiv-ity for non-small-cell lung cancer patientspostoperatively treated with UFT.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Br J Cancer 2006;95:607-15; PMID:16880781; http://dx.doi.org/ 10.1038/sj.bjc.6603297 [17] Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A,Nakamura Y, et al.",OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"J Clin Oncol2010; 28:3746-53; PMID:20625125; http://dx.doi.org/10.1200/JCO.2009.27.4662 [18] Kaira K, Serizawa M, Koh Y, Miura S, Kaira R, Abe M, Nakagawa K, Ohde Y, Okumura T, Murakami H, et al.Expression of thymidylate synthase, orotate phosphori-bosyltransferase and dihydropyrimidine dehydrogenasein thymic epithelial tumors.",OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Lung Cancer 2011; 74:419-25; PMID:21550686; http://dx.doi.org/10.1016/j.lungcan.2011.04.001 [19] Robinson BW, Musk AW, Lake RA.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Lancet 2005; 366:397-408; PMID:16054941; http://dx.doi.org/10.1016/S0140-6736(05)67025-0 [20] Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M. Thymidylate synthase, dihydropyrimi-dine dehydrogenase, orotate phosphoribosyltransferasemRNA and protein expression levels in solid tumors inlarge scale population analysis.",OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"Cancer Chemotherapy Pharmacol 2011; 68:497-504; http://dx.doi.org/10.1007/s00280-010-1503-x [22] Christoph DC, Asuncion BR, Mascaux C, Tran C, Lu X, Wynes MW, Gauler TC, Wohlschlaeger J, Thee-garten D, Neumann V, et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"J Thorac Oncol 2012; 7:1440-8; PMID:22895141; http://dx.doi.org/10.1097/JTO.0b013e318260deaa [23] Sakamoto E, Nagase H, Kobunai T, Oie S, Oka T, Fukushima M, Oka T. Orotate phosphoribosyltransferaseexpression level in tumors is a potential determinant ofthe ef ﬁcacy of 5- ﬂuorouracil.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
Biochem Biophysical Res Communications 2007; 363:216-22; http://dx.doi.org/10.1016/j.bbrc.2007.08.164[24] Diasio RB.,OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
"J Thorac Oncol2013; 8:469-77; PMID:23486267; http://dx.doi.org/10.1097/JTO.0b013e318283da3e [27] Mairinger F, Vollbrecht C, Halbwedl I, Hatz M, Stacher E, Gully C, Quehenberger F, Stephan-Falkenau S, Koll- meier J, Roth A, et al.",OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
J Thorac Oncol2013; 8:644-53; PMID:23449276; http://dx.doi.org/10.1097/JTO.0b013e318287c224e1165909-8 Y. HAMAMOTO ET AL.,Non-OADS,/arxiv_data1/oa_pdf/a5/8b/krad-04-01-1165909.PMC4878580.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055681.115.© 2016 Weng et al.,OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 22:813 –821; Published by Cold Spring Harbor Laboratory Press for the RNA Society 813",Non-OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
2013) or from http://johnlab.org/xpad/ (Lin et al.,Non-OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
"Allthe collected PASs, associated features and source code for predic-tion models are available at https://github.com/uci-cbcl/polyAcode.Deciphering the poly(A) code www.rnajournal.org 819",OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
"The com-plete list of features is available at https://github.com/uci-cbcl/polyAcode/blob/master/features_annotation.xls.Prediction models We applied several classifier models to distinguish tissue-specificand constitutive PASs based on the 658 RNA features and the se-quence context of each PAS, including logistic regression (LR), lin-ear support vector machine (LSVM) with regularization, SVM withWD-kernel (WDSVM), and Adaboost (adaptive boosting).Adaboost achieved the best performance and was used for down-stream analysis.",OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
All the prediction modelswere implemented using Python and Scikit-learn (http://jmlr.csail.mit.edu/papers/v12/pedregosa11a.html).,OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
The WDSVM model wasimplemented using shogun (http://www.shogun-toolbox.org/).,Non-OADS,/arxiv_data1/oa_pdf/50/7b/813.PMC4878608.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054882.115.© 2016 Ochi and Chiba This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b2/56/822.PMC4878609.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 822 RNA 22:822 –829; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/b2/56/822.PMC4878609.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055939.116.© 2016 Masamha et al.,OADS,/arxiv_data1/oa_pdf/30/db/830.PMC4878610.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/30/db/830.PMC4878610.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 830 RNA 22:830 –838; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/30/db/830.PMC4878610.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055780.115.© 2016 Talkish et al.,OADS,/arxiv_data1/oa_pdf/b8/ae/852.PMC4878612.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b8/ae/852.PMC4878612.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/b8/ae/852.PMC4878612.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.053272.115.This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.,Non-OADS,/arxiv_data1/oa_pdf/9e/4b/883.PMC4878614.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/9e/4b/883.PMC4878614.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055731.115.© 2016 Kalloush et al.,OADS,/arxiv_data1/oa_pdf/89/db/905.PMC4878616.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/89/db/905.PMC4878616.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/89/db/905.PMC4878616.pdf
The PCR efficiency of the MPMV assay was calculated using the online PCR efficiency calculator (http://srvgen.upct.es/index.html; Mallona et al.,OADS,/arxiv_data1/oa_pdf/89/db/905.PMC4878616.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055277.115.© 2016 Richardson and Znosko This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ac/f8/934.PMC4878618.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ac/f8/934.PMC4878618.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/8d/ndt-12-1229.PMC4878659.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1229–1231Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1229Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9442 6Low-dose aripiprazole for refractory burning  mouth syndrome Y ojiro Umezaki1 Miho Takenoshita2 akira T oyofuku2 1psychosomatic Dentistry Clinic,   Dental Hospital, 2psychosomatic  Dentistry, Graduate school of Medical  and Dental sciences, Tokyo Medical  and Dental University, T okyo, JapanAbstract:  We report a case of refractory burning mouth syndrome (BMS) ameliorated with  low dose of aripiprazole.",Non-OADS,/arxiv_data1/oa_pdf/f4/8d/ndt-12-1229.PMC4878659.pdf
"Based on the medication  effects, a candidal infection was excluded.Correspondence: Yojiro Umezaki psychosomatic Dentistry, Graduate  school of Medical and Dental sciences,  Tokyo Medical and Dental University,  1-5-45 Yushima, Bunkyo-ku, 113-8549  Tokyo, Japan email umezaki@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Umezaki et al Running head recto: Low-dose aripiprazole for refractory BMS DOI: http://dx.doi.org/10.2147/NDT.S94426",Non-OADS,/arxiv_data1/oa_pdf/f4/8d/ndt-12-1229.PMC4878659.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f4/8d/ndt-12-1229.PMC4878659.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/8d/ndt-12-1229.PMC4878659.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/aa/cia-11-683.PMC4878660.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 683–688Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  683OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10442 5Association between abdominal aortic plaque  and coronary artery disease Wei li1,2,* songyuan luo2,* Jianfang luo2 Yuan liu2 Wenhui huang2 Jiyan Chen2 1Department of Cardiology,   southern Medical University,   guangzhou, People’s republic of  China; 2Department of Cardiology,   guangdong Provincial Cardiovascular  Institute, guangdong general  hospital, guangdong Academy  of Medical sciences, guangzhou,   People’s  republic of China *These authors contributed equally  to this workObjective:  Currently, the association between abdominal aortic plaques and coronary artery  disease (CAD) has not yet been clarified clearly.",Non-OADS,/arxiv_data1/oa_pdf/26/aa/cia-11-683.PMC4878660.pdf
"As the prevalence of atherosclerosis increases glob - ally due to aging population, identifying atherosclerotic plaques will be of utmost  importance for early diagnosis and intervention, which will substantially decrease  the health care burden.1 Evidence is available indicating that subclinical atherosclerosis in carotid artery  is associated with the presence and severity of coronary artery disease (CAD) and  with an increased 10-year risk of cardiovascular events.2–5 The association between  thoracic aortic plaques and CAD has been often reported by using transesophageal Correspondence: Jianfang luo Department of Cardiology, guangdong  Provincial Cardiovascular Institute,  guangdong general hospital,  guangdong Academy of Medical  sciences, no 106, Zhongshan 2nd  road, guangzhou, guangdong 510080,  People’s republic of China Tel +86 20 8382 7812 email henryjfl@tom.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: Association between AAP and CAD DOI: http://dx.doi.org/10.2147/CIA.S104425",Non-OADS,/arxiv_data1/oa_pdf/26/aa/cia-11-683.PMC4878660.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/26/aa/cia-11-683.PMC4878660.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/26/aa/cia-11-683.PMC4878660.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f0/6a/cia-11-689.PMC4878661.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 689–697Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  689OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10478 3Factors associated with postoperative complications  and 1-year mortality after surgery for colorectal  cancer in octogenarians and nonagenarians  Y oung Wan Kim Ik Y ong Kim Division of Colorectal surgery,   Department of surgery, Yonsei  University Wonju College of Medicine,   Wonju, KoreaPurpose:  To identify the factors affecting 30-day postoperative complications and 1-year  mortality after surgery for colorectal cancer in octogenarians and nonagenarians.",Non-OADS,/arxiv_data1/oa_pdf/f0/6a/cia-11-689.PMC4878661.pdf
"Surgery is the primary treatment modality for colorectal cancer and is performed either  with curative intent or for problem solving when patients present with colon perforation Correspondence: Young Wan Kim Division of Colorectal surgery,  Department of surgery, Yonsei University  Wonju College of Medicine, 20 Ilsan-ro,  Wonju-si, gangwon-do 26426, Korea Tel +82 33 741 0573 Fax +82 33 741 0574 email youngwkim@yonsei.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim and Kim Running head recto: Surgery in octogenarians and nonagenarians DOI: http://dx.doi.org/10.2147/CIA.S104783",Non-OADS,/arxiv_data1/oa_pdf/f0/6a/cia-11-689.PMC4878661.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f0/6a/cia-11-689.PMC4878661.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f0/6a/cia-11-689.PMC4878661.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1b/ac/clep-8-097.PMC4878662.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1b/ac/clep-8-097.PMC4878662.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 97–107Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 97 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S96797 Epidemiological characteristics of chronic  fatigue syndrome/myalgic encephalomyelitis in  Australian patients Samantha C Johnston1,2 Donald R Staines1 Sonya M  Marshall-Gradisnik1,2 1National Centre for  Neuroimmunology and Emerging  Diseases, Menzies Health Institute Queensland,  2School of Medical  Sciences, Griffith University, Parklands,  QLD, AustraliaBackground: No epidemiological investigations have previously been conducted in Australia  according to the current clinical definitions of chronic fatigue syndrome/myalgic encepha- lomyelitis (CFS/ME).",Non-OADS,/arxiv_data1/oa_pdf/1b/ac/clep-8-097.PMC4878662.pdf
"Alternative criteria, Correspondence: Samantha C Johnston National Centre for Neuroimmunology and Emerging Diseases, Griffith Health Centre, Griffith University, Gold Coast Campus, Parklands Drive, QLD 4222, AustraliaTel +61 617 5678 9283Email samantha.johnston@griffith.edu.auJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Johnston et alRunning head recto: Epidemiological characteristics of CFS/ME in Australian patientsDOI: http://dx.doi.org/10.2147/CLEP .S96797",Non-OADS,/arxiv_data1/oa_pdf/1b/ac/clep-8-097.PMC4878662.pdf
Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.,OADS,/arxiv_data1/oa_pdf/1b/ac/clep-8-097.PMC4878662.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/1b/ac/clep-8-097.PMC4878662.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/04/ppa-10-863.PMC4878663.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2016:10 863–870Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  863OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7945 1Medication adherence in patients in treatment  for rheumatoid arthritis and systemic lupus  erythematosus in a university hospital in Brazil luciana resende Prudente1 Juliana de souza Diniz2 Tatyana Xavier Almeida  Matteucci Ferreira3 Dione Marçal lima2 nílzio Antônio silva4 guylherme saraiva4 erika Aparecida silveira4 nathalie de lourdes souza  Dewulf2 rita goreti Amaral2 1University Pharmacy, Faculty of  Pharmacy, 2Faculty of Pharmacy,   3clinical hospital, 4Faculty of  Medicine, Federal University of goiás,   goiânia, BrazilAbstract:  Medication adherence is essential for the control of symptoms and progression of rheuma - toid arthritis (RA) and systemic lupus erythematosus (SLE).",Non-OADS,/arxiv_data1/oa_pdf/71/04/ppa-10-863.PMC4878663.pdf
"For example, a study conducted in three  European countries in 2008 estimated that the annual cost in patients with hypertension  was €5,341, €2,682, and €5,957 in Germany, Spain, and Italy, respectively.5 Indirect correspondence: luciana resende  Prudente University Pharmacy, Faculty of  Pharmacy, Federal University of goiás,  University square 294, campusi,  74605-220, goiânia-goiás, Brazil Tel +55 62 3209 6459 Fax +55 62 3209 6459 email l resendeprudente@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Prudente et al Running head recto: Medication adherence in rheumatoid diseases DOI: http://dx.doi.org/10.2147/PPA.S79451",Non-OADS,/arxiv_data1/oa_pdf/71/04/ppa-10-863.PMC4878663.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/71/04/ppa-10-863.PMC4878663.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 159–162Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress 159 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S106494Discussion of causes and consequences of  sleepiness among college students, 2014  Brad Wolgast Center for Counseling and Student  Development, University of Delaware,  Newark, DE, USADear editor I was recently directed to, “Causes and consequences of sleepiness among college  students”, from Hershner and Chervin.1 As a psychologist who specializes in treating  college student sleep problems, I was very pleased to see this article.",Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
"While the US Food and Drug Administration tries to keep a control on energy  Correspondence: Brad Wolgast   University of Delaware,  Newark, 261 Perkins Student Center,   DE 19716, USAEmail bradw@udel.eduJournal name: Nature and Science of Sleep Article Designation: LETTERY ear: 2016V olume: 8Running head verso: WolgastRunning head recto: Causes and consequences of sleepiness among college studentsDOI: http://dx.doi.org/10.2147/NSS.S106494",Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
Available from http://www.caffeineinformer.com/complete-guide-to-dunkin-donuts-caffeine-content.,Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
Available from http://www.caffeineinformer.com/the-complete-guide-to-starbucks-caffeine.,Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
Available from: http://www.acha-ncha.org/ docs/NCHA-II%20FALL%202015%20REFERENCE%20GROUP%20EXECUTIVE%20SUMMAR Y .pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/da/nss-8-159.PMC4878664.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/85/tcrm-12-799.PMC4878665.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 799–806Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  799Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10251 8The potential utilizations of hydrogen as a promising  therapeutic strategy against ocular diseases Ye Tao1,* Lei Geng2,* wei-w ei Xu1 Li-Min Qin1 Guang-Hua Peng1 Yi-Fei Huang1 1Department of Ophthalmology,   2Department of Orthopaedics,   Chinese People’s Liberation Army  General Hospital, Ophthalmology &  visual Science Key Lab of PLA, Beijing,   People’s Republic of China *These authors contributed equally  to this workAbstract:  Hydrogen, one of the most well-known natural molecules, has been used in numerous  medical applications owing to its ability to selectively neutralize cytotoxic reactive oxygen  species and ameliorate hazardous inflammations.",Non-OADS,/arxiv_data1/oa_pdf/5e/85/tcrm-12-799.PMC4878665.pdf
"The beneficial effects induced by Correspondence: Yi-Fei Huang;  Guang-Hua Peng Department of Ophthalmology, Chinese  People’s Liberation Army General  Hospital, 28 Fuxing Road, Haidian  District, Beijing 100853, People’s  Republic of China Tel +86 10 6693 7943; +86 10 6693 7949 Fax +86 10 6828 6682; +86 10 6828 6637 email huangyf301@163.co m;  peng63088@163.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Tao et al Running head recto: Hydrogen as a promising therapeutic strategy against ocular diseases DOI: http://dx.doi.org/10.2147/TCRM.S102518",Non-OADS,/arxiv_data1/oa_pdf/5e/85/tcrm-12-799.PMC4878665.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5e/85/tcrm-12-799.PMC4878665.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/85/tcrm-12-799.PMC4878665.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/f6/ndt-12-1233.PMC4878666.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1233–1242Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1233OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10633 0effect of Jian-Pi-Zhi-Dong Decoction on striatal  glutamate and γ-aminobutyric acid levels detected  using microdialysis in a rat model of T ourette  syndrome Wen Zhang1,* li Wei2,* Wenjing Yu1 Xia cui1 Xiaofang liu2 Qian Wang1 sumei Wang2 1Department of Pediatrics, The Third  affiliated hospital, 2Department of  Pediatrics, Dongfang hospital, Beijing  University of chinese Medicine,   Beijing, People’s republic of china *These authors contributed equally  to this workBackground:  Jian-Pi-Zhi-Dong Decoction (JPZDD) is a dedicated treatment of Tourette  syndrome (TS).",Non-OADS,/arxiv_data1/oa_pdf/1b/f6/ndt-12-1233.PMC4878666.pdf
"Motor tics correspondence: sumei Wang Dongfang hospital, Beijing University of  chinese Medicine, No 6 Fangxingyuan,  Fengtai District, Beijing 100078, People’s  republic of china Tel +86 10 6768 9876 email wangsu_mei@hotmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zhang et al Running head recto: Anti-tic effects of JPZDD DOI: http://dx.doi.org/10.2147/NDT.S106330",Non-OADS,/arxiv_data1/oa_pdf/1b/f6/ndt-12-1233.PMC4878666.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1b/f6/ndt-12-1233.PMC4878666.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/f6/ndt-12-1233.PMC4878666.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 571–578Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  571OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9810 2Oral supplementation with a nutraceutical  formulation containing omega-3 fatty acids,  vitamins, minerals, and antioxidants in a large  series of patients with dry eye symptoms: results  of a prospective study Jordi gatell-T ortajada On behalf of the large Dry  eye Clinical study group  (lDeCsg) Cornea and Ocular surface  Department, Institut Català de retina,   Barcelona, spainPurpose:  To assess the benefits and tolerability of a dietary supplement based on omega-3  fatty acids to relieve dry eye symptoms.",Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
"It has been estimated that only 20% subjects with mild symptoms seek medical  care as compared to 50% of those with moderate disease and virtually all patients with  severe disease.3 In addition, the burden of dry eye disease to the patient is considerable  in relation to impact on visual function, daily activities, social and physical function - ing, workplace productivity, and health-related quality of life.4,5 Dry eye is a multifactorial disease of the tears and the ocular surface in which  dysfunction of the lacrimal functional unit with increased osmolarity of the tear film Correspondence: Jordi gatell-Tortajada Cornea and Ocular surface Department,  Institut Català de retina, ganduxer 117,  08022 Barcelona, spain Tel +34 93 254 7922 email jgatell@comb.ca t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gatell-Tortajada Running head recto: Omega-3 fatty acids in a large series of dry eye patients DOI: http://dx.doi.org/10.2147/CIA.S98102",Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
Available from: http://eur-lex.europa.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT 02128763?term =dream%26rank =5.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/cia-11-571.PMC4878667.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 787–797Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  787Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8384 4Critical evaluation of ceftolozane–tazobactam for  complicated urinary tract and intra-abdominal  infections Stephanie e Giancola1 Monica v Mahoney2 Tiffany e Bias3,4 elizabeth B Hirsch2,5 1Department of Pharmacy, St Mary’s  Medical Center, Huntington, wv, 2Beth  israel Deaconess Medical Center,   Boston, MA, 3Hahnemann University  Hospital, 4Drexel University College  of Medicine, Philadelphia, PA,   5Department of Pharmacy and Health  Systems Sciences, Northeastern  University, Boston, MA, USAAbstract:  The rise in resistant Gram-negative pathogens continues to challenge clinicians treating  infections.",Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
"Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae,  carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant (MDR)  P. aeruginosa  account for ~26,000, ~9,000, and ~6,700 health care-associated  infections, respectively, in the USA each year.2 Complicated urinary tract infections Correspondence: elizabeth B Hirsch Department of Pharmacy and Health  Systems Sciences, Northeastern  University, 360 Huntington Avenue,  R218 TF, Boston, MA 02115, USA Tel +1 617 373 7973 Fax +1 617 373 7655 email e.hirsch@neu.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Giancola et al Running head recto: Ceftolozane–tazobactam for cUTIs and cIAIs DOI: http://dx.doi.org/10.2147/TCRM.S83844",Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
Available from: http://www.zerbaxa.com/pdf/ PrescribingInformation .pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
"Avail - able from: http://www.fda.gov/Drugs/DrugSafety/ucm445919.ht m.  Accessed January 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/25/3e/tcrm-12-787.PMC4878668.pdf
"hawkins@childrens.harvard.edu Received 17 April 2015 Revised 8 September 2015 Accepted 10 September 2015 Published Online First 13 October 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004489▸http://dx.doi.org/10.1136/ bmjqs-2015-004827 To cite: Hawkins JB, Brownstein JS, Tuli G, et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Committee on Quality of Health Care in America, Institute of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
"Secondary Social Media Update 2014, 9 January2015; 2015. http://www.pewinternet.org/2015/01/09/social-media-update-2014/ 10 Hawn C. T ake two aspirin and tweet me in the morning: how T witter, Facebook, and other social media are reshaping healthcare.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
"Secondary Get Better Results with AmazonMechanical T urk Masters, 2011. https://aws.amazon.com/blogs/aws/amazon-mechanical-turk-master-workers/ 37 Viera AJ, Garrett JM.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
Secondary T extBlob: Simplified T ext Processing 2014. https://textblob.readthedocs.org/en/dev/index.html.,Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
Secondary pattern.en Documentation 2015. http://www.clips.ua.ac.be/pages/pattern-en 41 Medicare.gov.,Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
"measures, 2015. http://www.medicare.gov/hospitalcompare/ Data/30-day-measures.html?AspxAutoDetectCookieSupport=1 42 Centers for Medicare and Medicaid Services.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
"Secondary Frequently Asked Questions:CMS Publicly Reported Risk-Standardized Outcome andPayment Measures , 2015. http://www.qualitynet.org/dcs/ ContentServer?cid=1228774724512&pagename=QnetPublic%2FPage%2FQnetTier4&c=Page 43 Griffis MH, Kilaru SA, W erner MR, et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/bmjqs-2015-004309.PMC4878682.pdf
"This is an OpenAccess article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc- nd/4.0/), which permits non-commercial reproduction and distribution of thework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/c5/jiv598.PMC4878719.pdf
"In a collaboration initiated with the Broad Institute of MIT and Harvard, we have now determined the DNA sequence of >500 enterococcal genomes (availableat: https://olive.broadinstitute.org/pro jects/enterogenome ).",OADS,/arxiv_data1/oa_pdf/dc/c5/jiv598.PMC4878719.pdf
"Rock- ville, MD: Center for Veterinary Medicine, Foodand Drug Administration, Department of Healthand Human Services, 2014 .http://www.fda.gov/ downloads/ForIndustry/UserFees/AnimalDrug UserFeeActADUFA/UCM338170.pdf .",Non-OADS,/arxiv_data1/oa_pdf/dc/c5/jiv598.PMC4878719.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.11.002 2452-2473/Copyright ©2015 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/63/61/main.PMC4878730.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 111 e112,Non-OADS,/arxiv_data1/oa_pdf/63/61/main.PMC4878730.pdf
"Received 4  April  2015 Accepted  16  December  2015 Available online  3  February  2016 http://dx.doi.org/10.1016/j.bjhh.2015.12.003 1516-8484/©  2016  Associac ¸ã o  Brasileira  de  Hematologia, Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/main.PMC4878780.pdf
This  is  an  open  access  article  under  the  CC  BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/c3/main.PMC4878780.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Tonic –clonic seizure Visual hallucinationsTemporal lobe seizure 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/00/main.PMC4878784.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.001 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/00/main.PMC4878784.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/00/main.PMC4878784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Foxtail milletRNA-Seq Setalica italica TranscriptomeVariety Speci ﬁcations Organism/cell line/tissueFoxtail millet ( Setaria italica variety Taejin)/leaves Sex N.A.,Non-OADS,/arxiv_data1/oa_pdf/d9/48/main.PMC4878839.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRR3406552 forSetaria italica va- riety Taejin.,OADS,/arxiv_data1/oa_pdf/d9/48/main.PMC4878839.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.001 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/48/main.PMC4878839.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/48/main.PMC4878839.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Adzuki beanRNA-Seq Transcriptome VarietyVigna angularis Speci ﬁcations Organism/cell line/tissueAdzuki bean ( Vigna angularis )/leaves Sex N.A.,Non-OADS,/arxiv_data1/oa_pdf/05/4e/main.PMC4878840.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRR3406660 forVigna angularis variety Taejin Black.,Non-OADS,/arxiv_data1/oa_pdf/05/4e/main.PMC4878840.pdf
http://www.ncbi.nlm.nih.gov/sra/SRR3406553 forV.,Non-OADS,/arxiv_data1/oa_pdf/05/4e/main.PMC4878840.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.004 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/05/4e/main.PMC4878840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/4e/main.PMC4878840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/f9/main.PMC4878841.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.05.001 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b2/f9/main.PMC4878841.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RNA-SeqSorghum bicolor Transcriptome Variety Speci ﬁcations Organism/cell line/tissueSorghum ( Sorghum bicolor variety Taejin)/leaves Sex N.A.,Non-OADS,/arxiv_data1/oa_pdf/c1/e5/main.PMC4878842.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX1715644 forSorghum bicolor variety Taejin.,OADS,/arxiv_data1/oa_pdf/c1/e5/main.PMC4878842.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.002 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/c1/e5/main.PMC4878842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/e5/main.PMC4878842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.024 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 8 (2016) 21 e27,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
"Avail- able from:: http://www.medforum.pk/index.php/article-database/9-articles/ 92-treatment-and-incidence-of-recurrence-of-varicose-veins-of-lower-limb [5]M.J. Callam, Epidemiology of varicose veins, Br.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
Available from: https://www.nice.org.uk/ guidance/cg168/resources/varicose-veins-diagnosis-and-management- 35109698485957 [Cited 2016 Apr 20].,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
Available from: http://print.ispub.com/api/0/ispub-article/13926 .,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
intechopen.com/books/vascular-surgery-principles-and-practice/day-case- management-of-varicose-veins http://dx.doi.org/10.5772/51935 .,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
Available from: http://www.phlebolymphology.org/a-retrospective-study-of-100-patients-with-varicose-veins-treated-with-radiofrequency-ablation-and-stripping/ .,Non-OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
"Available from:: http://www.phlebologia.com/en/ saph_access.asp [Cited 2015 Sep 7] [19] J. Saarinen, V. Suominen, M. Heikkinen, R. Saaristo, R. Zeitlin, J. Vainio, I. Nordback, J.P. Salenius, The pro ﬁle of leg symptoms, clinical disability and reﬂux in legs with previously operated Varicose disease, Scand.",OADS,/arxiv_data1/oa_pdf/2a/98/main.PMC4878844.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/3c/main.PMC4878847.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.022 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5e/3c/main.PMC4878847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/db/main.PMC4878848.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.021 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/db/main.PMC4878848.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/1d/main.PMC4878922.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 86 e89 http://dx.doi.org/10.1016/j.radcr.2016.02.002 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/14/1d/main.PMC4878922.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/1d/main.PMC4878922.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/80/main.PMC4878923.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 116 e120 http://dx.doi.org/10.1016/j.radcr.2016.02.004 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/76/80/main.PMC4878923.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/80/main.PMC4878923.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/ad/main.PMC4878927.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 106 e109 http://dx.doi.org/10.1016/j.radcr.2015.12.007 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/ad/main.PMC4878927.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/ad/main.PMC4878927.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/0a/main.PMC4878929.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 45 e49 http://dx.doi.org/10.1016/j.radcr.2016.02.007 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/ee/0a/main.PMC4878929.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/0a/main.PMC4878929.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/8f/main.PMC4878930.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 78 e82 http://dx.doi.org/10.1016/j.radcr.2016.02.009 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/22/8f/main.PMC4878930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/8f/main.PMC4878930.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d1/main.PMC4878931.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 50 e53 http://dx.doi.org/10.1016/j.radcr.2016.02.017 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/eb/d1/main.PMC4878931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d1/main.PMC4878931.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/fd/main.PMC4878932.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 113 e115 http://dx.doi.org/10.1016/j.radcr.2016.02.018 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/fd/fd/main.PMC4878932.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/fd/main.PMC4878932.pdf
http://www.has- sante.fr/portail/upload/docs/application/pdf/2008-11/pnds_atr esie_oesophage_web.pdf .A c c e s s e d1 4N o v2 0 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/fd/fd/main.PMC4878932.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/ba/main.PMC4878933.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 74 e77 http://dx.doi.org/10.1016/j.radcr.2016.02.012 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/0d/ba/main.PMC4878933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/ba/main.PMC4878933.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/1e/main.PMC4878934.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 98 e101 http://dx.doi.org/10.1016/j.radcr.2016.02.014 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/5d/1e/main.PMC4878934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/1e/main.PMC4878934.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/75/main.PMC4878935.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 62 e66 http://dx.doi.org/10.1016/j.radcr.2016.02.010 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/82/75/main.PMC4878935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/75/main.PMC4878935.pdf
http://www.acr.org/Quality- Safety/Resources/LIRADS .,Non-OADS,/arxiv_data1/oa_pdf/82/75/main.PMC4878935.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC4878936.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 93 e97 http://dx.doi.org/10.1016/j.radcr.2016.02.019 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC4878936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC4878936.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/b6/main.PMC4878939.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 67 e69 http://dx.doi.org/10.1016/j.radcr.2016.02.006 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/95/b6/main.PMC4878939.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/b6/main.PMC4878939.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/5e/main.PMC4878946.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 70 e73 http://dx.doi.org/10.1016/j.radcr.2016.02.005 1930-0433/Copyright ©2016, the Author.",Non-OADS,/arxiv_data1/oa_pdf/fe/5e/main.PMC4878946.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/5e/main.PMC4878946.pdf
http://dx.doi.org/ 10.1093/jscr/rjt028 .,OADS,/arxiv_data1/oa_pdf/fe/5e/main.PMC4878946.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/06/main.PMC4878948.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 90 e92 http://dx.doi.org/10.1016/j.radcr.2016.02.001 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/a1/06/main.PMC4878948.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/06/main.PMC4878948.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/f2/main.PMC4878949.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 110 e112 http://dx.doi.org/10.1016/j.radcr.2016.02.003 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/2a/f2/main.PMC4878949.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/f2/main.PMC4878949.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/main.PMC4878950.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 121 e123 http://dx.doi.org/10.1016/j.radcr.2015.12.005 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/6f/f9/main.PMC4878950.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/main.PMC4878950.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/d5/main.PMC4878953.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 58 e61 http://dx.doi.org/10.1016/j.radcr.2016.02.015 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/b2/d5/main.PMC4878953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/d5/main.PMC4878953.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d3/main.PMC4878955.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 83 e85 http://dx.doi.org/10.1016/j.radcr.2016.03.001 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/eb/d3/main.PMC4878955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d3/main.PMC4878955.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/a2/main.PMC4878957.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 54 e57 http://dx.doi.org/10.1016/j.radcr.2016.02.016 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/c5/a2/main.PMC4878957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/a2/main.PMC4878957.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/f9/main.PMC4878958.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 11 (2016) 102 e105 http://dx.doi.org/10.1016/j.radcr.2016.02.013 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/f9/main.PMC4878958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/f9/main.PMC4878958.pdf
"Received:  April 15, 2015    Revised:  September 22, 2015     Accepted:  October 2, 2015    Available online:  February 17, 2016  Correspondence:  Elif Funda Sener, PhD Department of Medical Biology, Erciyes University Medical Faculty, Kayseri  38039, Turkey Tel: +90352 2076666-13600, Fax: +90352 4379316, E-mail:  efefunda@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.255",Non-OADS,/arxiv_data1/oa_pdf/a2/6a/pi-13-255.PMC4878959.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.265",Non-OADS,/arxiv_data1/oa_pdf/88/0e/pi-13-265.PMC4878960.pdf
"Received: February 24, 2015    Revised: May 15, 2015 Accepted:  May 15, 2015    Available online: January 11, 2016  Correspondence: Y asong Du, PhD  Department of Child & Adolescent Psychiatry, Shanghai Mental Health Cen- ter, Shanghai Jiaotong University School of Medicine, No.600 Wanping Road, Shanghai 200030, ChinaTel: +86-21-64387250-3420, Fax: +86-21-64387986, E-mail: nanzixie@126.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.277",Non-OADS,/arxiv_data1/oa_pdf/c4/1b/pi-13-277.PMC4878961.pdf
"Received:  February 25, 2015    Revised:  May 28, 2015 Accepted:  July 4, 2015    Available online:  January 8, 2016  Correspondence:  Fang-pei Chen, PhD Department of Social Welfare, National Chung-Cheng University, 168 Univer - sity Road, Minhsiung Township, Chiayi County 62102, Taiwan, ROC Tel: +886-5-272-0411, Fax: +886-5-272-0560, E-mail:  fc10311@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.288",Non-OADS,/arxiv_data1/oa_pdf/d8/d0/pi-13-288.PMC4878962.pdf
Available at: http://www.nhi.gov.tw/English/webdata/ webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_ id=4456.,Non-OADS,/arxiv_data1/oa_pdf/d8/d0/pi-13-288.PMC4878962.pdf
Available  at: http://www.culturementalhealth.com/wp-content/uploads/2013/10/ Stigma_TimeforAction_MHCommission.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/d0/pi-13-288.PMC4878962.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.297",Non-OADS,/arxiv_data1/oa_pdf/63/e5/pi-13-297.PMC4878963.pdf
Available at: http://www.nap.edu/.,Non-OADS,/arxiv_data1/oa_pdf/63/e5/pi-13-297.PMC4878963.pdf
"1 Friendship Road, Chongqing 400016, China Tel: +86-23-89012878, Fax: +86-23-89012878, E-mail: jlxfcn@126.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.305",Non-OADS,/arxiv_data1/oa_pdf/96/71/pi-13-305.PMC4878964.pdf
"Received:  May 12, 2015    Revised:  June 27, 2015    Accepted:  July 22, 2015    Available online:  January 11, 2016  Correspondence:  Omar Salem Gammoh, PhD Faculty of Health Sciences, American University of Madaba, King Road Street,  Al Muraijmeh, Madaba, Jordan Tel: +962 5 329 4444, Fax: +962 5 329 4440, E-mail:  o.gammouh@aum.edu.jo cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.3.311ORIGINAL ARTICLE   Copyright © 2016 Korean Neuropsychiatric Association   311",Non-OADS,/arxiv_data1/oa_pdf/c5/4a/pi-13-311.PMC4878965.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.316",Non-OADS,/arxiv_data1/oa_pdf/5d/48/pi-13-316.PMC4878966.pdf
"Received: May 14, 2015    Revised: August 23, 2015 Accepted:  August 23, 2015    Available online: January 8, 2016  Correspondence: Hong Jin Jeon, MD, PhD Department of Psychiatry, Depression Center, Samsung Medical Center, Sung- kyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul  06351, Republic of KoreaTel: +82-2-3410-3586, Fax: +82-2-3410-0050, E-mail: jeonhj@skku.edu cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.321",Non-OADS,/arxiv_data1/oa_pdf/83/0b/pi-13-321.PMC4878967.pdf
"386, Ta-Chung 1st Road, Kaohsiung, 81362, Taiwan, R.O.C.Tel: +886-7-3422121#2067, Fax: +886-7-3468346, E-mail: mdjim0814@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.327",Non-OADS,/arxiv_data1/oa_pdf/49/c6/pi-13-327.PMC4878968.pdf
"Received:  July 2, 2015    Revised:  August 19, 2015 Accepted:  August 20, 2015    Available online:  January 8, 2016  Correspondence:  Do-Hyung Kang, MD, PhD  Department of Neuropsychiatry, Seoul National University Hospital, 101 Dae - hak-ro, Jongno-gu, Seoul 03080, Republic of Korea Tel: +82-2-2072-0690, Fax: +82-2-747-9063, E-mail:  basuare@daum.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.333",Non-OADS,/arxiv_data1/oa_pdf/ce/ea/pi-13-333.PMC4878969.pdf
"Received: March 5, 2015    Revised: July 31, 2015 Accepted:  September 28, 2015    Available online: February 17, 2016  Correspondence: Doh Kwan Kim, MD, PhD Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea Tel: +82-2-3410-3582, Fax: +82-2-3410-0941, E-mail: paulkim@skku.edu cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.341",Non-OADS,/arxiv_data1/oa_pdf/ac/2c/pi-13-341.PMC4878970.pdf
"Received:  April 30, 2015    Revised:  September 15, 2015 Accepted:  September 15, 2015    Available online:  February 17, 2016  Correspondence:  Chang-Hwan Im, PhD  Department of Biomedical Engineering, Hanyang University, 222 Wangsim - ni-ro, Seongdong-gu, Seoul 04763, Republic of Korea Tel: +82-2-2220-2322, Fax: +82-2-2296-5943, E-mail:  ich@hanyang.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.349",Non-OADS,/arxiv_data1/oa_pdf/70/30/pi-13-349.PMC4878971.pdf
"Available from  Nature Precedings, http://precedings.nature.com/documents/3446/ version/1/files/npre20093446-1.pdf.",Non-OADS,/arxiv_data1/oa_pdf/70/30/pi-13-349.PMC4878971.pdf
"Received:  July 9, 2015    Revised:  September 21, 2015 Accepted:  October 2, 2015    Available online:  March 23, 2016  Correspondence:  Subin Park, MD, PhD Department of Research and Planning, National Center for Mental Health, 127  Y ongmasan-ro, Gwangjin-gu, Seoul 04933, Republic of Korea Tel: +82-2-2204-0108, Fax: +82-2-2204-0280, E-mail:  subin-21@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.360",Non-OADS,/arxiv_data1/oa_pdf/f1/c5/pi-13-360.PMC4878972.pdf
"Received: August 6, 2015    Revised: September 28, 2015 Accepted:  September 28, 2015    Available online: February 17, 2016  Correspondence: Hyun Kook Lim, MD, PhD  Department of Psychiatry, St. Vincent’s Hospital, College of Medicine, The  Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Re- public of KoreaTel: +82-31-249-8167, Fax: +82-31-248-6758, E-mail: drblues@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.364",Non-OADS,/arxiv_data1/oa_pdf/43/cb/pi-13-364.PMC4878973.pdf
"Considering the growing interest over the last decades into  shared pathophysiologies across psychiatric disorders, stud -LETTER TO THE EDITOR Comorbid Bipolar Disorder and Obsessive-Compulsive   Disorder: An Old Debate Renewed   Andrea Amerio1,2 , Matteo Tonna3, Anna Odone4, and S. Nassir Ghaemi2,5 1Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy 2Mood Disorders Program, Tufts Medical Center, Boston, MA, USA 3Department of Mental Health, Local Health Service, Parma, Italy 4Department of Biomedical, Biotechnological and Translational Sciences, Unit of Public Health, University of Parma, Parma, Italy 5Tufts University Medical School, Department of Psychiatry and Pharmacology, Boston, MA, USA Received:  October 7, 2015    Revised:  November 22, 2015 Accepted:  November 22, 2015    Available online:  March 23, 2016  Correspondence:  Andrea Amerio, MD Department of Clinical and Experimental Medicine, University of Parma, c/o  Ospedale Maggiore, Viale A. Gramsci 14, Parma 43126, Italy Tel: +39 0521 903594, Fax: +39 0521 347047 E-mail:  andrea.amerio@studenti.unipr.it cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.3.370",Non-OADS,/arxiv_data1/oa_pdf/97/46/pi-13-370.PMC4878974.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):157-162 http://dx.doi.org/10.3341/kjo.2016.30.3.157 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.157 Original ArticleSilicone tube intubation was first introduced by Keith [1],  who used the technique in patients with nasolacrimal duct obstruction as an alternative to dacryocystorhinostomy.",Non-OADS,/arxiv_data1/oa_pdf/12/e7/kjo-30-157.PMC4878975.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):163-171 http://dx.doi.org/10.3341/kjo.2016.30.3.163 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.163 Original ArticleDry eye syndrome (DES) is generally known as a multi - factorial disease, which includes lacrimal gland disorder,  neurotrophic deficiency, and meibomian gland dysfunction  [1].",Non-OADS,/arxiv_data1/oa_pdf/ab/60/kjo-30-163.PMC4878976.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):172-179 http://dx.doi.org/10.3341/kjo.2016.30.3.172 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.172 Original ArticleOxidative stress is involved in the pathogenesis of many  eye diseases, including dry eye syndrome, cataract, and  age-related macular degeneration [ 1-3].",Non-OADS,/arxiv_data1/oa_pdf/9a/68/kjo-30-172.PMC4878977.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):180-191 http://dx.doi.org/10.3341/kjo.2016.30.3.180 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.180 Original ArticleVisual Outcomes, Patient Satisfaction and Spectacle Independence  with a Trifocal Diffractive Intraocular Lens Florian Tobias Alwin Kretz1,2,3, Chul Young Choi1,4, Matthias Müller2,3, Matthias Gerl2,3, Ralf Helmar Gerl2,3,   Gerd Uwe Auffarth1,2 1International Vision Correction and Research Centre (IVCRC) & David J Apple International Laboratory of Ocular Pathology,  Department of Ophthalmology, University of Heidelberg, Heidelberg,  Germany 2International Vision Correction Research Network (IVCRC.net), Heidelberg, Germany 3Augenklinik Ahaus-Raesfeld-Rheine, Gerl Group, Ahaus, Germany 4Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine, Seoul, Korea Purpose:  To evaluate visual outcomes following implantation of a trifocal diffractive intraocular lens (IOL) and to  analyze their correlation with patient satisfaction and ease of performing daily tasks.",Non-OADS,/arxiv_data1/oa_pdf/00/fc/kjo-30-180.PMC4878978.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):192-197 http://dx.doi.org/10.3341/kjo.2016.30.3.192 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.192 Original ArticleSubmacular hemorrhage (SMH) is a common manifesta - tion of neovascular age-related macular degeneration  (nAMD).",Non-OADS,/arxiv_data1/oa_pdf/45/20/kjo-30-192.PMC4878979.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):198-205 http://dx.doi.org/10.3341/kjo.2016.30.3.198 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.198 Original ArticlePolypoidal choroidal vasculopathy (PCV) is a disorder  characterized by a branching vascular network and polyp -oidal lesions on indocyanine green angiography (ICGA)  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/92/6a/kjo-30-198.PMC4878980.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):206-213 http://dx.doi.org/10.3341/kjo.2016.30.3.206 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.206 Original ArticlePrimary angle closure (PAC) glaucoma is one of the  leading causes of blindness, especially in Asian eyes [1-3].",Non-OADS,/arxiv_data1/oa_pdf/a6/cc/kjo-30-206.PMC4878981.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):214-224 http://dx.doi.org/10.3341/kjo.2016.30.3.214 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.214 Original ArticleRefractive Errors in Koreans: The Korea National Health and  Nutrition Examination Survey 2008-2012 Tyler Hyungtaek Rim1, Seung-Hyun Kim2, Key Hwan Lim3, Moonjung Choi1, Hye Young Kim4*,   Seung-Hee Baek5*; Epidemiologic Survey Committee of the Korean Ophthalmological Society 1The Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea 3Department of Ophthalmology, Ewha Womans University School of Medicine, Seoul, Korea 4Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Korea 5Department of Ophthalmology, Kim ’s Eye Hospital, Myung-Gok Eye Research Institute, Konyang University College of Medicine, Seoul, Korea Purpose:  Our study provides epidemiologic data on the prevalence of refractive errors in all age group ≥5 years  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/98/f2/kjo-30-214.PMC4878982.pdf
"The Korea National Health and Nutrition Examination  Survey (KNHANES, http://knhanes.cdc.go.kr) is an annu - al nationally representative survey conducted by the Min - istry of Health and Welfare in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/98/f2/kjo-30-214.PMC4878982.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(3):225-233 http://dx.doi.org/10.3341/kjo.2016.30.3.225 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.225 Original ArticleMolteno introduced the modern glaucoma implant in  1969, and many different types and associated materials  have since been developed.",Non-OADS,/arxiv_data1/oa_pdf/bb/34/kjo-30-225.PMC4878983.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.234Primary Systemic Amyloidosis  Involving the Lacrimal Sac Dear Editor, Amyloidosis is a heterogeneous group of diseases char - acterized by extracellular amyloid deposits in different or - gans [1] .",Non-OADS,/arxiv_data1/oa_pdf/ee/5f/kjo-30-234.PMC4878984.pdf
The patient under -Korean J Ophthalmol 2016;30(3):234-235 http://dx.doi.org/10.3341/kjo.2016.30.3.234Correspondence  Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/5f/kjo-30-234.PMC4878984.pdf
"However, positional abnormalities due to lac -Korean J Ophthalmol 2016;30(3):236-237 http://dx.doi.org/10.3341/kjo.2016.30.3.236 Fig.",Non-OADS,/arxiv_data1/oa_pdf/b9/57/kjo-30-236.PMC4878985.pdf
"Go - nioscopy of his right eye revealed no angle structures 360°, Korean J Ophthalmol 2016;30(3):237-239 http://dx.doi.org/10.3341/kjo.2016.30.3.237",Non-OADS,/arxiv_data1/oa_pdf/b9/57/kjo-30-236.PMC4878985.pdf
"Go - nioscopy of his right eye revealed no angle structures 360°, Korean J Ophthalmol 2016;30(3):237-239 http://dx.doi.org/10.3341/kjo.2016.30.3.237",Non-OADS,/arxiv_data1/oa_pdf/a9/fc/kjo-30-237.PMC4878986.pdf
"C-reactive protein levels, as well as the e ryth- rocyte  sedimentation rate , were also elevated to be 14.5 Korean J Ophthalmol 2016;30(3):239-241 http://dx.doi.org/10.3341/kjo.2016.30.3.239",OADS,/arxiv_data1/oa_pdf/a9/fc/kjo-30-237.PMC4878986.pdf
"C-reactive protein levels, as well as the e ryth- rocyte  sedimentation rate , were also elevated to be 14.5 Korean J Ophthalmol 2016;30(3):239-241 http://dx.doi.org/10.3341/kjo.2016.30.3.239",OADS,/arxiv_data1/oa_pdf/82/ba/kjo-30-239.PMC4878987.pdf
"In the present studies, thedata obtained were imported to SNP and Variation Suite (SVS) 7.6.7 (Golden Helix, Bozeman, MT, USA; http://www.goldenhelix.com) for association analyses.",OADS,/arxiv_data1/oa_pdf/ca/95/mp2015172a.PMC4879118.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Genomic variants and ADHD endophenotypes CA Mastronardi et al 1440 Molecular Psychiatry (2016), 1434 –1440",Non-OADS,/arxiv_data1/oa_pdf/ca/95/mp2015172a.PMC4879118.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a7/d1/40291_2016_Article_193.PMC4879158.pdf
All critical care nurses and physicians were members of the ICU staff in the Aca - demic Medical Center.non-inferiority of nurse-led interhospital critical transport could not be established (http://www.controlled-trials.com/ ISRCTN39701540).,Non-OADS,/arxiv_data1/oa_pdf/ae/b0/134_2016_Article_4355.PMC4879164.pdf
http://www.anzca.edu.au/resources/professional-documents/pdfs/ps52-2015-guidelines-for-transport-of-critically-ill-patients.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ae/b0/134_2016_Article_4355.PMC4879164.pdf
http://connect.jems.com/forum/topics/critical-care-paramedic .,Non-OADS,/arxiv_data1/oa_pdf/ae/b0/134_2016_Article_4355.PMC4879164.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"Results of general analysis of fragmented CP1563 powder Analytical items Content Detection limit Analytical method Water 3.3 g/100 g /C1 Ambient-pressure heat method Protein 81.9 g/100 g /C1 Kjeldahl method Lipid 5.8 g/100 g /C1 Acid digestion method Ash 5.9 g/100 g /C1 Direct carburization method Carbohydrate 3.1 g/100 g /C1/C1 Energy 392 kcal/100 g /C1/C1 Sodium 0.441 g/100 g /C1 Atomic absorption method Arsenicum 0.5 ppm /C1 Atomic absorption method Heavy metals 5 ppm /C1 Sodium sulfide method Lead N.D. 0.05 ppm Atomic absorption methodCadmium 0.09 ppm /C1 Atomic absorption method Mercury N.D. 0.01 ppm Reduction vaporization atomic absorption method Standard plate count bacteria Negative 300/g Standard agar plate culture methodColiform bacteria Negative 1/2.22 g BGLB methodFungus Negative 10/g Potato dextrose agar plate culture method All analyses were performed at General Foundation Japan Food Research Laboratories (Tokyo, Japan).Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"Flow diagram of the trial.Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"Statistical signiﬁcance was determined according to the inter- action of the factor group /C29time using ANCOV A for repeated measures.Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"Statistical signiﬁcance was determined accor- ding to the interaction of the factor group /C29time using ANCOV A.Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"10 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"Statistical signiﬁcance was determined according to the interaction of the factor group /C29time using ANCOV A for repeated measures.Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"12 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"Statistical signiﬁcance was determined according to the inter- action of the factor group /C29time using ANCOV A for repeated measures.Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
doi: http://dx.doi.org/10.1007/s13340-015-0206-2:1-37 13.,Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"14 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
Microb Ecol Health Dis 2016; 27: 30259. doi: http://dx.doi.org/10.3402/mehd.v27.,Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
"30259Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism Citation: Microbial Ecology in Health & Disease 2016, 27: 30312 - http://dx.doi.org/10.3402/mehd.v27.30312 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ab/13/MEHD-27-30312.PMC4879181.pdf
Available at: http://www.mentalhealth.org.uk/ help-information/mental-health-a-z/D/diet/ (accessed on January 2016).,Non-OADS,/arxiv_data1/oa_pdf/f4/c0/mp201650a.PMC4879184.pdf
Approvedresearchers can obtain the SSC population data set described in this study byapplying at https://base.sfari.org.,OADS,/arxiv_data1/oa_pdf/20/f3/mp2015152a.PMC4879187.pdf
"Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) OPEN BDNF Val66Met genotype determines hippocampus-dependent behavior viasensitivity to glucocorticoid signaling Molecular Psychiatry (2016) 21,730–732; doi:10.1038/mp.2015.152; published online 6 October 2015 The BDNF gene Val66Met single-nucleotide polymorphism is carried by ~ 0.55% of Sub-Saharan Africans, 19.9% of Europeansand 43.6% of Asians, but may be carried by up to 72% of someSub-Asian population groups.",Non-OADS,/arxiv_data1/oa_pdf/20/f3/mp2015152a.PMC4879187.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Letters to the Editor 732 Molecular Psychiatry (2016), 724 –732 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/20/f3/mp2015152a.PMC4879187.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Inﬂammasome signaling affects behavior and gut microbiome composition M-L Wong et al 805 © 2016 Macmillan Publishers Limited Molecular Psychiatry (2016), 797 –805",Non-OADS,/arxiv_data1/oa_pdf/54/1f/mp201646a.PMC4879188.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.011,Non-OADS,/arxiv_data1/oa_pdf/9d/b1/main.PMC4879238.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,5 4–56 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/9d/b1/main.PMC4879238.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,5 4–56 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/9d/b1/main.PMC4879238.pdf
"ZIKAV strain MRS_OPY_- Martinique_PaRi_2015 was isolated after cytopathic effect (passage 1, day 3) on Vero cells (ATCC-CCL 81) from the patient ’s serum (available from the global European Virus Archive —http://global.european-virus-archive.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/e6/fb/main.PMC4879239.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.013,Non-OADS,/arxiv_data1/oa_pdf/e6/fb/main.PMC4879239.pdf
N Engl J Med 2016. http://dx.doi.org/10.1056/NEJMoa1600651 .,OADS,/arxiv_data1/oa_pdf/e6/fb/main.PMC4879239.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,5 2–53 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/fb/main.PMC4879239.pdf
However isolation of mucoid New Microbe and New Infect 2016; 11:57–58 © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.010,Non-OADS,/arxiv_data1/oa_pdf/19/26/main.PMC4879249.pdf
"Staphylococcus haemolyticus showing mucoid colonies.58 New Microbes and New Infections , Volume 11 Number C, May 2016 NMNI © 2016 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,11,5 7–58 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/19/26/main.PMC4879249.pdf
http://aphysics2.lanl.,Non-OADS,/arxiv_data1/oa_pdf/36/36/ncomms11652.PMC4879250.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/36/36/ncomms11652.PMC4879250.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Pico´n, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/36/36/ncomms11652.PMC4879250.pdf
- Korean J Orthod 2015;45:282-8 http://dx.doi.org/10.4041/kjod.2016.46.3.127127www.e-kjo.orgpIssN 2234-7518 eIssN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/a0/36/kjod-46-127.PMC4879314.pdf
"We  www.e-kjo.org http://dx.doi.org/10.4041/kjod.2016.46.3.127This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.believe that using the 2D standards is a valid and practical  alternative given the absence of consensus in 3D standard norms.",Non-OADS,/arxiv_data1/oa_pdf/a0/36/kjod-46-127.PMC4879314.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.129",Non-OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
"Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 130 http://dx.doi.org/10.4041/kjod.2016.46.3.129 INTRODUCTION   Dental study models are essential records for ortho- dontic diagnosis, planning, and treatment evaluations.",OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
"Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 131 http://dx.doi.org/10.4041/kjod.2016.46.3.129 materials according to their respective manufacturer’s  instructions, maxillary impressions of each subject were taken using a plastic impression tray (President Impression Tray System; Coltène/Whaledent AG, Altstätten, Switzerland).",Non-OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 132 http://dx.doi.org/10.4041/kjod.2016.46.3.129 first molar to the maxillary midline.,Non-OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 133 http://dx.doi.org/10.4041/kjod.2016.46.3.129 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 134 http://dx.doi.org/10.4041/kjod.2016.46.3.129 from the time point of 2 hours after the impression in  all three materials (Table 1).,OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 135 http://dx.doi.org/10.4041/kjod.2016.46.3.129 were no significant differences among the materials.,Non-OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
Jiang et al • Digital dental model from alginate impressions www.e-kjo.org 136 http://dx.doi.org/10.4041/kjod.2016.46.3.129 51.,Non-OADS,/arxiv_data1/oa_pdf/27/82/kjod-46-129.PMC4879315.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.137",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
"Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 138 http://dx.doi.org/10.4041/kjod.2016.46.3.137 INTRODUCTION   Epidemiology is defined as the study of the patterns,  causes, and effects of health and disease conditions in defined populations.",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
"Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 139 http://dx.doi.org/10.4041/kjod.2016.46.3.137 patients who did not undergo surgical procedures and  details of orthognathic surgeries, was obtained from the records of 4,861 patients for whom orthodontic treatment was initiated.",OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
"Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 140 http://dx.doi.org/10.4041/kjod.2016.46.3.137 patients exhibited Class I and Class II, with skeletal  Class III being the least frequent (31.4%; p = 0.002).",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 141 http://dx.doi.org/10.4041/kjod.2016.46.3.137 (Table 7).,OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
"Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 142 http://dx.doi.org/10.4041/kjod.2016.46.3.137 DISCUSSION   The characteristics of orthodontic patients gradually  change over time, warranting periodic epidemiologic studies.",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
"Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 143 http://dx.doi.org/10.4041/kjod.2016.46.3.137 treating orthodontic patients, rather than a decrease in  orthodontic treatment demand.",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 144 http://dx.doi.org/10.4041/kjod.2016.46.3.137 it decreased.,Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
Piao et al • Five-year investigation of large orthodontic population www.e-kjo.org 145 http://dx.doi.org/10.4041/kjod.2016.46.3.137 University.,Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kjod-46-137.PMC4879316.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.146",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
"Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 147 http://dx.doi.org/10.4041/kjod.2016.46.3.146 INTRODUCTION   Most orthodontic patients are adults, especially  women.",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 148 http://dx.doi.org/10.4041/kjod.2016.46.3.146 heating was 5oC/minute.,OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 149 http://dx.doi.org/10.4041/kjod.2016.46.3.146 also compact and homogeneous.,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 150 http://dx.doi.org/10.4041/kjod.2016.46.3.146 irradiation.,OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
"Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 151 http://dx.doi.org/10.4041/kjod.2016.46.3.146 activity, were chosen for the photocatalytic antibacterial  test under UV-A light irradiation, and the results are shown in Figure 6.",OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
"Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 152 http://dx.doi.org/10.4041/kjod.2016.46.3.146 acidophilus  and 15% for C. albicans , which exhibited the  best antimicrobial performance against both microbes  compared with the rest of the samples.",OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 153 http://dx.doi.org/10.4041/kjod.2016.46.3.146 assistance with devices used in this study.,OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
Cao et al • Antibacterial assay of ceramic brackets www.e-kjo.org 154 http://dx.doi.org/10.4041/kjod.2016.46.3.146 316L stainless steel.,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/kjod-46-146.PMC4879317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.155",Non-OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 156 http://dx.doi.org/10.4041/kjod.2016.46.3.155 INTRODUCTION   With increasing numbers of adult patients seeking  orthodontic care, it is becoming more common to treat patients with periodontal disease.",Non-OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 157 http://dx.doi.org/10.4041/kjod.2016.46.3.155 bone loss (0, 2, 4, and 6 mm) was assumed to be  equivalent in the buccolingual and mesiodistal direc - tions.",OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 158 http://dx.doi.org/10.4041/kjod.2016.46.3.155 total displacement of the apical root node was the  sum of the displacements in 3 dimensions, as shown in Figure 3C.",OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 159 http://dx.doi.org/10.4041/kjod.2016.46.3.155 was defined in reference to a previous study.5   For each inclination and simulated bone loss amount,  we plotted the relationship between the Mt/F ratio and  principal stresses on the PDL (Figure 5).",OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 160 http://dx.doi.org/10.4041/kjod.2016.46.3.155   The patterns of stress distributed over the root were  examined under conditions with an Mt/F value near  that of Mt/Fcont (Figure 6).",OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 161 http://dx.doi.org/10.4041/kjod.2016.46.3.155 CONCLUSION   When controlled tipping was applied to incisors,  alveolar bone loss and labial tooth inclination caused increases in the maximum compressive and tensile stresses at the root apices.",Non-OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"Choi et al • Controlled tipping, bone loss, and periodontal stress www.e-kjo.org 162 http://dx.doi.org/10.4041/kjod.2016.46.3.155 25.",Non-OADS,/arxiv_data1/oa_pdf/58/a9/kjod-46-155.PMC4879318.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.163",Non-OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 164 http://dx.doi.org/10.4041/kjod.2016.46.3.163 INTRODUCTION   There is a societal trend towards increased awareness  and emphasis on beauty and facial aesthetics.,Non-OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
"Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 165 http://dx.doi.org/10.4041/kjod.2016.46.3.163 of their shoulders, and their arms relaxed.",OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 166 http://dx.doi.org/10.4041/kjod.2016.46.3.163 of the box was later used as a parallel plane to the true  horizontal plane (THP) passing through nasion.,OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
"Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 167 http://dx.doi.org/10.4041/kjod.2016.46.3.163   (RE, random error; d, difference between the two  measurements; n, number of subjects)   Digitizing method errors were 0.53 mm for the NTVP  to A-point, 0.38 mm for the NTVP to B-point, and 0.46 mm from the NTVP to Pog (Table 1).",OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 168 http://dx.doi.org/10.4041/kjod.2016.46.3.163 treatment results.,OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
"Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 169 http://dx.doi.org/10.4041/kjod.2016.46.3.163 commonly, the image can be retaken.",Non-OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
Park et al • Assessment A–P jaw relationships using NTVP www.e-kjo.org 170 http://dx.doi.org/10.4041/kjod.2016.46.3.163 17.,OADS,/arxiv_data1/oa_pdf/62/f7/kjod-46-163.PMC4879319.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.171 171",Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
"Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 172 http://dx.doi.org/10.4041/kjod.2016.46.3.171 INTRODUCTION   To accomplish good occlusion with proper inter- digitation and a good vertical and horizontal relationship, there must be optimal mesiodistal (MD) dimensions with regard to the teeth and good seating of the occlusion.",Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
"The sample size for objectives 1−3 was calculated (PS software version 3.0; http://biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize) at a power of 80%, utilizing estimated standard deviations of 0.60 mm, 13 a  biologi cally meaningful mean difference of 0.3 mm, and  equal sample sizes.14 The calculated sample size was 128",OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 173 http://dx.doi.org/10.4041/kjod.2016.46.3.171 subjects (64 males and 64 females).,Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 174 http://dx.doi.org/10.4041/kjod.2016.46.3.171 of the study were the SMaxCPM and SMandCPM.,OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 175 http://dx.doi.org/10.4041/kjod.2016.46.3.171 Table 4.,Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
"Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 176 http://dx.doi.org/10.4041/kjod.2016.46.3.171 −1.744, and −1.290 mm in the maxillary arch for males  and females combined, males, and females respectively, and they were −0.260, −2.650, and −2.136 mm in the mandibular arch.",Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 177 http://dx.doi.org/10.4041/kjod.2016.46.3.171 between them.,Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 178 http://dx.doi.org/10.4041/kjod.2016.46.3.171   The current study investigated new formulas derived  via digital dental models.,Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
Shahid et al • Prediction of canine and premolar widths www.e-kjo.org 179 http://dx.doi.org/10.4041/kjod.2016.46.3.171 elaboration.,Non-OADS,/arxiv_data1/oa_pdf/3a/ef/kjod-46-171.PMC4879320.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSBrief Report pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.3.180",Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
www.e-kjo.org 181 http://dx.doi.org/10.4041/kjod.2016.46.3.181 INTRODUCTION   Developments in three-dimensional imaging and  manufacturing processes have made the customization of orthodontic appliances to improve treatment efficiency possible.,Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
"www.e-kjo.org 182 http://dx.doi.org/10.4041/kjod.2016.46.3.181 scanned 3 −5 months after the initial alignment.7 That  paper included a report of seven Suresmile® cases,  and a statistical comparison of the overall treatment times between cases treated with the Suresmile® system and conventionally treated patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
www.e-kjo.org 183 http://dx.doi.org/10.4041/kjod.2016.46.3.181 Table 1.,OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
"www.e-kjo.org 184 http://dx.doi.org/10.4041/kjod.2016.46.3.181 between the means included zero and this suggests no  significant difference.25   The efficiency of orthodontic treatment facilitated by Acceledent® devices has not been demonstrated in a reliable, independent, randomized, controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
Available from: http://acceledent.com/orthodontists/clinical-evidence.,Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
www.e-kjo.org 185 http://dx.doi.org/10.4041/kjod.2016.46.3.181 trial.,Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
Available from: http://kevinobrienorthoblog.com/acceledent-again-cyclic-vibration-accelerates-tooth-movement-a-clinical-trial.,Non-OADS,/arxiv_data1/oa_pdf/6f/3d/kjod-46-180.PMC4879321.pdf
"Information on the population size of mainland Portugal was provided by the Instituto Nacional deEstatística (http://www.ine.pt) and corresponds to esti- mates of the resident population at the end of each year, according to age and sex.",OADS,/arxiv_data1/oa_pdf/7c/9f/bmjdrc-2015-000181.PMC4879333.pdf
Diabetes: Factos e Números 2013 —Relatório Anual do Observatório Nacional da Diabetes 2013. http://www.apdp.pt/index.php/diabetes/factos-e-numeros/diabetes-factos-e-numeros-2013.,Non-OADS,/arxiv_data1/oa_pdf/7c/9f/bmjdrc-2015-000181.PMC4879333.pdf
http://www.cdc.gov/nchs/icd/icd9.htm.,Non-OADS,/arxiv_data1/oa_pdf/7c/9f/bmjdrc-2015-000181.PMC4879333.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ vetreco-2015-000166).,Non-OADS,/arxiv_data1/oa_pdf/2f/22/vetreco-2015-000166.PMC4879334.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES Brenten, T., Morris, P. J., Salt, C., Raila, J., Kohn, B., Brunnberg, L., Schweigert, F. J., Zentek, J.",Non-OADS,/arxiv_data1/oa_pdf/2f/22/vetreco-2015-000166.PMC4879334.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015- 000236).,Non-OADS,/arxiv_data1/oa_pdf/15/df/rmdopen-2015-000236.PMC4879337.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2016-000245).,Non-OADS,/arxiv_data1/oa_pdf/36/2d/rmdopen-2016-000245.PMC4879338.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2015-000234).,Non-OADS,/arxiv_data1/oa_pdf/b7/ff/rmdopen-2015-000234.PMC4879339.pdf
"OA was deﬁned on the basis of the clinical criteria of the American College of Rheumatology as presence of pain on most days of the prior month and at least three of the following criteria: 1age >50 years,2stiffness <30 min duration,3crepitus on active motion,4bony tenderness,5 bony enlargement,6no palpable warmth.10 Statistical analysis Data were analysed using SPSS V.20 (SPSS Inc, Chicago, Illinois, USA), Matlab version R2014a (MathWorks,Natick, Massachusetts, USA) and R V .3.0.1 (R founda- tion; http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/b7/ff/rmdopen-2015-000234.PMC4879339.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjresp-2015- 000102) Received 10 July 2015 Revised 5 September 2015 Accepted 7 September 2015 For numbered affiliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/c3/3c/bmjresp-2015-000102.PMC4879340.pdf
October 2010. http://guidance.nice.org.uk/CG101/Guidance/pdf/English ViewedJanuary 2014.3.,Non-OADS,/arxiv_data1/oa_pdf/c3/3c/bmjresp-2015-000102.PMC4879340.pdf
Oxygen Update April 2009. http://www2.warwick.ac.uk/fac/med/research/hsri/emergencycare/prehospitalcare/jrcalcstakeholderwebsite/clinicalpracticeupdates/oxygen_guideline_combined_final_published_version_22apr09sb.pdf (accessed Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/3c/bmjresp-2015-000102.PMC4879340.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2014-000009).,Non-OADS,/arxiv_data1/oa_pdf/4d/10/rmdopen-2014-000009.PMC4879342.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015- 000195).,Non-OADS,/arxiv_data1/oa_pdf/47/85/rmdopen-2015-000195.PMC4879343.pdf
2015. http://www.diliguide.nl/ document/3249/reumatoide-artritis.html 17.,Non-OADS,/arxiv_data1/oa_pdf/47/85/rmdopen-2015-000195.PMC4879343.pdf
Arthritis Rheumatol 2015;67. http://acrabstracts.org/ abstract/a-national-electronic-health-record-enabled-registry-in-rheumatology-the-acrs-rheumatology-informatics-system-for- effectiveness-rise/ 26.,Non-OADS,/arxiv_data1/oa_pdf/47/85/rmdopen-2015-000195.PMC4879343.pdf
"Efforts, such as DARPA’s “Big Mechanism” pro-gram (DARPA-BAA-14-14, http://www.ncbi.nlm.nih.gov/pubmed/26178259), are underway to advance this field.Until such tools become efficient, literature review remainsa bottleneck in the scoping process and focusing on keyaspects becomes critical.",Non-OADS,/arxiv_data1/oa_pdf/51/7c/PSP4-5-235.PMC4879472.pdf
78–80A list of tools that support dynamical systems analysis is currently available through the Dynamical Sys-tems website (http://www.dynamicalsystems.org/sw/sw/).,OADS,/arxiv_data1/oa_pdf/51/7c/PSP4-5-235.PMC4879472.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)A Six-Stage Workflow for Robust Application of Systems Pharmacology Gadkar et al.,OADS,/arxiv_data1/oa_pdf/51/7c/PSP4-5-235.PMC4879472.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Pharmacokinetic Modeling of Naloxegol Zhou et al .,OADS,/arxiv_data1/oa_pdf/94/48/PSP4-5-250.PMC4879473.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Mechanism of AZD3514-Induced Decrease in PSA Mistry et al.,Non-OADS,/arxiv_data1/oa_pdf/e3/c5/PSP4-5-258.PMC4879474.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)MBMA-Based Simulations of a Phase II HCC Trial Zierhut et al .,OADS,/arxiv_data1/oa_pdf/9d/e0/PSP4-5-274.PMC4879476.pdf
<http://www.ppgia.pucpr.br/ /C24alceu/ mestrado/aula3/PSO_2.pdf >(1995).,Non-OADS,/arxiv_data1/oa_pdf/7f/ba/PSP4-5-283.PMC4879477.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Prospective Design of Anti-Transferrin Receptor Bispecific Antibodies Kanodia et al .,Non-OADS,/arxiv_data1/oa_pdf/7f/ba/PSP4-5-283.PMC4879477.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6c/b7/main.PMC4879478.pdf
E-mail address: b.mcguinness@qub.ac.uk http://dx.doi.org/10.1016/j.dadm.2015.10.003 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/b7/main.PMC4879478.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/b7/main.PMC4879478.pdf
"Immediate and delayed memory: It was tested using the New York University immediate and delayed para- graph recall test (NYU 1 and 2, respectively) [19]and the paired associate learning (PAL) test from the Cam-bridge Neuropsychological Test Automated Battery(http://www.camcog.com/cantab-tests.asp ).",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/main.PMC4879478.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/13/main.PMC4879480.pdf
E-mail address: forlenza@usp.br http://dx.doi.org/10.1016/j.dadm.2015.09.003 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/13/main.PMC4879480.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/13/main.PMC4879480.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/5d/main.PMC4879481.pdf
E-mail address: Niklas.mattsson@med.lu.se http://dx.doi.org/10.1016/j.dadm.2015.09.001 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/5d/main.PMC4879481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/5d/main.PMC4879481.pdf
Available at: http://www.fda.gov/downloads/Drugs/Guid anceComplianceRegulatoryInformation/Guidances/UCM338287.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d2/5d/main.PMC4879481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/b6/main.PMC4879485.pdf
http://dx.doi.org/10.1016/j.dadm.2015.08.003A.R.,OADS,/arxiv_data1/oa_pdf/56/b6/main.PMC4879485.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/5d/main.PMC4879487.pdf
E-mail address: itarnanas@ethz.ch http://dx.doi.org/10.1016/j.dadm.2015.10.005 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/5d/main.PMC4879487.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/5d/main.PMC4879487.pdf
"As an illustration [24], proposed two computer- processable cause-and-effect models are based on the Bio-logical Expression Language ( http://www.openbel.org/ ), which support the automatic reasoning of interlinked mole-cules, and normal and abnormal biological processes.",Non-OADS,/arxiv_data1/oa_pdf/dd/5d/main.PMC4879487.pdf
All regional volumes were normalized by dividing by totalintracranial volume for each subject and calculated at base-line using FreeSurfer version 4.3 ( http://surfer.nmr.mgh.,OADS,/arxiv_data1/oa_pdf/dd/5d/main.PMC4879487.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/26/4e/main.PMC4879488.pdf
E-mail address: hossein.tabatabaei@anu.edu.au http://dx.doi.org/10.1016/j.dadm.2015.11.002 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/26/4e/main.PMC4879488.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/4e/main.PMC4879488.pdf
Available at: http://www.ohri.,Non-OADS,/arxiv_data1/oa_pdf/26/4e/main.PMC4879488.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/dd/main.PMC4879490.pdf
E-mail address: y.pijnenburg@vumc.nl http://dx.doi.org/10.1016/j.dadm.2015.11.001 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/dd/main.PMC4879490.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/dd/main.PMC4879490.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/main.PMC4879491.pdf
E-mail address: m.a.ikram@erasmusmc.nl http://dx.doi.org/10.1016/j.dadm.2015.10.004 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/main.PMC4879491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/ef/main.PMC4879491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/d6/main.PMC4879494.pdf
"Lp-PLA2is well recognized as both an inﬂammatory marker and a risk factor for coronary heart disease, stroke, and CVD http://dx.doi.org/10.1016/j.dadm.2015.08.001 2352-8729/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0e/d6/main.PMC4879494.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/d6/main.PMC4879494.pdf
E-mail address: isabelle.leber@upmc.fr http://dx.doi.org/10.1016/j.dadm.2015.10.002 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b8/main.PMC4879495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/main.PMC4879495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b8/main.PMC4879495.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.10.002 .,OADS,/arxiv_data1/oa_pdf/42/b8/main.PMC4879495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
1All the data used in preparation of this article were obtained from the ADNI database ( http://adni.loni.usc.edu ).,OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
A complete listing of ADNI in- vestigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/ how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
http://dx.doi.org/10.1016/j.dadm.2015.11.008 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
Additional details regarding data acqui-sition are available elsewhere ( http://www.adni-info.org ).,OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
Three-Tesla T1-weighted MRI images were processed using a standardMontreal Neurological Institute (MNI) anatomic pipeline (version 1.1.9; http://wiki.bic.mni.mcgill.ca/index.php/ CIVET ).,OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
The details of the acquisition are availableathttp://www.adni-info.org .,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.11.008 .,OADS,/arxiv_data1/oa_pdf/ba/2c/main.PMC4879518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/7c/main.PMC4879519.pdf
E-mail address: Lidia.Glodzik@nyumc.org http://dx.doi.org/10.1016/j.dadm.2016.02.007 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/7c/main.PMC4879519.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/7c/main.PMC4879519.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.02.007 .,OADS,/arxiv_data1/oa_pdf/22/7c/main.PMC4879519.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3a/b5/main.PMC4879643.pdf
E-mail address: ark5@nyu.edu http://dx.doi.org/10.1016/j.dadm.2016.01.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/b5/main.PMC4879643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/b5/main.PMC4879643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/e2/main.PMC4879644.pdf
E-mail address: azhou@u.washington.edu http://dx.doi.org/10.1016/j.dadm.2015.11.005 2352-8729/ /C2112016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/57/e2/main.PMC4879644.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.11.005 .,OADS,/arxiv_data1/oa_pdf/57/e2/main.PMC4879644.pdf
Available at: http://cran.r-project.org/ web/packages/quantreg/quantreg.pdf .,Non-OADS,/arxiv_data1/oa_pdf/57/e2/main.PMC4879644.pdf
Available at: http://cran.r-project.org/web/packages/lmtest/index.html .,Non-OADS,/arxiv_data1/oa_pdf/57/e2/main.PMC4879644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/cb/main.PMC4879645.pdf
E-mail address: esiemers@lilly.com http://dx.doi.org/10.1016/j.dadm.2016.02.006 2352-8729/ /C2112016 Eli Lilly and Company.,Non-OADS,/arxiv_data1/oa_pdf/9f/cb/main.PMC4879645.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/cb/main.PMC4879645.pdf
E-mail address: yen.lim@ﬂorey.edu.au http://dx.doi.org/10.1016/j.dadm.2015.11.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/main.PMC4879646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/94/main.PMC4879646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/94/main.PMC4879646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/ce/main.PMC4879647.pdf
E-mail address: c.carlson@lilly.com http://dx.doi.org/10.1016/j.dadm.2016.02.004 2352-8729/ /C2112016 Eli Lilly and Company.,Non-OADS,/arxiv_data1/oa_pdf/47/ce/main.PMC4879647.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/ce/main.PMC4879647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/main.PMC4879648.pdf
E-mail address: uc41483@uc.pt http://dx.doi.org/10.1016/j.dadm.2015.11.004 2352-8729/ /C2112016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/main.PMC4879648.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.11.004 .,OADS,/arxiv_data1/oa_pdf/5a/2c/main.PMC4879648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/77/1d/main.PMC4879649.pdf
A com-plete listing of ADNI investigators can be found at: http://adni.loni.usc/wp- content/uploads/how_to_apply/ADNI_Acknowledgment_List.pdf .,OADS,/arxiv_data1/oa_pdf/77/1d/main.PMC4879649.pdf
E-mail address: nagelero@rowan.edu http://dx.doi.org/10.1016/j.dadm.2016.03.002 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/1d/main.PMC4879649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/1d/main.PMC4879649.pdf
Participants with MCI were enrolled based on criteria outlined in the ADNI protocol ( http://www.adni-info.org/ Scientists/AboutADNI.aspx ).,OADS,/arxiv_data1/oa_pdf/77/1d/main.PMC4879649.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.03.002 .RESEARCH IN CONTEXT 1.,OADS,/arxiv_data1/oa_pdf/77/1d/main.PMC4879649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4879650.pdf
E-mail address: royall@uthscsa.edu http://dx.doi.org/10.1016/j.dadm.2016.02.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4879650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4879650.pdf
Serum samples were sent frozen to rules-based medicine (RBM) ( http://www.rulesbasedmedicine.,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4879650.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.02.003 .,OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4879650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/81/main.PMC4879652.pdf
E-mail address: ralph.n.martins@gmail.com http://dx.doi.org/10.1016/j.dadm.2015.12.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/81/main.PMC4879652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/81/main.PMC4879652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/af/main.PMC4879653.pdf
E-mail address: nzawia@uri.edu http://dx.doi.org/10.1016/j.dadm.2016.02.002 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/af/main.PMC4879653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/af/main.PMC4879653.pdf
Available at: http://www.ncbi.nlm.nih.gov/books/ NBK158766/ .,Non-OADS,/arxiv_data1/oa_pdf/f8/af/main.PMC4879653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/main.PMC4879654.pdf
E-mail address: c.teunissen@vumc.nl http://dx.doi.org/10.1016/j.dadm.2015.12.004 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/main.PMC4879654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/4f/main.PMC4879654.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2015.12.004 .,OADS,/arxiv_data1/oa_pdf/9f/4f/main.PMC4879654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/48/main.PMC4879655.pdf
A complete listing of ADNI investigatorscan be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_ apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/f0/48/main.PMC4879655.pdf
E-mail address: shlee@nki.rfmh.org http://dx.doi.org/10.1016/j.dadm.2016.01.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/48/main.PMC4879655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/48/main.PMC4879655.pdf
Subjects Data used in the preparation of this article were obtained from the ADNI database ( http://adni.loni.usc.edu ).,OADS,/arxiv_data1/oa_pdf/f0/48/main.PMC4879655.pdf
"CC segmentation The CC was segmented using our Automatic Registration Toolbox (ART) software module Yuki, available online (http://www.nitrc.org/projects/art ).",OADS,/arxiv_data1/oa_pdf/f0/48/main.PMC4879655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/e6/main.PMC4879657.pdf
E-mail address: shlomitbeker@gmail.com http://dx.doi.org/10.1016/j.dadm.2016.01.002 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/e6/main.PMC4879657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/e6/main.PMC4879657.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.01.002 .,OADS,/arxiv_data1/oa_pdf/15/e6/main.PMC4879657.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/15/e6/main.PMC4879657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/4c/main.PMC4879663.pdf
E-mail address: jens.pruessner@mcgill.ca http://dx.doi.org/10.1016/j.dadm.2015.11.007 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/4c/main.PMC4879663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/4c/main.PMC4879663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/e5/main.PMC4879664.pdf
E-mail address: clarkda@musc.edu http://dx.doi.org/10.1016/j.dadm.2016.02.001 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/19/e5/main.PMC4879664.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.02.001 .RESEARCH IN CONTEXT 1.,OADS,/arxiv_data1/oa_pdf/19/e5/main.PMC4879664.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/df/19/ircmj-18-03-21938.PMC4879759.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/ircmj-18-03-23131.PMC4879760.pdf
Avail - able from: http://sites.stat.psu.edu/~jls/misoftwa.html.,OADS,/arxiv_data1/oa_pdf/40/f9/ircmj-18-03-23131.PMC4879760.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cb/c6/ircmj-18-03-23847.PMC4879761.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c1/12/ircmj-18-03-23628.PMC4879762.pdf
Temperature 2016; 3:38-9; http://dx.doi.org/10.1080/23328940.2015.1111289;Bosland PW.,OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature 2016; 3:40-1; http://dx.doi.org/10.1080/23328940.2015.1130521;Caterina MJ.,OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Temperature 2016; 3:45-6; http://dx.doi.org/10.1080/23328940.2015.1133878;Gutierrez R, Simon SA.",OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature2016; 3:47-8; http://dx.doi.org/10.1080/23328940.2015.1119616;M/C19ozsik G. It remains a mystery why people living in hot climates consume spicier food.,Non-OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature 2016; 3:49-50; http://dx.doi.org/10.1080/23328940.2015.1131033;Thornton JS.,OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Temperature2016; 3:51-2; http://dx.doi.org/10.1080/23328940.2015.1130522 Dear Editor-in-Chief, This is my reply to the answers1-7submitted in response to my “puzzle ”as to “Why do people living in hot cli- mates consume more hot pepper than those living in the North?",Non-OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"1, 54 –55 http://dx.doi.org/10.1080/23328940.2016.1139964",Non-OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature 2016; 3:39-40; http://dx.doi.org/10.1080/23328940.2015.1111289 [2] Bosland PW.,OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature 2016; 3:43-5; http://dx.doi.org/10.1080/ 23328940.2016.1139963 [4] Chahl LA.,Non-OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Temperature 2016; 3:46-7; http://dx.doi.org/10.1080/23328940.2015.1133878[5] Gutierrez R, Simon SA.",OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature 2016; 3:48-9; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
Temperature 2016; 3:52-3; http://dx.doi.org/ 10.1080/23328940.2015.1130522 [8] Romanovksy AA.,OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Temperature 2015; 2:142-9; http://dx.doi.org/10.1080/23328940.2015.1047078 [9] Levey DJ, Tewksbury JJ, Cipollini ML, Carlo TA.",OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Oecolo- gia 2006; 150:61-8; PMID:16896774; http://dx.doi.org/10.1007/s00442-006-0496-y [10] Tewksbury JJ, Nabhan GP.",Non-OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Nature 2001; 412:403-4; PMID: 11473305; http://dx.doi.org/10.1038/35086653 [11] Billing J, Sherman PW.",OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"Quart Rev Biol 1998; 73:3-49; PMID: 9586227; http://dx.doi.org/10.1086/420058 [12] Molina-Torres J, Garc /C19ıa-Ch /C19avez A, Ram /C19ırez-Ch /C19avez E. Antimicrobial properties of alkamides present in ﬂavouring plants tra- ditionally used in Mesoamerica: af ﬁnin and capsaicin.",OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
J Ethnopharmacol 64:241-8; PMID:10363839; http://dx.doi.org/ 10.1016/S0378-8741(98)00134-2 [13] Too hot isn ’th e a l t h y –food with very high capsaicin concentrations can damage health.,Non-OADS,/arxiv_data1/oa_pdf/4f/fd/ktmp-03-01-1139964.PMC4879781.pdf
"1, 146 –160 http://dx.doi.org/10.1080/23328940.2016.1143760",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
J Hyg 1905; 5:494 –513; PMID:20474239; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
Acta Physiol Scand 1973; 89:342 –51; PMID:4767236; http://dx.doi.org/10.1111/j.1748-1716.,Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
J Appl Physiol 2006; 101:655 –63; PMID: 16565352; http://dx.doi.org/10.1152/japplphysiol.,Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
J ApplPhysiol 2006; 101:664 –8; PMID:16675613; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Respir Physiol1966; 1:193 –205; PMID:5911881; http://dx.doi.org/ 10.1016/0034-5687(66)90016-8 [13] Laitinen LA, Lindqvist A, Heino M. Lungs and ventila- tion in sauna.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Core temperature thresholds for hyperpnea during passive hyperthermia in humans.Eur J Appl Physiol 1995; 71:71 –6; PMID:7556135; http://dx.doi.org/10.1007/BF00511235 [16] Findlay JD, Ingram DL.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
J Appl Physiol 2008; 104:998 –1005; PMID: 18174395; http://dx.doi.org/10.1152/japplphysiol.,Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2012; 113:1388 –97; PMID: 22923504; http://dx.doi.org/10.1152/japplphysiol.00335.2012 [19] Hayashi K, Honda Y, Ogawa T, Kondo N, Nishiyasu T. Relationship between ventilatory response and body temperature during prolonged submaximal exercise.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Am J Physiol Regul Integr Comp Physiol 2012; 302:R94 –R102; PMID:21957164; http://dx.doi.org/ 10.1152/ajpregu.00048.2011 [21] Lucas RA, Ainslie PN, Fan JL, Wilson LC, Thomas KN, Cotter JD.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol 1972; 225:297 –308; PMID:4627523; http://dx.doi.org/10.1113/jphysiol.1972.sp009941 [23] Holmes RL, Newman PP, Wolstencroft JH.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol 1960; 152:93 –8; PMID:14402798; http://dx.doi.org/10.1113/jphysiol.1960.sp006472 [24] Tryba AK, Ramirez JM.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Neurophysiol 2003;89:2975 –83; PMID:12612007; http://dx.doi.org/10.1152/ jn.00743.2002 [25] Tryba AK, Ramirez JM.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Neurophysiol 2004; 92:2844 –52; PMID:15190095; http://dx.doi.org/ 10.1152/jn.00752.2003 [26] Eyzaguirre C, Zapata P. Perspectives in carotid body research.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Exp Physiol 2008; 93:994 –1001; PMID:18403444; http://dx.doi.org/10.1113/expphysiol.2008.042143 [28] Jessen C, Feistkorn G, Nagel A.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Med Sci Sports Exerc 1992; 24:303 –12; PMID:1549024; http://dx.doi.org/10.1249/00005768- 199203000-00005 [34] Kondo N, Takano S, Aoki K, Shibasaki M, Tominaga H, Inoue Y.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
